
<html lang="en"     class="pb-page"  data-request-id="c7c48ba7-7cfb-45ae-9a26-9ac401707df0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2016.59.issue-1;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b01562;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor" /></meta><meta name="dc.Creator" content="Shailesh N.  Mistry" /></meta><meta name="dc.Creator" content="Manuela  Jörg" /></meta><meta name="dc.Creator" content="Herman  Lim" /></meta><meta name="dc.Creator" content="Natalie B.  Vinh" /></meta><meta name="dc.Creator" content="Patrick M.  Sexton" /></meta><meta name="dc.Creator" content="Ben  Capuano" /></meta><meta name="dc.Creator" content="Arthur  Christopoulos" /></meta><meta name="dc.Creator" content="J. Robert  Lane" /></meta><meta name="dc.Creator" content="Peter J.  Scammells" /></meta><meta name="dc.Description" content="Positive allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits associated with diseases including ..." /></meta><meta name="Description" content="Positive allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits associated with diseases including ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 31, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01562" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01562" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01562" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01562" /></link>
        
    
    

<title>4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01562" /></meta><meta property="og:title" content="4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0007.jpeg" /></meta><meta property="og:description" content="Positive allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits associated with diseases including Alzheimer’s and schizophrenia. Herein, we report the design, synthesis, and characterization of a novel family of M1 mAChR PAMs. The most active compounds of the 4-phenylpyridin-2-one series exhibited comparable binding affinity to the reference compound, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA) (1), but markedly improved positive cooperativity with acetylcholine, and retained exquisite selectivity for the M1 mAChR. Furthermore, our pharmacological characterization revealed ligands with a diverse range of activities, including modulators that displayed both high intrinsic efficacy and PAM activity, those that showed no detectable agonism but robust PAM activity and ligands that displayed robust allosteric agonism but little modulatory activity. Thus, the 4-phenylpyridin-2-one scaffold offers an attractive starting point for further lead optimization." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01562"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01562">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01562&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01562&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01562&amp;href=/doi/10.1021/acs.jmedchem.5b01562" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 388-409</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01558" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01622" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M<sub>1</sub> Muscarinic Acetylcholine Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shailesh+N.++Mistry">Shailesh N. Mistry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++J%C3%B6rg">Manuela Jörg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herman++Lim">Herman Lim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natalie+B.++Vinh">Natalie B. Vinh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+M.++Sexton">Patrick M. Sexton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Capuano">Ben Capuano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur++Christopoulos">Arthur Christopoulos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Robert++Lane">J. Robert Lane</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Scammells">Peter J. Scammells</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Medicinal Chemistry and <sup>‡</sup>Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div><div class="corresp-info"><strong>*</strong>For P.J.S.: phone, +61 (0)3 9903 9542; E-mail, <a href="/cdn-cgi/l/email-protection#2474415041560a77474549494148485764494b4a45574c0a414051"><span class="__cf_email__" data-cfemail="c090a5b4a5b2ee93a3a1adada5acacb380adafaea1b3a8eea5a4b5">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For J.R.L.: phone, +61 (0)3 9903 9095; E-mail, <a href="/cdn-cgi/l/email-protection#92c0fdf0bcdef3fcf7d2fffdfcf3e1fabcf7f6e7"><span class="__cf_email__" data-cfemail="1f4d707d31537e717a5f7270717e6c77317a7b6a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01562&amp;href=/doi/10.1021%2Facs.jmedchem.5b01562" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 388–409</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 1, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 October 2015</li><li><span class="item_label"><b>Published</b> online</span>31 December 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01562" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01562</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D388%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShailesh%2BN.%2BMistry%252C%2BManuela%2BJ%25C3%25B6rg%252C%2BHerman%2BLim%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D1%26contentID%3Dacs.jmedchem.5b01562%26title%3D4-Phenylpyridin-2-one%2BDerivatives%253A%2BA%2BNovel%2BClass%2Bof%2BPositive%2BAllosteric%2BModulator%2Bof%2Bthe%2BM1%2BMuscarinic%2BAcetylcholine%2BReceptor%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D409%26publicationDate%3DJanuary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01562"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2014</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01562" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shailesh&quot;,&quot;last_name&quot;:&quot;N. Mistry&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Jörg&quot;},{&quot;first_name&quot;:&quot;Herman&quot;,&quot;last_name&quot;:&quot;Lim&quot;},{&quot;first_name&quot;:&quot;Natalie&quot;,&quot;last_name&quot;:&quot;B. Vinh&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;M. Sexton&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Capuano&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;Christopoulos&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Robert Lane&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Scammells&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;388-409&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01562&quot;},&quot;abstract&quot;:&quot;Positive allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits associated with diseases including Alzheimer’s and schizophrenia. Herein, we report the design, synthesis, and characterization of a novel family of M1 mAChR PAMs. The most active compounds of the 4-phenylpyridin-2-one series exhibited comparable binding affinity to the reference compound, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA) (1), but markedly improved positive cooperativity with acetylcholine, and retained exquisite selectivity for the M1 mAChR. Furthermore, our pharmacological characterization revealed ligands with a diverse range of activities, including modulators that displayed both high intrinsic efficacy and PAM activity, those that showed no detectable agonism but robust PAM activity and ligands that displayed robust allosteric agonism but little modulatory activity. Thus, the 4-phenylpyridin-2-one scaffold &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01562&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01562" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01562&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01562" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01562&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01562" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01562&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01562&amp;href=/doi/10.1021/acs.jmedchem.5b01562" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01562" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01562" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01562%26sid%3Dliteratum%253Aachs%26pmid%3D26624844%26genre%3Darticle%26aulast%3DMistry%26date%3D2016%26atitle%3D4-Phenylpyridin-2-one%2BDerivatives%253A%2BA%2BNovel%2BClass%2Bof%2BPositive%2BAllosteric%2BModulator%2Bof%2Bthe%2BM1%2BMuscarinic%2BAcetylcholine%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D1%26spage%3D388%26epage%3D409%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=291188" title="Cooperativity">Cooperativity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/jmcmar.2016.59.issue-1/20160114/jmcmar.2016.59.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Positive allosteric modulators (PAMs) of the M<sub>1</sub> muscarinic acetylcholine receptor (M<sub>1</sub> mAChR) are a promising strategy for the treatment of the cognitive deficits associated with diseases including Alzheimer’s and schizophrenia. Herein, we report the design, synthesis, and characterization of a novel family of M<sub>1</sub> mAChR PAMs. The most active compounds of the 4-phenylpyridin-2-one series exhibited comparable binding affinity to the reference compound, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA) (<b>1</b>), but markedly improved positive cooperativity with acetylcholine, and retained exquisite selectivity for the M<sub>1</sub> mAChR. Furthermore, our pharmacological characterization revealed ligands with a diverse range of activities, including modulators that displayed both high intrinsic efficacy and PAM activity, those that showed no detectable agonism but robust PAM activity and ligands that displayed robust allosteric agonism but little modulatory activity. Thus, the 4-phenylpyridin-2-one scaffold offers an attractive starting point for further lead optimization.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Selective activation of the M<sub>1</sub> mAChR may provide a useful approach for the treatment of the cognitive deficits associated with Alzheimer’s disease (AD) and schizophrenia (SZ).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Evidence of cholinergic loss in the cortex of AD patients and in the striatum of SZ patients suggested a link between mAChR function and disease pathology.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> The M<sub>1</sub> mAChR has received particular attention for its role in cognition. It is expressed predominantly in the hippocampus, striatum, and cortex, and activation of the receptor causes cognition-enhancing effects in animal models and M<sub>1</sub> mAChR knockout mice display a range of cognitive deficits.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15">(6-15)</a> In addition, both acetylcholinesterase (AChE) inhibitors and the M<sub>1</sub>/M<sub>4</sub> mAChR preferring agonist, xanomeline, improved cognitive function, and/or have antipsychotic efficacy in human patients of AD and SZ.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Unfortunately, both AChE inhibitors and xanomeline display limiting gastrointestinal side effects, likely due to their lack of selectivity across the muscarinic receptor subtype family and, in particular, action at the M<sub>2</sub> and M<sub>3</sub> mAChRs, which are widely expressed in the periphery.</div><div class="NLM_p">Unfortunately, the development of subtype-selective drugs that target the orthosteric site (i.e., the ACh binding site) remains challenging because this site is highly conserved across the mAChR receptor family. Therefore, considerable research efforts have focused upon targeting less conserved and spatially distinct allosteric sites with allosteric modulators, allosteric agonists, and bitopic ligands.<a onclick="showRef(event, 'ref7 ref8 ref9 ref14 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref14 ref19 ref20 ref21">(7-9, 14, 19-21)</a> 1-(4-Methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA) (<b>1</b>) is a prototypical example of a highly selective positive allosteric modulator (PAM) for the M<sub>1</sub> mAChR.<a onclick="showRef(event, 'ref9 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref9 ref22 ref23">(9, 22, 23)</a> Although <b>1</b> has a low affinity for the allosteric site on the M<sub>1</sub> mAChR, it nonetheless displays in vivo activity in animal models of cognitive deficits, an action most likely driven by very high positive cooperativity with ACh when both molecules are cobound on the receptor. We have recently published a SAR study of <b>1</b> that incorporated analytical modeling into our pharmacological analysis to relate PAM structural features to changes in allosteric ligand binding affinity (p<i>K</i><sub>B</sub>), intrinsic efficacy (τ<sub>B</sub>), cooperativity with ACh binding (α), and/or modulatory effects upon ACh efficacy (β). The standout analogue of this series, 5,8-difluoro-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>2</b>), demonstrated higher affinity, intrinsic efficacy, and functional cooperativity with ACh compared to <b>1</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Furthermore, the studies revealed a strong correlation between the intrinsic efficacy and cooperativity of this series of ligands, whereby the greater the level of allosteric agonism displayed by the modulator, the greater the level of observed cooperativity when combined with ACh.</div><div class="NLM_p">The findings with <b>1</b> and the aforementioned analogues adhere to the classic Monod–Wyman–Changeux (MWC) two-state model of allostery, which predicts a correlation between allosteric agonism and allosteric modulation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As with orthosteric agonists, the degree of allosteric agonism can also be dependent upon the pathway stimulus–response coupling efficiency and/or receptor density. However, to truly understand the relationship between in vitro measures of allosteric ligand behavior and the actual in vivo efficacy of such modulators, one needs a broader suite of M<sub>1</sub> mAChR PAMs that display a range of different allosteric behaviors. Indeed, a recent study revealed that two selective M<sub>1</sub> mAChR agonists could differentially regulate coupling of the M<sub>1</sub> mAChR to specific signaling pathways and lead to selective actions on some, but not all, M<sub>1</sub> mAChR mediated responses in brain circuits important for memory, learning and psychosis, a property not consistent with the MWC model and instead suggestive of pathway-biased allosteric modulation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Such region-specific effects may be therapeutically advantageous.</div><div class="NLM_p">We have recently combined site-directed mutagenesis and molecular modeling/docking experiments to infer the structural nature of the M<sub>1</sub> mAChR allosteric binding site to which compound <b>1</b> binds.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In particular, our results highlighted the role of Tyr179 within the second extracellular loop (ECL2) of the M<sub>1</sub> mAChR for binding via formation of hydrophobic/edge-to-face π–π interactions with both the bicyclic 4-oxo-1,2-dihydroquinoline core and the benzylic pendant moiety of <b>1</b>. Similarly, Trp400 at the top of transmembrane domain 7 (TM7) was predicted to make a π–π interaction with the benzylic pendant. Herein, we report the design, synthesis, and detailed pharmacological characterization of a novel family of positive allosteric modulators at the M<sub>1</sub> mAChR. The compound design was based on the desire to explore simpler heterocyclic cores that can maintain the key receptor–ligand interactions described above, in combination with formalizing the presence of the pseudo third ring present in <b>1</b> (due to intramolecular hydrogen bonding between the carboxylic acid and ketone moieties).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Accordingly, we devised the general scaffold depicted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conceptual development of the novel M<sub>1</sub> mAChR PAM scaffold starting from <b>1</b><a onclick="showRef(event, 'ref9 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref9 ref22 ref23">(9, 22, 23)</a> via 5,8-difluoro-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>2</b>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> to evolve to the general structure of the novel 4-phenylpyridin-2-one based compounds reported herein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The commercial availability of both 4-bromo-2-hydroxypyridine (<b>3</b>) and 1,2-cyclohexene oxide allowed easy access to both the pyridine derivative <b>4a</b> and the pyridin-2-one <b>4b</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Initially, we adapted a literature procedure that reported alkylation of <b>3</b> in the presence of K<sub>2</sub>CO<sub>3</sub> in DMF, giving a mixture of the <i>O</i>- and <i>N</i>-alkyl products.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> More specifically, heating compound <b>3</b> in a 2.5-fold excess of both K<sub>2</sub>CO<sub>3</sub> and 1,2-cyclohexene oxide in DMF at 120 °C overnight gave a mixture of the 2-alkoxypyridine (<b>4a</b>) and the <i>N</i>-alkylpyridin-2-one (<b>4b</b>). These isomers were easily separated based on their contrasting solubility profiles in EtOAc and the ability to remove remaining impurities through aqueous washing. While the overall yield was good, no selectivity was observed in terms of the site of alkylation with <b>4a</b> and <b>4b</b> being formed in a ∼1:1 ratio. In each case, only the <i>trans</i>-isomer was observed as a racemic mixture. The target alkylation products arose from the tautomeric nature of compound <b>3</b>, with the ability to exist in both the 2-hydroxypyridine (<b>3a</b>) and pyridin-2(1<i>H</i>)-one (<b>3b</b>) forms. Although crystallization studies on 2-pyridone have demonstrated the amide tautomer to predominate in the solid state,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> tautomerism in solution is heavily dependent on solvent nature.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> As a consequence, a solvent screen was performed to evaluate the preferred product formation (<b>4a</b> versus <b>4b</b>) after addition of 1,2-cyclohexene oxide. The nonpolar solvent toluene formed exclusively the 2-alkoxypyridine <b>4a</b> within 1 h at reflux. Polar solvents including DMF, ethanol, DME, and DMSO exhibited ratios between 30:70 and 70:30 of compounds <b>4a</b> and <b>4b</b>, and reaction times were generally about 1 day (as assessed by LC-MS). In water, no reaction was observed, while under neat conditions (using 10 equiv of reagent) after 1 h reaction time at 120 °C, a product ratio of ∼30:70 of compound <b>4a</b> versus <b>4b</b> was obtained. Hence, when the reaction was performed under neat conditions using 5 equiv of 1,2-cyclohexene oxide, the <i>N</i>-alkylpyridin-2-one (<b>4b</b>) was obtained in an improved isolated yield of 77%.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Initial Series of 4-Phenylpyridin-2-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,2-cyclohexene oxide, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 77% (rac-<i>trans</i>); (b) 2-hydroxyphenylboronic acid or 2-(4,4,5,5-tetramethyl-1,2,3-dioxaborolan-2-yl)aniline, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 83–100%; (c) substituted benzyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 18–93%; (d) NaOH, EtOH/H<sub>2</sub>O, 50 °C, 82–93%; (e) NH<sub>4</sub>OH/MeOH, rt, 14–52%; (f) boronic acid or boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 29–77%; (g) 4-bromobenzaldehyde, AcOH, NaB(OAc)<sub>3</sub>H, 1,2-dichloroethane, rt, 50%.</p></p></figure><div class="NLM_p">With the aim of identifying a tractable scaffold, we elected to first synthesize comparable examples by incorporating the scaffold of molecules <b>4a</b> and <b>4b</b> before embarking on a more in-depth SAR campaign. Initially, we carried out parallel Suzuki coupling of both <b>4a</b> and <b>4b</b> with 2-hydroxyphenylboronic acid in the presence of 10% PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> in 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF at 100 °C, giving the 2-arylphenol derivatives <b>5</b> and <b>7</b> in excellent yield after flash column chromatography (FCC). A 4-phenylbenzylic pendant was attached to the phenolic group of compounds <b>5</b> and <b>7</b>, on the basis of such a moiety imparting improvements in affinity (<i>K</i><sub>B</sub>) and binding cooperativity (α) with ACh in our previously reported enriched SAR study of <b>1</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This was achieved using Finkelstein-type modification of standard alkylation conditions, with catalytic KI, 4-(bromomethyl)biphenyl, and K<sub>2</sub>CO<sub>3</sub> in DMF at room temperature, to give the desired ethers <b>6</b> and <b>8a</b>.</div><div class="NLM_p">Subsequent analogues <b>8b</b>–<b>t</b> were synthesized as a parallel series in the same manner as compound <b>8a</b> by varying the nature of the alkyl halide used to alkylate phenol <b>7</b>. The methyl benzoate compounds <b>8o</b> and <b>8p</b> offered an ideal starting point to generate the corresponding benzoic acid (<b>9a</b> and <b>9b</b>) and benzamide (<b>9c</b> and <b>9d</b>) analogues through basic hydrolysis and direct aminolysis with NH<sub>4</sub>OH, respectively.</div><div class="NLM_p">While the 4-bromobenzyl derivative <b>8t</b> was of interest in building SAR around this series in its own right, it was also an attractive moiety to further elaborate the core structure. This was achieved through a second series of Suzuki couplings, with selected boronic acids and boronate esters, to give 4-arylbenzyl ether compounds <b>10a</b>–<b>d</b>.</div><div class="NLM_p">Finally, a focused selection of aniline derivatives <b>13a</b>–<b>e</b> was also synthesized to compare directly to the corresponding phenol analogue <b>8a</b> as well as <b>10a</b>–<b>d</b> and investigate activity in relation to the nature of atom used to link the benzylic pendant to the parent core. Installation of the aniline moiety was carried out using Suzuki chemistry as before, coupling 4-bromo-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>4b</b>) with 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline. Selective monoalkylation of the free aniline was achieved through established reductive alkylation methodology reported by Abdel-Magid et al.,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> employing 4-bromobenzaldehyde to introduce the benzylic pendant, giving 4-bromobenzylamino derivative <b>12</b>. Suzuki coupling of compound <b>12</b> with the previously selected group of boronic acids and boronate esters gave the desired analogues <b>13a</b>–<b>e</b>.</div><div class="NLM_p">A smaller second series of compounds was synthesized to investigate changes to the pyrazole moiety of compound <b>10d</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Therefore, the unsubstituted pyrazole derivative <b>14</b> was obtained via Suzuki reaction of intermediate <b>8t</b> with the <i>N</i>-Boc protected pyrazole boronic ester. These reaction conditions afforded the Boc deprotected product <b>14</b>, circumventing the need for an additional acid-mediated cleavage procedure to remove the Boc group. It is worth noting that compound <b>14</b> could not be synthesized efficiently when using (1<i>H</i>-pyrazol-4-yl)boronic acid, hence the use of the <i>N</i>-Boc protected pyrazole boronate ester. In the next step, alkylation of compound <b>14</b> afforded analogues <b>15a</b>–<b>j</b> in yields varying from 6 to 82%. Depending on the steric bulk of the alkyl halide the alkylation reactions proceeded at room temperature or at elevated temperatures of up to 100 °C. The alkylation with bromocyclobutane was unsuccessful even at elevated temperature and extended reaction time.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of a Series of <i>N</i>-Substituted Pyrazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(<i>tert</i>-butoxycarbonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 77%; (b) alkyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt to 100 °C, 6–82%.</p></p></figure><div class="NLM_p">We subsequently synthesized two additional compounds, <b>17</b> and <b>19</b>, incorporating modifications to the benzyl component of the 1-methylpyrazol-4-yl)benzyl pendant of <b>10d</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). This was achieved through initial alkylation of intermediate <b>7</b> with 2-chloro-5-(chloromethyl)pyridine or 4-bromo-1-(bromomethyl)-2-fluorobenzene, giving <b>16</b> and <b>18</b>, respectively. The desired analogues <b>17</b> and <b>19</b> were subsequently obtained via Suzuki coupling of <b>16</b> and <b>18</b> with 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues with Modifications to the 4-(1-Methylpyrazol-4-yl)benzyl Pendant<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) substituted benzyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 63% for <b>16</b>, 62% for <b>18</b>; (b) boronic acid/boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, THF degassed, 100 °C, 32% for <b>17</b>, 30% for <b>19</b>.</p></p></figure><div class="NLM_p">Next, we synthesized analogue <b>23</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), incorporating fluoro substituents in analogous positions to those present in <b>2</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which were previously shown to influence intrinsic efficacy in compounds of the 4-oxo-1,4-dihydroquinoline class.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The intermediate <b>4b</b> was coupled with the commercially available (3,6-difluoro-2-methoxyphenyl)boronic acid to afford a 1:1 mixture of <b>20</b> and an unidentified side product in an overall yield of 23% (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). <i>O</i>-Demethylation of intermediate <b>20</b> was achieved with BBr<sub>3</sub> to afford the corresponding phenol (<b>21</b>) in good yield. Purification of <b>21</b> via FCC permitted separation of the unidentified side product from the previous step. Alkylation with 1-bromo-4-(bromomethyl)benzene was performed at room temperature to give ether <b>22</b>, followed by a Suzuki coupling reaction with 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole at 100 °C to give <b>23</b> in modest yield.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Difluoro-substituted 4-Phenylpyridin-2-one <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 23% for <b>20</b>, 31% for <b>23</b>; (b) 1 M BBr<sub>3</sub> in hexane, DCM, 0 °C to rt, 72%; (c) 4-bromobenzyl bromide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 73%.</p></p></figure><div class="NLM_p">Finally, we synthesized the 6-phenylpyrimidin-4-one analogue <b>29</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). This analogue allowed us to probe if further interaction with the allosteric pocket of the M<sub>1</sub> mAChR can be achieved through the introduction of an additional hydrogen bond acceptor (tertiary nitrogen) to the scaffold. In the case of <b>29</b>, the order of the reaction steps was altered because the epoxide ring opening reaction with 1,2-cyclohexene oxide and 6-chloropyrimidin-4(3<i>H</i>)-one (<b>24</b>) did not afford the desired intermediate. The failure of this reaction may be explained by the preference for polymerization through the 6-chloro group over the epoxide ring opening reaction with 1,2-cyclohexene oxide. As a consequence, starting material <b>24</b> was first coupled with (2-methoxyphenyl)boronic acid to afford intermediate <b>25</b> in modest yield (20%) before subsequent reaction with 1,2-cyclohexene oxide to give compound <b>26</b>. LC-MS indicated the formation of the 4-alkoxypyrimidine and <i>N</i>-alkylpyrimidin-4-one (<b>26</b>) in an approximately 1:3 ratio. Nonetheless, only the <i>N</i>-alkylpyrimidin-4-one (<b>26</b>) could be isolated after FCC due to side products interfering with the 4-alkoxypyrimidine product. We then converted the 2-methoxyphenyl moiety to a phenol using boron tribromide to give intermediate <b>27</b> in good yield (87%). The last two steps involved alkylation with 1-bromo-4-(bromomethyl)benzene and Suzuki coupling with 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole under the same conditions as reported for the pyridinone analogues to give the desired 6-phenylpyrimidin-2-one <b>29</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the 6-Phenylpyrimidin-4-one Analogue <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (2-methoxyphenyl)boronic acid, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, THF degassed, 100 °C, 20%; (b) 1,2-cyclohexene oxide, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 38%; (c) 1 M BBr<sub>3</sub> in hexane, DCM, 0 °C to rt, 87%; (d) 4-bromobenzyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 55%; (e) boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, THF degassed, 100 °C, 11%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pharmacology</h3><div class="NLM_p">Our recent SAR study of <b>1</b> allowed us to correlate chemical modifications to changes in parameters that describe allosteric action at the M<sub>1</sub> mAChR. We applied the same approach in this study for selected intermediates and all final compounds. Competition binding studies between ACh and the radiolabeled antagonist [<sup>3</sup>H]NMS at the M<sub>1</sub> mAChR expressed in FlpIN CHO cells were performed in the absence and presence of increasing concentrations of test compound, and data were analyzed with an allosteric ternary complex model to determine the binding affinity of the test compound (<i>K</i><sub>B</sub>) for the unoccupied M<sub>1</sub> mAChR and its cooperativity with ACh (α). To assess the ability of our test compounds to modulate ACh function, we used myo-inositol 1 phosphate (IP<sub>1</sub>) accumulation as a measure of M<sub>1</sub> mAChR activation resulting from preferential activation of canonical G<sub>q</sub> proteins. Concentration–response curves of ACh were generated in the presence of increasing concentrations of test compound, and an operational model of allostery was applied to the data, with the <i>K</i><sub>B</sub> parameter fixed to that determined in the binding studies, thus allowing an overall estimate of functional cooperativity with ACh (αβ, where β describes the modulatory effect upon ACh efficacy) and any intrinsic efficacy (τ<sub>B</sub>) of the allosteric ligand. Values of α or β > 1 describe a positive modulatory effect upon ACh, whereas values <1 (but greater than 0) describe a negative allosteric effect. Because it is well established that the logarithms of affinity and cooperativity values are normally distributed, whereas their absolute values (antilogarithms) are not,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> all statistical comparisons for interpretation of the SAR described below (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) were performed on the logarithmic values. For ease of interpretation, however, allosteric parameter antilogarithms are also highlighted in the main text for selected key derivatives.</div><div class="NLM_p">As described in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, we devised a general molecular scaffold, distinct from that of <b>1</b>, that we hypothesized would maintain key receptor–ligand interactions. As a starting point, we compared the ether analogue <b>6</b> with the pyridinone analogue <b>8a</b> (both of which incorporate the 4-phenylbenzylic pendant). Compound <b>8a</b> displayed an affinity for the M<sub>1</sub> mAChR of approximately 10 μM and positive cooperativity with ACh binding and function. The affinity and cooperativity displayed by <b>8a</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) were not significantly different from that of <b>1</b> (<i>p</i> > 0.05, one way ANOVA), while the intrinsic efficacy of <b>8a</b> (τ<sub>B</sub> = 1.38) was superior to that of <b>1</b> (τ<sub>B</sub> = 0.22). In contrast, analogue <b>6</b> was inactive. As a consequence, compounds based on the 1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one moiety were further investigated (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), whereas the development of analogues containing a 2-(pyridin-2-yloxy)cyclohexan-1-ol moiety was discontinued.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding and Functional Parameters of 4-Phenylpyridin-2-one Analogues <b>7</b>, <b>8a</b>–<b>t</b>, <b>9a</b>–<b>d</b>, <b>10a</b>–<b>d</b>, <b>11</b>, <b>12</b>, and <b>13a</b>–<b>e</b> at the M<sub>1</sub> mAChR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0003.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">radioligand binding ([<sup>3</sup>H]NMS)</th><th class="rowsep1 colsep0" colspan="2" align="center">IP<sub>1</sub> accumulation</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">p<i>K</i><sub>B</sub> (<i>K</i><sub>B</sub>, μM)</th><th class="colsep0 rowsep0" align="center">Log α′<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">Log α (α)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Log αβ (αβ)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Log τ<sub>B</sub> (τ<sub>B</sub>)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">4.78 ± 0.06 (17)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.77 ± 0.13 (58)</td><td class="colsep0 rowsep0" align="center">1.84 ± 0.08 (69)</td><td class="colsep0 rowsep0" align="center">–0.60 ± 0.10 (0.22)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">4.10 ± 0.08 (79)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">–0.04 ± 0.11 (0.91)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-Ph</td><td class="colsep0 rowsep0" align="char" char="±">4.99 ± 0.10 (10)</td><td class="colsep0 rowsep0" align="center">–0.27 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.22 ± 0.07 (17)</td><td class="colsep0 rowsep0" align="center">1.09 ± 0.15 (12)</td><td class="colsep0 rowsep0" align="center">0.14 ± 0.04 (1.38)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">4.55 ± 0.10 (28)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.20 ± 0.08 (15)</td><td class="colsep0 rowsep0" align="center">0.94 ± 0.21 (9)</td><td class="colsep0 rowsep0" align="center">–0.24 ± 0.13 (0.58)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char="±">4.52 ± 0.07 (30)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.30 ± 0.10(20)</td><td class="colsep0 rowsep0" align="center">0.62 ± 0.26 (4)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–0.36 ± 0.16 (0.44)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char="±">4.38 ± 0.07 (41)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.50 ± 0.07 (31)</td><td class="colsep0 rowsep0" align="center">0.85 ± 0.26 (7)</td><td class="colsep0 rowsep0" align="center">–0.11 ± 0.12 (0.78)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8e</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="±">4.22 ± 0.01 (60)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.63 ± 0.07 (43)</td><td class="colsep0 rowsep0" align="center">1.15 ± 0.10 (14)</td><td class="colsep0 rowsep0" align="center">0.00 ± 0.24 (1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8f</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-OMe</td><td class="colsep0 rowsep0" align="char" char="±">4.53 ± 0.15 (30)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">0.53 ± 0.14 (3)</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8g</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="char" char="±">4.19 ± 0.02 (65)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.37 ± 0.05 (23)</td><td class="colsep0 rowsep0" align="center">0.84 ± 0.14 (7)</td><td class="colsep0 rowsep0" align="center">0.16 ± 0.04 (1.45)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8h</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="char" char="±">4.28 ± 0.10 (52)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.67 ± 0.09 (47)</td><td class="colsep0 rowsep0" align="center">0.80 ± 0.06 (6)</td><td class="colsep0 rowsep0" align="center">–1.10 ± 0.17 (0.08)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8i</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">4.48 ± 0.12 (33)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">–0.07 ± 0.22 (1)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">4.53 ± 0.17 (30)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.10 (7.9)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">= 0</td><td class="colsep0 rowsep0" align="center">0.01 ± 0.12 (1.02) </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8k</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">4.44 ± 0.10 (36)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.36 ± 0.11 (23)</td><td class="colsep0 rowsep0" align="center">0.40 ± 0.31 (2.5)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–0.11 ± 0.18 (0.77)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8l</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-CN</td><td class="colsep0 rowsep0" align="char" char="±">4.38 ± 0.07 (42)</td><td class="colsep0 rowsep0" align="center">–0.65 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.59 ± 0.08 (3.8)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8m</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="char" char="±">4.06 ± 0.14 (87)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.55 ± 0.11 (35) </td><td class="colsep0 rowsep0" align="center">0.88 ± 0.35 (8)</td><td class="colsep0 rowsep0" align="center">–0.59 ± 0.35 (0.25)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8n</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char="±">4.85 ± 0.13 (14)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–0.29 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.09 (7)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.49 ± 0.16 (3)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–0.73 ± 0.16 (0.19) </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8o</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char="±">3.99 ± 0.08 (100)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.49 ± 0.10 (31) </td><td class="colsep0 rowsep0" align="center">0.52 ± 0.22 (3)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–0.82 ± 0.28 (0.15)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8p</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char="±">4.06 ± 0.14 (87)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.32 ± 0.09 (21)</td><td class="colsep0 rowsep0" align="center">0.96 ± 0.28 (9)</td><td class="colsep0 rowsep0" align="center">–0.26 ± 0.18 (0.54)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8q</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-(oxazol-2-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.56 ± 0.08 (28)</td><td class="colsep0 rowsep0" align="center">–0.68 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.43 ± 0.09 (27)</td><td class="colsep0 rowsep0" align="center">1.61 ± 0.18 (41)</td><td class="colsep0 rowsep0" align="center">–0.24 ± 0.24 (0.57)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8r</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-(thiazol-2-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.96 ± 0.05 (11)</td><td class="colsep0 rowsep0" align="center">–0.45 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">1.40 ± 0.08 (25)</td><td class="colsep0 rowsep0" align="center">0.80 ± 0.19 (6)</td><td class="colsep0 rowsep0" align="center">–0.35 ± 0.13 (0.45)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8s</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-O-Ph</td><td class="colsep0 rowsep0" align="char" char="±">4.71 ± 0.08 (19)</td><td class="colsep0 rowsep0" align="center">–0.30 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.08 ± 0.10 (1)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8t</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="char" char="±">4.24 ± 0.11 (58)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.26 ± 0.15 (18)</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-COOH</td><td class="colsep0 rowsep0" align="char" char="±">4.04 ± 0.10 (91)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.38 ± 0.11 (24)</td><td class="colsep0 rowsep0" align="center">1.08 ± 0.06 (12)</td><td class="colsep0 rowsep0" align="center">–0.69 ± 0.09 (0.20)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-COOH</td><td class="colsep0 rowsep0" align="char" char="±">3.88 ± 0.06 (130)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.31 ± 0.09 (20)</td><td class="colsep0 rowsep0" align="center">0.92 ± 0.08 (8)</td><td class="colsep0 rowsep0" align="center">–1.24 ± 0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">4.04 ± 0.05 (91)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.46 ± 0.11 (29) </td><td class="colsep0 rowsep0" align="center">0.87 ± 0.09 (7)</td><td class="colsep0 rowsep0" align="center">–3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">4.66 ± 0.12 (22)</td><td class="colsep0 rowsep0" align="center">–0.86 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">2.51 ± 0.10 (320)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">2.36 ± 0.08 (230)</td><td class="colsep0 rowsep0" align="center">0.05 ± 0.08 (0.89)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-(pyrid-3-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.72 ± 0.09 (19)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">1.76 ± 0.11 (58)</td><td class="colsep0 rowsep0" align="center">1.29 ± 0.12 (19)</td><td class="colsep0 rowsep0" align="center">–0.42 ± 0.37 (0.38)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-(pyrid-4-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.95 ± 0.14 (11)</td><td class="colsep0 rowsep0" align="center">–0.76 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">1.49 ± 0.09 (31)</td><td class="colsep0 rowsep0" align="center">1.01 ± 0.29 (10)</td><td class="colsep0 rowsep0" align="center">–0.37 ± 0.19 (0.43)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-(pyrimid-5-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.45 ± 0.09 (35)</td><td class="colsep0 rowsep0" align="center">–0.37 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">1.56 ± 0.07 (36)</td><td class="colsep0 rowsep0" align="center">1.34 ± 0.28 (22)</td><td class="colsep0 rowsep0" align="center">–0.80 ± 0.35 (0.16)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-(1-methyl pyrazol-4-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.37 ± 0.07 (43)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">2.57 ± 0.17 (370)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">2.30 ± 0.08 (200)</td><td class="colsep0 rowsep0" align="center">–0.68 ± 0.15 (0.21)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">3.86 ± 0.06 (138)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">–0.01 ± 0.14 (1)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="char" char="±">4.35 ± 0.10 (45)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.08 (2)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-(pyrid-3-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.67 ± 0.04 (21)</td><td class="colsep0 rowsep0" align="center">–0.57 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.08 ± 0.05 (12)</td><td class="colsep0 rowsep0" align="center">0.47 ± 0.11 (3)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–0.13 ± 0.04 (0.74)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-(pyrid-4-yl)</td><td class="colsep0 rowsep0" align="char" char="±">5.03 ± 0.02 (9.3)</td><td class="colsep0 rowsep0" align="center">–0.69 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.90 ± 0.08 (8)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-(pyrimid-5-yl)</td><td class="colsep0 rowsep0" align="char" char="±">3.86 ± 0.10 (138)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">0.97 ± 0.19 (9)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.68 ± 0.16 (5)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.04 ± 0.05 (1.10)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-(1-methyl pyrazol-4-yl)</td><td class="colsep0 rowsep0" align="char" char="±">4.18 ± 0.07 (66)</td><td class="colsep0 rowsep0" align="center">–0.58 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">1.97 ± 0.04 (93)</td><td class="colsep0 rowsep0" align="center">1.44 ± 0.09 (28)</td><td class="colsep0 rowsep0" align="center">–0.36 ± 0.08 (0.44)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13e</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-Ph</td><td class="colsep0 rowsep0" align="char" char="±">4.16 ± 0.15 (69)</td><td class="colsep0 rowsep0" align="center">–0.30 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.44 ± 0.11 (2.8)*<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Binding cooperativity with [<sup>3</sup>H]NMS; for instances where a complete inhibition of [<sup>3</sup>H]NMS binding by the allosteric modulator was observed (consistent with a high level of negative cooperativity), Log α′ was fixed to −3.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Binding cooperativity with ACh.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Functional cooperativity with ACh.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Intrinsic efficacy of the modulator; for instances where no intrinsic efficacy was observed, Log τ<sub>B</sub> was fixed to −3.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">* = significant difference (<i>p</i> < 0.05) relative to same parameter determined for <b>1</b>, one-way ANOVA with Dunnett’s post-test. nd = inactive at concentrations up to 30 μM; values represent the mean ± SEM from at least three experiments performed in duplicate.</p></div></div></div><div class="NLM_p">Intermediate <b>7</b> exhibited a binding affinity not significantly different from that of <b>1</b> but essentially neutral binding cooperativity with ACh (α = 0.91), demonstrating that the 4-phenylbenzylic pendant is important for the positive cooperativity of compound <b>8a</b> with ACh. Interestingly, analogue <b>8b</b>, with an unsubstituted benzylic pendant (i.e., lacking the additional 4-phenyl group), maintained binding affinity and positive cooperativity with ACh comparable to that displayed by compound <b>8a</b>. Therefore, we investigated the effect of incorporating a range of substituted monocyclic ligands (compounds <b>8c</b>–<b>p</b> and <b>9a</b>–<b>d</b>) instead of the 4-phenylbenzylic pendant present in compound <b>8a</b>.</div><div class="NLM_p">While affinity was unchanged across these compounds, phenyl rings substituted at the <i>ortho</i>-position with methoxy, trifluoromethyl or nitrile groups (<b>8f</b>, <b>8i</b>, and <b>8l</b>, respectively) exhibited lower binding (α) and functional (αβ) cooperativity compared to the respective <i>meta</i>- and <i>para</i>-substituted analogues (<b>8g</b>–<b>h</b>, <b>8j</b>–<b>k</b>, and <b>8m</b>–<b>n</b>). While a similar trend was observed for the fluoro-substituted analogues (<b>8c</b>–<b>e</b>), this change was not significant. However, for the ester and carboxylic acid analogues (<b>8o</b>–<b>p</b> and <b>9a</b>–<b>b</b>), the <i>meta</i>-substituted analogue displayed similar activity to the corresponding <i>para</i>-substituted compound. The stand out compound of this series was the <i>para</i>-substituted carboxamide <b>9d</b>, which exhibited a binding affinity comparable to <b>1</b>, but significantly improved binding (α = 320) and functional (αβ = 230) cooperativity with ACh. The observed intrinsic efficacy (τ<sub>B</sub>) of compound <b>9d</b> was 4-fold greater than that of <b>1</b>. While the <i>meta</i>-substituted carboxamide analogue <b>9c</b> displayed binding and functional cooperativity with ACh comparable to that of <b>1</b>, it did not display any detectable allosteric agonism. Because of the promising properties of the carboxamide analogue <b>9d</b>, the structurally related oxazole <b>8q</b> and thiazole <b>8r</b> were also synthesized. However, both bioisosteres (<b>8q</b> and <b>8r</b>) displayed a significant reduction in binding cooperativity with ACh (α = 27 and α = 25, respectively) as compared to <b>9d</b>.</div><div class="NLM_p">Next, we investigated the effect of replacing the distal phenyl ring of the 4-phenylbenzyl moiety present on <b>8a</b> with a variety of bioisosteres. These included six-membered heterocycles (<b>10a</b>–<b>c</b>), a five-membered heterocycle (<b>10d</b>), and a simple bromo substituent (<b>8t</b>) that has previously been used as a phenyl isostere. All the compounds displayed a binding affinity not significantly different from that of <b>1</b> and comparable binding and functional cooperativity with ACh and intrinsic efficacy, with the notable exception of the pyrazole analogue <b>10d</b>, which displayed significantly improved binding cooperativity (α = 370) as compared to that of <b>1</b>. Incorporation of an oxygen atom between the two ring systems, as for the phenoxy analogue <b>8s</b>, resulted in total loss of the binding cooperativity with ACh but maintenance of affinity for the M<sub>1</sub> mAChR.</div><div class="NLM_p">We next investigated modification of the linker atom between the benzylic pendant and the parent core. A comparison of aniline analogues <b>12</b> and <b>13a</b>–<b>e</b> with the corresponding ether analogues <b>8t</b>, <b>10a</b>–<b>d</b>, and <b>8a</b>, respectively, revealed that this modification resulted in a reduction in binding and functional cooperativity with ACh but no change in affinity for the M<sub>1</sub> mAChR. The unsubstituted aniline intermediate <b>11</b> exhibited both an 8-fold reduction in binding affinity to that of <b>1</b> and neutral binding cooperativity (α = 0.98) with ACh, demonstrating the importance of the presence of the benzylic pendant linked to the parent core for the allosteric action of this series. Furthermore, in terms of binding cooperativity with ACh, the trend seen for the different ligands of the aniline series (<b>13d</b> > <b>13a</b> = <b>13c</b> = <b>13b</b> > <b>13e</b> = <b>12</b>) is similar to the trend observed for the ether analogues (<b>10d</b> > <b>10a</b> = <b>10c</b> = <b>10b</b> = <b>8a</b> = <b>8t</b>), whereby the 4-(1-methylpyrazol-4-yl) analogue was the most active compound in both series.</div><div class="NLM_p">None of the compounds in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> showed a significant improvement in intrinsic efficacy compared to <b>1</b>. However, it is interesting to note that both <b>8j</b> and <b>8k</b>, which display neutral functional cooperativity with ACh, still displayed robust allosteric agonism comparable to that of <b>1</b> (τ<sub>B</sub> = 1.02 and 0.77, respectively). Taking compound <b>10d</b> as the most active from this initial series, we then tested whether the novel compound displayed selectivity toward the M<sub>1</sub> mAChR. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, while both <b>1</b> and <b>10d</b> display robust modulatory activity at the M<sub>1</sub> mAChR in a [<sup>3</sup>H]NMS binding assay, they exhibit no activity up to a concentration of 10 μM at the other mAChR subtypes. As such, the novel 4-phenylpyridin-2-one scaffold appears to share the same exquisite selectivity for the M<sub>1</sub> mAChR as the benzyl-4-oxo-1,4-dihydroquinoline scaffold.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a–d) Pharmacological characterization of <b>1</b> and <b>10d</b> in binding and function at the mAChRs. (a,b) Radioligand binding experiments were performed using FlpIn-CHO cells expressing the M<sub>1</sub> mAChR, 0.1 nM of the radiolabeled antagonist [<sup>3</sup>H]NMS, increasing concentrations of ACh, with or without increasing concentrations of either <b>1</b> (a) or <b>10d</b> (b). (c,d) IP<sub>1</sub> accumulation experiments were performed using FlpIn-CHO cells expressing the M<sub>1</sub> mAChR and increasing concentrations of ACh with or without increasing concentrations of either compound <b>1</b> (c) or <b>10d</b> (d). 100% represents the maximal stimulation of ACh in the absence of test compound. (e–h) Activity of <b>1</b> and <b>10d</b> at the human M<sub>2–5</sub> mAChRs in a [<sup>3</sup>H]NMS binding assay. No detectable effect of these compounds was observed at the other mAChR subtypes up to a concentration of 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further studies were performed around the 4-(1-methylpyrazol-4-yl) analogue <b>10d</b>, which, together with carboxamide analogue <b>9d</b>, displayed the greatest level of positive cooperativity with ACh of the first series of compounds in both binding and function. We initially investigated the exchange of the methyl group with a hydrogen atom (<b>14</b>), linear and branched aliphatic carbon chains (<b>15a</b>–<b>e</b>), as well as cyclic unsaturated and aromatic substituents (<b>15f</b>–<b>j</b>) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The removal of the methyl group (compound <b>14</b>) caused a 120-fold loss in positive binding cooperativity with ACh in comparison to the methylpyrazole analogue <b>10d</b>. This dramatic effect could potentially be explained by the loss of an important hydrophobic interaction within the allosteric binding pocket or the change of the tautomeric properties of the pyrazole moiety. Of interest, this loss of binding and functional cooperativity was accompanied by a significant 5-fold increase in intrinsic efficacy (τ<sub>B</sub> = 1.10). Elongation of the chain length from the methyl (<b>10d</b>) to the ethyl (<b>15a</b>) derivative had no effect upon affinity or cooperativity with ACh. However, a loss in binding cooperativity was observed with further extension to the propyl (<b>15c</b>, <i>α = </i> 40; 10-fold loss) and isopropyl (<b>15d</b>, α = 120; 3-fold loss) and, most dramatically, the <i>n</i>-butyl derivate (<b>15e</b>, α = 6; 120-fold loss). In contrast, no significant change in intrinsic efficacy was observed. The hydroxethyl derivative <b>15b</b> showed comparable cooperativity with ACh compared to that of the methyl and ethyl pyrazole (<b>10d</b> and <b>15a</b>). The incorporation of cyclic unsaturated and aromatic substituents (<b>15f</b>–<b>j</b>) caused a decrease in binding cooperativity with ACh as compared to <b>10d</b> with the most dramatic effect being the 170-fold decrease observed upon incorporation of a benzyl group (<b>15j</b>). Interestingly, compounds with larger cyclic aliphatic substituents attached to the pyrazole moiety, such as compounds <b>15f</b> and <b>15g</b>, exhibited higher ligand binding affinity (<i>K</i><sub>B</sub> < 10 μM) but with no improvement of binding and functional cooperativity. In the case of <b>15h</b>, the lack of intrinsic efficacy was also noteworthy.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding and Functional Allosteric Parameters of Pyrazole Analogues <b>10d</b>, <b>14</b>, and <b>15a</b>–<b>j</b> at the M<sub>1</sub> mAChR<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0004.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0005.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Binding cooperativity with [<sup>3</sup>H]NMS; for instances where a complete inhibition of [<sup>3</sup>H]NMS binding by the allosteric modulator was observed (consistent with a high level of negative cooperativity), Log α′ was fixed to −3;</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Binding cooperativity with ACh.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Functional cooperativity with ACh.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Intrinsic efficacy of the modulator; for instances where no intrinsic efficacy of the modulator was observed Log τ<sub>B</sub> was fixed to −3.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">* = significant difference (<i>p</i> < 0.05) relative to same parameter determined for <b>10d</b>, one-way ANOVA with Dunnett’s post-test. nd = inactive at concentrations up to 30 μM; values represent the mean ± SEM from at least three experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_p">We subsequently investigated compounds with small changes to the parent core of the 4-(1-methylpyrazol-4-yl) analogue <b>10d</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Compound <b>17</b>, which incorporates a 2-(1-methylpyrazol-4-yl)pyridinyl moiety, exhibited comparable binding cooperativity with ACh as compared to that of <b>10d</b> but, of particular interest, displayed no detectable intrinsic efficacy. The 2-fluorobenzyl analogue <b>19</b> did not exhibit a change in binding cooperativity or intrinsic efficacy as compared to compound <b>10d</b>. Intermediate <b>18</b> displayed a substantial reduction in binding cooperativity as compared to <b>10d</b>, demonstrating the importance of the 4-(1-methylpyrazol-4-yl) substituent of compound <b>19</b>. In comparison, the introduction of fluoro groups to analogues of <b>1</b> at the corresponding positions to those in compound <b>2</b> (see <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), translated to a small improvement of potency.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Our earlier work demonstrated that the introduction of 5,8-difluoro groups to the 4-oxo-1,4-dihydroquinoline core of <b>1</b> increased intrinsic activity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The introduction of the corresponding 3,6-difluoro groups to our novel 4-phenylpyridin-2-one scaffold (compound <b>23</b>) caused a 60-fold decrease in binding cooperativity (α = 6) but a significant 6-fold increase in intrinsic efficacy (τ<sub>B</sub> = 1.34). Finally, we investigated the effect of adding an additional nitrogen atom, therefore changing the pyridine-2(1<i>H</i>)-one core to a pyrimidin-4(3<i>H</i>)-one core. Although no gain in affinity for the M<sub>1</sub> mAChR was observed, <b>29</b> was the standout compound of the series displaying a 4-fold increase in binding cooperativity with ACh and a 11-fold increase in intrinsic efficacy as compared to <b>10d</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Furthermore, compound <b>29</b> displays a similar affinity as reference compound <b>1</b>, but a significant 24-fold increase in binding cooperativity with ACh and a 11-fold increase in intrinsic activity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding and Functional Allosteric Parameters at the M<sub>1</sub> mAChR of 4-(1-Methylpyrazol-4-yl) Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0006.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">radioligand binding ([<sup>3</sup>H]NMS)</th><th class="rowsep1 colsep0" colspan="2" align="center">IP<sub>1</sub> accumulation</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">W</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center" char="±">p<i>K</i><sub>B</sub><i>(K</i><sub>B</sub>, μM)</th><th class="colsep0 rowsep0" align="center">Log α′<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">Log α <b>(</b>α<b>)</b><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Log αβ (αβ)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Log τ<sub>B</sub> (τ<sub>B</sub>)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">4.37 ± 0.07 (43)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">2.57 ± 0.17 (370)</td><td class="colsep0 rowsep0" align="center">2.30 ± 0.08 (200)</td><td class="colsep0 rowsep0" align="center">–0.68 ± 0.15 (0.21)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">4.45 ± 0.26 (35)</td><td class="colsep0 rowsep0" align="center">–0.09 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">0.48 ± 0.19 (3)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.68 ± 0.16 (5)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.04 ± 0.05 (1.09)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char="±">4.50 ± 0.04 (32)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">2.10 ± 0.02 (125) </td><td class="colsep0 rowsep0" align="center">2.15 ± 0.09 (141) </td><td class="colsep0 rowsep0" align="center">–3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">4.75 ± 0.10 (18)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">0.75 ± 0.14 (6)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">4.51 ± 0.08 (31)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">2.24 ± 0.17 (174)</td><td class="colsep0 rowsep0" align="center">1.93 ± 0.11 (85)</td><td class="colsep0 rowsep0" align="center">–0.37 ± 0.14 (0.43)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">4.38 ± 0.12 (42)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">0.76 ± 0.30 (6)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">–0.41 ± 0.43(0.39)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.13 ± 0.03(1.34)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char="±">4.88 ± 0.04 (13)</td><td class="colsep0 rowsep0" align="center">–3</td><td class="colsep0 rowsep0" align="char" char="±">3.14 ± 0.09 (1380)</td><td class="colsep0 rowsep0" align="center">2.75 ± 0.15 (562)</td><td class="colsep0 rowsep0" align="center">0.40 ± 0.15 (2.51)*<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Binding cooperativity with [<sup>3</sup>H]NMS; for instances where a complete inhibition of [<sup>3</sup>H]NMS binding by the allosteric modulator was observed (consistent with a high level of negative cooperativity), Log α′ was fixed to −3;</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Binding cooperativity with ACh.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Functional cooperativity with ACh.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Intrinsic efficacy of the modulator; for instances where no intrinsic efficacy of the modulator was observed Log τ<sub>B</sub> was fixed to −3.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">* = significant difference (<i>p</i> < 0.05) relative to same parameter determined for <b>10d</b>, one-way ANOVA with Dunnett’s post-test. nd = inactive at concentrations up to 30 μM; values represent the mean ± SEM from at least three experiments performed in duplicate.</p></div></div></div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacological characterization of <b>29</b> in binding and function at the mAChRs. (a) Radioligand binding experiments were performed using FlpIn-CHO cells stably expressing the M<sub>1</sub> mAChR, 0.1 nM of the radiolabeled antagonist [<sup>3</sup>H]NMS, increasing concentrations of ACh, with or without increasing concentrations of <b>29</b>. (b) IP<sub>1</sub> accumulation experiments were performed using FlpIn-CHO cells stably expressing the M<sub>1</sub> mAChR, increasing concentrations of ACh with or without increasing concentrations of <b>29</b>. 100% represents the maximal stimulation of ACh in the absence of <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is interesting to note that compound <b>1</b> exhibited equivalent values for both binding (α = 60) and functional (αβ = 62) cooperativity, suggesting that it is the allosteric effect on ACh binding affinity that underlies the cooperativity measured in our functional assay. Similarly, there was no significant difference between values of binding (α) and functional (αβ) cooperativity determined for any compound in this novel series based around the 4-phenylpyridin-2-one scaffold (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, Student’s <i>t</i> test, <i>p</i> < 0.05). Indeed, we observed a strong correlation between Log αβ and Log α (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a), demonstrating that binding cooperativity mediates the modulatory effect upon ACh in the functional assay observed for the compounds in this series. Another key observation from our characterization is that the compounds based around the 4-phenylpyridin-2-one scaffold was the apparent “uncoupling” of the correlation between positive cooperativity with ACh and allosteric ligand intrinsic efficacy, in contrast to our previous SAR study of compound <b>1</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b,c). Although the most active compound of the current series (<b>29</b>) displayed both the largest positive cooperativity with ACh and the largest intrinsic efficacy (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), we also identified analogues ranging from <b>17</b>, which displayed no intrinsic efficacy but robust positive cooperativity with ACh (α = 125, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>e), to <b>14</b>, which displayed intrinsic efficacy comparable to that of <b>1</b> (τ<sub>B</sub> = 1.1, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>d) but only very weak positive cooperativity with ACh (α = 3). This range of different ligand activities suggests that the action of some ligands within the current series no longer adhere to a simple two-state allosteric model of action. Further evidence of this is provided by our binding assay. In the majority of cases, a robust inhibition of the orthosteric antagonist, [<sup>3</sup>H]NMS, by increasing concentrations of test compound was observed, consistent with these ligands displaying positive cooperativity with agonists but high negative cooperativity with the binding of antagonists. This is consistent with a two-state mode of action and our previous observations of the action of <b>1</b> or analogues.<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20, 22)</a> However, in the present series, we observed a number of compounds (for example <b>15a</b>, <b>15c</b>–<b>e</b>) that displayed neutral cooperativity with [<sup>3</sup>H]NMS but robust positive cooperativity with the agonist ACh. As such, these observations suggest that a simple two-state model can no longer accommodate the action of these ligands.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Correlation between binding and functional cooperativity for 4-phenylpyridin-2-one derivatives generated in the present study (Pearson’s test, <i>r</i> = 0.84, <i>p</i> < 0.05, slope = 1.00 ± 0.01). (b) Plots of functional cooperativity (Log αβ) versus intrinsic efficacy (Log τ<sub>B</sub>) for derivatives of <b>1</b> generated and characterized in our previous study reveal a positive correlation (Pearson’s test, <i>r</i> = 0.65, <i>p</i> < 0.05) between these two parameters. (c) A similar plot for 4-phenylpyridin-2-one derivatives generated in the present study reveals no such correlation. (d,e) IP<sub>1</sub> accumulation experiments were performed using FlpIn-CHO cells stably expressing the M<sub>1</sub> mAChR, increasing concentrations of ACh with or without increasing concentrations of <b>14</b> (d) and <b>17</b> (e). (d) <b>14</b> displays intrinsic activity comparable to that of <b>1</b>, but very weak positive cooperativity with ACh (e) <b>17</b> displays no intrinsic activity but robust positive cooperativity with ACh. 100% represents the maximal stimulation of ACh in the absence of test compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76877" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76877" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we report the design and characterization of a structurally novel series of M<sub>1</sub> mAChR PAMs based on the novel 4-phenylpyridin-2-one scaffold that offer potentially greater scope for future development than the extensively investigated BQCA core. Our previous studies have revealed that, while <b>1</b> displays low affinity for the M<sub>1</sub> mAChR, it displays high positive cooperativity with agonist binding and has exquisite subtype selectivity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, BQCA does contain a carboxylic acid group that is often associated with poor permeability.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a></div><div class="NLM_p">The majority of active compounds displayed both comparable binding affinities and intrinsic efficacy to those of <b>1</b>. Indeed, the lack of significant gains in affinity may be due to the nature of the binding pocket, which if it is indeed the same as that of <b>1</b>, lies at the extracellular interface of the M<sub>1</sub> mAChR and is largely defined by aromatic residues. However, we also generated a number of compounds that displayed markedly higher binding and functional cooperativity with ACh than <b>1</b>. Furthermore, compound <b>10d</b> displayed high selectivity toward the M<sub>1</sub> mAChR over other mAChR subtypes (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Bioisosteric replacement of the carboxamide functionality of compound <b>9d</b> with an oxazole (<b>8q</b>) or thiazole (<b>8r</b>) was not well tolerated, whereas small changes to the pyrazole moiety of compound <b>10d</b> were generally better accommodated. However, replacement of the <i>N</i>-methyl group (compound <b>14</b>) with longer chains and bulkier alkyl as well as aromatic-bearing groups (compounds <b>15e</b>, <b>15i</b>, and <b>15j</b>) had a detrimental effect on the cooperativity with ACh in comparison to the <i>N</i>-methylpyrazole analogue <b>10d</b>. The standout PAM in terms of binding cooperativity with ACh was the 6-phenylpyrimidin-4-one analogue <b>29</b> with an α value of 1380, i.e., a 1380-fold potentiation of ACh affinity. Consequently, compound <b>29</b> represents a promising lead for future investigations of the previously unreported 6-phenylpyrimidin-4-one scaffold.</div><div class="NLM_p last">We have previously shown that <b>1</b> adheres to a two-state mode of action, whereby the degree of agonism of <b>1</b> is dependent upon the pathway stimulus–response coupling efficiency and/or receptor density.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Furthermore, in an SAR exploration of analogues of <b>1</b>, we have shown a strong positive correlation between the degree of cooperativity and the level of allosteric agonism.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We have also made similar observations in an SAR study of M<sub>4</sub> mAChR allosteric modulators.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, in the case of the present series of 6-phenylpyrimidin-4-one derivatives, we observe no such correlation. Instead, our characterization revealed a range of behaviors from ligands that displayed little or weak positive cooperativity with ACh but robust allosteric agonism to those that displayed no agonism but a high level of positive cooperativity with ACh (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). This range of behaviors may, in the future, allow us to explore the relationship between in vivo efficacy and in vitro parameters that describe the functional cooperativity and intrinsic efficacy of allosteric M<sub>1</sub> mAChR ligands. This is particularly relevant given recent observations of M<sub>1</sub> mAChR agonists displaying signaling-pathway and brain-region specific effects that may be of therapeutic relevance.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p">Chemicals and solvents were purchased from standard suppliers and used without further purification. Davisil silica gel (40–63 μm) for flash column chromatography was supplied by Grace Davison Discovery Sciences (Victoria, Australia), and deuterated solvents were purchased from Cambridge Isotope Laboratories, Inc. (USA, distributed by Novachem PTY. Ltd., Victoria, Australia).</div><div class="NLM_p">Unless otherwise stated, reactions were carried out at ambient temperature. Reactions were monitored by thin layer chromatography on commercially available precoated aluminum-backed plates (Merck Kieselgel 60 F<sub>254</sub>). Visualization was by examination under UV light (254 and 366 nm). General staining was carried out with KMnO<sub>4</sub> or phosphomolybdic acid. A solution of ninhydrin (in ethanol) was used to visualize primary and secondary amines. All organic extracts collected after aqueous workup procedures were dried over anhydrous MgSO<sub>4</sub> or Na<sub>2</sub>SO<sub>4</sub> before gravity filtering and evaporation to dryness. Organic solvents were evaporated in vacuo at ≤40 °C (water bath temperature). Purification using preparative layer chromatography (PLC) was carried out on Analtech preparative TLC plates (200 mm × 200 mm × 2 mm).</div><div class="NLM_p"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance Nanobay III 400 MHz Ultrashield Plus spectrometer at 400.13 and 100.62 MHz, respectively. Chemical shifts (δ) are recorded in parts per million (ppm) with reference to the chemical shift of the deuterated solvent. Coupling constants (<i>J</i>) and carbon–fluorine coupling constants (<i>J</i><sub>CF</sub>) are recorded in Hz, and the significant multiplicities described by singlet (s), doublet (d), triplet (t), quadruplet (q), broad (br), multiplet (m), doublet of doublets (dd), and doublet of triplets (dt). Spectra were assigned using appropriate COSY, distortionless enhanced polarization transfer (DEPT), HSQC, and HMBC sequences.</div><div class="NLM_p">LC-MS were run to verify reaction outcome and purity using an Agilent 6120 series single quad coupled to an Agilent 1260 series HPLC. The following buffers were used: buffer A, 0.1% formic acid in H<sub>2</sub>O; buffer B, 0.1% formic acid in MeCN. The following gradient was used with a Poroshell 120 EC-C18 50 mm × 3.0 mm 2.7 μm column, and a flow rate of 0.5 mL/min and total run time of 5 min; 0–1 min 95% buffer A and 5% buffer B, from 1 to 2.5 min up to 0% buffer A and 100% buffer B, held at this composition until 3.8 min, 3.8–4 min 95% buffer A and 5% buffer B, held until 5 min at this composition. Mass spectra were acquired in positive and negative ion mode with a scan range of 100–1000 <i>m</i>/<i>z</i>. UV detection was carried out at 214 and 254 nm. All retention times (<i>t</i><sub>R</sub>) are quoted in minutes.</div><div class="NLM_p">Preparative HPLC was performed using an Agilent 1260 infinity coupled with a binary preparative pump and Agilent 1260 FC-PS fraction collector, using Agilent OpenLAB CDS software (Rev C.01.04) and an Altima 5 μM C8 22 mm × 250 mm column. The following buffers were used: buffer A, H<sub>2</sub>O; buffer B, MeCN, with sample being run at a gradient of 5% buffer B to 100% buffer B over 20 min at a flow rate of 20 mL/min. All screening compounds were of >95% purity unless specified in the individual monologue.</div><div class="NLM_p">All NMR experiments were performed in DMSO-<i>d</i><sub>6</sub> allowing comparison of the spectra of the various analogues. It is important to point out that the <sup>13</sup>C NMR signals of the hydroxycyclohexane moiety were often difficult to be obtained in DMSO-<i>d</i><sub>6</sub>. Especially one tertiary carbon of the hydroxycyclohexane moiety was not observed in the <sup>13</sup>C NMR spectra of all the respective analogues even with extended relaxation time and another tertiary aromatic carbon was only ever observed by using HSQC experiments. However, additional experiments were performed on selected compounds to confirm the integrity of the presented NMR data. These results have shown that the all the signals can be observed when the NMR solvent was changed to CDCl<sub>3</sub>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Furthermore, the quaternary carbon of the pyrazole moiety was not always observed depending on individual analogue.</div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Procedure A: Suzuki Coupling of Aryl Halides and Boronic Acids</h4><div class="NLM_p last">A mixture of the aryl halide (1.0 equiv) and boronic acid (1.5 equiv) in degassed (by sonication followed by a stream of nitrogen) THF/1 M Na<sub>2</sub>CO<sub>3(aq)</sub> (3:1 4 mL/100 mg) was evacuated and flushed with nitrogen. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv) was added, and the reaction mixture boiled under reflux for 3 h. THF was evaporated under reduced pressure. The mixture was diluted with water (20 mL) and extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (20 mL), dried over anhydrous MgSO<sub>4</sub>, and filtered before concentration under reduced pressure. The crude product was purified by flash column chromatography.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure B: <i>O</i>-Alkylation of 1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxy-phenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.1 equiv), KI (0.1 equiv), and the appropriately substituted benzyl halide (1.1 equiv) were stirred in DMF (2 mL/100 mg) at rt overnight. Reaction progress was monitored through TLC analysis, with further addition of K<sub>2</sub>CO<sub>3</sub> (0.5 equiv) and substituted benzyl halide (0.5 equiv) every 24 h until the reaction appeared complete. The reaction mixture was poured onto ice/water and stirred for 30 min before extraction with EtOAc (3 × 20 mL). The combined organic layers were washed with 2 M NaOH<sub>(aq)</sub> (20 mL), water (20 mL), and brine (20 mL) before concentration under reduced pressure. The resulting crude product was purified by flash column chromatography.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure C: Ester Hydrolysis with NaOH</h4><div class="NLM_p last">To a solution of the ester (1.0 equiv) in EtOH/H<sub>2</sub>O (1:1, 2 mL/0.1 mmol) was added NaOH (4.0 equiv). The reaction mixture was heated at 50 °C for 2 h. EtOH was evaporated under reduced pressure before acidifying with 1 M HCl<sub>(aq)</sub> to pH 2. The resulting precipitate was filtered (vacuum) to give the desired product as the free acid.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure D: Ester Aminolysis with Ammonium Hydroxide</h4><div class="NLM_p last">A mixture of ester (1.0 equiv) in MeOH/NH<sub>4</sub>OH (1:1, 1.0 mL/100 mg) in a sealed tube was stirred at rt for 3 d. The resulting precipitate was collected by filtration (vacuum) and washed with EtOAc to give the desired carboxamide product.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure E: <i>N</i>-Alkylation of 4-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">4-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.1 equiv), KI (0.1 equiv), and the appropriate organohalide (1.1 equiv) were stirred in DMF (2 mL/100 mg) at the indicated temperature. Reaction progress was monitored through TLC analysis, with further addition of K<sub>2</sub>CO<sub>3</sub> and organohalide until the reaction appeared complete or conversion remained stagnant. The reaction mixture was poured onto ice/water and stirred for 30 min before extraction with EtOAc (3 × 20 mL). The combined organic layers were washed with 2 M NaOH<sub>(aq)</sub> (20 mL), water (20 mL), and brine (20 mL) before concentration under reduced pressure. The resulting crude product was purified by flash column chromatography.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (±)-<i>trans</i>-2-((4-Bromopyridin-2-yl)oxy)cyclohexan-1-ol (<b>4a</b>) and (±)-<i>trans</i>-4-Bromo-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>4b</b>)</h4><div class="NLM_p">A mixture of 4-bromo-2-hydroxypyridine (<b>1</b>) (10.0 g, 57.5 mmol), 1,2-cyclohexene oxide (29.1 mL, 287 mmol, 5.0 equiv), and K<sub>2</sub>CO<sub>3</sub> (19.9 g, 144 mmol, 2.5 equiv) was heated at 120 °C for 4 h. The reaction mixture was cooled to rt and concentrated to dryness under reduced pressure. The remaining residue was diluted with EtOAc (50 mL) and sonicated for 15 min at rt before the resulting suspension was collected by filtration (vacuum) and washed with EtOAc (filter cake 1). The EtOAc washings were concentrated under reduced pressure, then taken up in DCM (15 mL) and sonicated for 15 min at rt before the resulting suspension was collected by filtration (vacuum) (filter cake 2). Filter cake 2 was washed with further DCM to give 2-((4-bromopyridin-2-yl)oxy)cyclohexan-1-ol (<b>4a</b>) as 1.11 g of a beige solid (7%). <sup>1</sup>H NMR δ 8.15–7.89 (m, 1H), 7.17 (dd, <i>J</i> = 5.5/1.7 Hz, 1H), 7.10–6.93 (m, 1H), 4.93–4.66 (m, 2H), 3.67–3.42 (m, 1H), 2.11–1.94 (m, 1H), 1.94–1.75 (m, 1H), 1.74–1.47 (m, 2H), 1.44–1.07 (m, 4H). <sup>13</sup>C NMR δ 164.2, 147.9, 133.3, 119.8, 114.0, 78.6, 70.5, 33.1, 29.2, 23.3, 23.2. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>11</sub>H<sub>15</sub>BrNO<sub>2</sub> [M + H]<sup>+</sup> calcd, 272.0; found, 272.1. LC-MS <i>t</i><sub>R</sub>: 3.72 min.</div><div class="NLM_p last">Filter cake 1 was taken up in water (70 mL) and stirred for 15 min at rt. Any remaining solid was collected by filtration (vacuum) and washed with water to give 4-bromo-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>4b</b>) as 12.1 g of a white solid (77%). <sup>1</sup>H NMR δ 7.68 (d, <i>J</i> = 7.4 Hz, 1H), 6.67 (d, <i>J</i> = 2.2 Hz, 1H), 6.44 (dd, <i>J</i> = 7.4/2.3 Hz, 1H), 4.79 (d, <i>J</i> = 5.8 Hz, 1H), 4.44 (br s, 1H), 3.74 (br s, 1H), 2.04–1.88 (m, 1H), 1.76–1.60 (m, 3H), 1.51 (m, 1H), 1.40–1.18 (m, 3H). <sup>13</sup>C NMR δ 160.8, 136.6, 134.1, 121.0, 108.9, 69.1, 35.2, 30.8, 24.9, 23.9; resonance at δ 136.6 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>11</sub>H<sub>15</sub>BrNO<sub>2</sub> [M + H]<sup>+</sup> calcd, 272.0; found, 272.1. LC-MS <i>t</i><sub>R</sub>: 3.33 min.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(2-((2-Hydroxycyclohexyl)oxy)pyridin-4-yl)phenol (<b>5</b>)</h4><div class="NLM_p last">2-((4-Bromopyridin-2-yl)oxy)cyclohexan-1-ol (<b>4a</b>) (500 mg, 1.84 mmol) and 2-hydroxyphenylboronic acid (380 mg, 2.76 mmol, 1.5 equiv) were dispersed in 1 M Na<sub>2</sub>CO<sub>3(aq)</sub> (5 mL) and THF (10 mL) in a 30 mL microwave vial. The mixture was sonicated at rt, then degassed with a stream of nitrogen for 10 min. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (129 mg, 0.18 mmol, 0.1 equiv) was added and the vial sealed before heating at 100 °C for 2.5 h. The mixture was cooled before adding water (30 mL) and extracting with EtOAc (3 × 30 mL). The combined organic layers were washed with brine (30 mL) before concentration under reduced pressure. The resulting residue was purified by FCC (eluent EtOAc/PE 10:90 to 100:0, wet load in DCM) to give 609 mg of a pale-yellow solid (quantitative). <sup>1</sup>H NMR δ 9.80 (s, 1H), 8.11 (dd, <i>J</i> = 5.4/0.5 Hz, 1H), 7.33 (dd, <i>J</i> = 7.7/1.7 Hz, 1H), 7.23 (ddd, <i>J</i> = 8.2/7.4/1.7 Hz, 1H), 7.12 (dd, <i>J</i> = 5.4/1.5 Hz, 1H), 6.97 (dd, <i>J</i> = 8.2/1.0 Hz, 1H), 6.94 (d, <i>J</i> = 0.8 Hz, 1H), 6.90 (ddd, <i>J</i> = 7.5/7.5/1.1 Hz, 1H), 4.83 (td, <i>J</i> = 8.5/4.6 Hz, 1H), 3.56 (td, <i>J</i> = 9.0/4.2 Hz, 1H), 2.19–2.01 (m, 1H), 1.96–1.83 (m, 1H), 1.70–1.50 (m, 2H), 1.43–1.20 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 163.5, 154.7, 149.0, 146.0, 129.9, 129.9, 124.8, 119.6, 117.2, 116.3, 110.8, 77.6, 70.6, 33.2, 29.3, 23.3, 23.2. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>20</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd, 286.1; found, 286.2. LC-MS <i>t</i><sub>R</sub>: 3.23 min.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-((4-(2-([1,1′-Biphenyl]-4-ylmethoxy)phenyl)pyridin-2-yl)oxy)cyclohexan-1-ol (<b>6</b>)</h4><div class="NLM_p last">2-(2-((2-Hydroxycyclohexyl)oxy)pyridin-4-yl)phenol (<b>5</b>) (100 mg, 0.35 mmol), K<sub>2</sub>CO<sub>3</sub> (53 mg, 0.39 mmol, 1.1 equiv), KI (7 mg, 0.04 mmol, 0.1 equiv), and 4-(bromomethyl)biphenyl (95 mg, 0.39 mmol, 1.1 equiv) were dispersed in DMF (2 mL). The mixture was stirred at rt overnight. The mixture was diluted with water/ice and stirred for 10 min before collecting the resulting precipitate by filtration (vacuum) and washing with water. The crude solid product was further purified by FCC (eluent MeOH/DCM 0:100 to 10:90, with a plateau at 5:95). Mixed fractions were combined and repurified by FCC (eluent EtOAc/PE 0:100 to 30:70). A combined total of 87 mg of glassy solid (55%) was obtained. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.11 (d, <i>J</i> = 5.4 Hz, 1H), 7.69–7.51 (m, 4H), 7.51–7.29 (m, 7H), 7.19 (dd, <i>J</i> = 5.4/1.3 Hz, 1H), 7.13–6.99 (m, 3H), 5.16 (s, 2H), 4.78 (ddd, <i>J</i> = 10.9/8.9/4.7 Hz, 1H), 3.70 (ddd, <i>J</i> = 11.0/8.9/4.7 Hz, 1H), 2.24–2.08 (m, 2H), 1.85–1.62 (m, 2H), 1.59–1.14 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.1, 155.8, 150.6, 144.8, 141.0, 140.8, 135.8, 130.6, 130.5, 128.9, 128.1, 127.6, 127.5, 127.4, 127.2, 121.7, 118.8, 113.5, 112.6, 81.5, 74.2, 70.5, 33.7, 31.0, 24.3, 24.0. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>30</sub>H<sub>30</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd, 452.2; found, 452.3. LC-MS <i>t</i><sub>R</sub>: 4.18 min.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">4-Bromo-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>4b</b>) (2.00 g, 7.35 mmol) was coupled to 2-hydroxyphenyl boronic acid (1.52 g, 11.0 mmol) according to general procedure A. After the THF was evaporated under reduced pressure, the resulting brown precipitate was filtered (vacuum). The precipitate was taken up in MeOH and adsorbed onto Telos bulk sorbent and dry loaded onto the column (no extractive workup was necessary). FCC purification (eluent MeOH/DCM 0:100 to 20:80) gave 1.75 g of a white solid (83%). <sup>1</sup>H NMR δ 9.84 (s, 1H), 7.65 (d, <i>J</i> = 7.3 Hz, 1H), 7.30 (dd, <i>J</i> = 7.7/1.7 Hz, 1H), 7.22 (ddd, <i>J</i> = 8.2/7.4/1.7 Hz, 1H), 6.94 (dd, <i>J</i> = 8.1/1.0 Hz, 1H), 6.87 (td, <i>J</i> = 7.5/1.1 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.79 (br s, 1H), 2.07–1.93 (m, 1H), 1.80–1.63 (m, 3H), 1.53 (br s, 1H), 1.44–1.22 (m, 3H). <sup>13</sup>C NMR δ 161.9, 154.8, 148.5, 134.0, 130.0, 129.6, 124.5, 119.5, 118.0, 116.3, 106.8, 69.2, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.0 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>20</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 286.1; found, 286.2. LC-MS <i>t</i><sub>R</sub>: 3.33 min.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-(2-([1,1′-Biphenyl]-4-ylmethoxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8a</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 4-(bromomethyl)biphenyl (95 mg, 0.39 mmol) according to general procedure B. A precipitate formed after pouring the reaction mixture into ice/water. The precipitate was collected by filtration (vacuum), then purified by FCC (eluent EtOAc/PE 30:70 to 100:0, wet load in DCM) to give 97 mg of a white solid (61%). <sup>1</sup>H NMR δ 7.74–7.60 (m, 5H), 7.58–7.43 (m, 4H), 7.43–7.31 (m, 3H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 7.11–6.99 (m, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.46 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.25 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (s, 1H), 3.80 (s, 1H), 2.09–1.87 (m, 1H), 1.85–1.43 (m, 4H), 1.43–1.21 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.3, 148.3, 139.8, 139.6, 136.2, 134.3, 130.3, 129.9, 129.0, 127.9, 127.5, 127.2, 126.8, 126.7, 121.2, 118.5, 113.4, 107.0, 69.3, 69.2, 35.4, 31.1, 25.0, 24.0. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>30</sub>H<sub>30</sub>NO<sub>3</sub> [MH]<sup>+</sup> calcd, 452.2; found, 452.30. LC-MS <i>t</i><sub>R</sub>: 3.60 min.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(2-(Benzyloxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8b</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with benzyl bromide (37 μL, 0.31 mmol) according to general procedure B. After a total of 72 h of stirring with two further additions of K<sub>2</sub>CO<sub>3</sub> and benzyl bromide, the mixture was heated at 90 °C for 2 h, cooled, then worked up. The crude product was purified by FCC (eluent EtOAc/PE 50:50 to 100:0) to give 19.4 mg of a colorless oil (18%). <sup>1</sup>H NMR δ 7.67 (d, <i>J</i> = 7.2 Hz, 11H), 7.47–7.26 (m, 7H), 7.19 (d, <i>J</i> = 8.3 Hz, 1H), 7.04 (ddd, <i>J</i> = 7.6/7.6/0.7 Hz, 1H), 6.50 (d, <i>J</i> = 1.9 Hz, 1H), 6.44 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.19 (s, 2H), 4.53 (br s, 1H), 3.79 (br s, 1H), 2.08–1.91 (m, 1H), 1.81–1.62 (m, 3H), 1.53 (m, 1H), 1.43–1.11 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.3, 148.3, 137.0, 134.1, 130.3, 129.9, 128.5, 127.7, 127.3, 127.1, 121.2, 118.5, 113.4, 107.0, 69.6, 69.2, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>20</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 376.2; found, 376.2. LC-MS <i>t</i><sub>R</sub>: 3.74 min.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(2-((2-Fluorobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8c</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with 2-fluorobenzyl bromide (37 μL, 0.31 mmol) according to general procedure B. After a total of 72 h of stirring with two further additions of K<sub>2</sub>CO<sub>3</sub> and 2-fluorobenzyl bromide, the mixture was heated at 90 °C for 2 h, cooled, then worked up. The crude product was purified by FCC (eluent EtOAc/PE 30:70 to 100:0) to give 47 mg of a pale-yellow solid (43%). <sup>1</sup>H NMR δ 7.64 (d, <i>J</i> = 7.3 Hz, 1H), 7.50 (ddd, <i>J</i> = 7.6/7.6/1.7 Hz, 1H), 7.44–7.35 (m, 3H), 7.28–7.17 (m, 3H), 7.06 (ddd, <i>J</i> = 7.5/7.5/0.9 Hz, 1H), 6.47 (d, <i>J</i> = 1.9 Hz, 1H), 6.40 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.22 (s, 2H), 4.52 (br s, 1H), 3.79 (br s, 1H), 2.06–1.92 (m, 1H), 1.80–1.61 (m, 3H), 1.54 (m, 1H), 1.41–1.20 (m, 3H). <sup>13</sup>C NMR δ 161.8, 160.2 (d, <i>J</i><sub>CF</sub> = 245.9 Hz), 155.1, 148.2, 134.1, 130.4, 130.3 (d, <i>J</i><sub>CF</sub> = 6.2 Hz), 130.3 (d, <i>J</i><sub>CF</sub> = 6.0 Hz), 129.9, 127.1, 124.6 (d, <i>J</i><sub>CF</sub> = 3.4 Hz), 123.7 (d, <i>J</i><sub>CF</sub> = 14.4 Hz), 121.4, 118.4, 115.4 (d, <i>J</i><sub>CF</sub> = 20.9 Hz), 113.3, 106.8, 69.2, 64.1 (d, <i>J</i><sub>CF</sub> = 3.8 Hz), 35.4, 31.0, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>25</sub>FNO<sub>3</sub> [M + H]<sup>+</sup> calcd, 394.2; found, 394.2. LC-MS <i>t</i><sub>R</sub>: 3.73 min.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-(2-((3-Fluorobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8d</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with 3-fluorobenzyl bromide (38 μL, 0.31 mmol) according to general procedure B. The crude product was purified by FCC (eluent EtOAc/PE 50:50 to 100:0) to give 82 mg of a yellow oil (74%). <sup>1</sup>H NMR δ 7.68 (d, <i>J</i> = 7.2 Hz, 2H), 7.46–7.34 (m, 3H), 7.28–7.10 (m, 4H), 7.09–7.02 (m, 1H), 6.50 (d, <i>J</i> = 1.9 Hz, 1H), 6.44 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.21 (s, 2H), 4.74 (br s, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.07–1.92 (m, 1H), 1.82–1.62 (m, 3H), 1.54 (m, 1H), 1.43–1.12 (m, 3H). <sup>13</sup>C NMR δ 162.2 (d, <i>J</i><sub>CF</sub> = 243.7 Hz), 161.8, 155.1, 148.3, 139.9 (d, <i>J</i><sub>CF</sub> = 7.4 Hz), 134.2, 130.5 (d, <i>J</i><sub>CF</sub> = 8.3 Hz), 130.3, 129.9, 127.2, 123.1 (d, <i>J</i><sub>CF</sub> = 2.7 Hz), 121.3, 118.5, 114.5 (d, <i>J</i><sub>CF</sub> = 20.9 Hz), 113.9 (d, <i>J</i><sub>CF</sub> = 22.0 Hz), 113.4, 107.0, 69.2, 68.8 (d, <i>J</i><sub>CF</sub> = 1.4 Hz), 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>25</sub>FNO<sub>3</sub> [M + H]<sup>+</sup> calcd, 394.2; found, 394.2. LC-MS <i>t</i><sub>R</sub>: 3.75 min.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(2-((4-Fluorobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8e</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 4-fluorobenzyl chloride (46 μL, 0.39 mmol) according to general procedure B, with the reaction temperature changed to 90 °C. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 90 mg of a yellow solid (65%). <sup>1</sup>H NMR δ 7.66 (d, <i>J</i> = 7.3 Hz, 1H), 7.49–7.42 (m, 2H), 7.42–7.34 (m, 2H), 7.23–7.15 (m, 3H), 7.08–7.01 (m, 1H), 6.47 (d, <i>J</i> = 1.7 Hz, 1H), 6.42 (dd, <i>J</i> = 7.2/1.8 Hz, 1H), 5.16 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.52 (br s, 1H), 3.79 (br s, 1H), 2.06–1.93 (s, 1H), 1.79–1.62 (m, 3H), 1.53 (m, 1H), 1.42–1.23 (m, 3H). <sup>13</sup>C NMR δ 161.7 (d, <i>J</i><sub>CF</sub> = 243.4 Hz), 161.8, 155.2, 148.3, 134.1, 133.1 (d, <i>J</i><sub>CF</sub> = 3.0 Hz), 130.3, 129.8, 129.6 (d, <i>J</i><sub>CF</sub> = 8.3 Hz), 127.2, 121.2, 118.4, 115.3 (d, <i>J</i><sub>CF</sub> = 21.4 Hz), 113.5, 107.0, 69.2, 69.0, 35.4, 30.8, 25.0, 24.0; resonances at δ 134.1 and 30.8 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>25</sub>FNO<sub>3</sub> [M + H]<sup>+</sup> calcd, 394.2; found, 394.2. LC-MS <i>t</i><sub>R</sub>: 3.73 min.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(2-Hydroxycyclohexyl)-4-(2-((2-methoxybenzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8f</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with 2-methoxybenzyl chloride (43 μL, 0.31 mmol) according to general procedure B. After a total of 48 h of stirring with one further addition of K<sub>2</sub>CO<sub>3</sub> and 2-methoxybenzyl chloride, the mixture was worked up. Purification by FCC (eluent EtOAc/PE 30:70 to 80:20) gave 66 mg of a white solid (58%). <sup>1</sup>H NMR δ 7.64 (d, <i>J</i> = 7.1 Hz, 1H), 7.43–7.28 (m, 4H), 7.18 (d, <i>J</i> = 8.1 Hz, 1H), 7.09–6.99 (m, 2H), 6.93 (t, <i>J</i> = 7.3 Hz, 1H), 6.52 (s, 1H), 6.44 (d, <i>J</i> = 6.9 Hz, 1H), 5.12 (s, 2H), 4.73 (d, <i>J</i> = 5.7 Hz, 1H), 4.52 (br s, 1H), 3.84 (s, 3H), 3.80 (br s, 1H), 1.98 (br s, 1H), 1.80–1.61 (m, 3H), 1.54 (m, 1H), 1.42–1.18 (m, 3H). <sup>13</sup>C NMR δ 161.8, 157.0, 155.5, 148.2, 134.0, 130.3, 129.8, 129.4, 129.0, 127.0, 124.3, 121.0, 120.2, 118.5, 113.2, 110.9, 106.9, 69.2, 65.4, 55.4, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.0 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>28</sub>NO<sub>4</sub> [M + H]<sup>+</sup> calcd, 406.2; found, 406.2. LC-MS <i>t</i><sub>R</sub>: 3.76 min.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-(2-Hydroxycyclohexyl)-4-(2-((3-methoxybenzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8g</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 3-methoxybenzyl chloride (56 μL, 0.39 mmol) according to general procedure B with the reaction temperature changed to 90 °C. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 110 mg of a yellow oil (77%). <sup>1</sup>H NMR δ 7.68 (d, <i>J</i> = 7.2 Hz, 1H), 7.41–7.35 (m, 2H), 7.27 (t, <i>J</i> = 7.9 Hz, 1H), 7.21–7.17 (m, 1H), 7.04 (ddd, <i>J</i> = 7.6/7.6/0.9 Hz, 1H), 7.01–6.94 (m, 2H), 6.88–6.83 (m, 1H), 6.53 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.54 (br s, 1H), 3.77 (br s, 1H), 3.74 (s, 3H), 2.05–1.94 (m, 1H), 1.79–1.63 (m, 3H), 1.54 (m, 1H), 1.41–1.23 (m, 3H). <sup>13</sup>C NMR δ 161.8, 159.4, 155.2, 148.3, 138.6, 134.2, 130.3, 129.9, 129.5, 127.1, 121.1, 119.1, 118.5, 113.7, 113.3, 112.0, 107.0, 69.4, 69.2, 55.0, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>28</sub>NO<sub>4</sub> [M + H]<sup>+</sup> calcd, 406.2; found, 406.3. LC-MS <i>t</i><sub>R</sub>: 3.72 min.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-methoxybenzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8h</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with 4-methoxybenzyl chloride (42 μL, 0.31 mmol) according to general procedure B. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 66 mg of a beige solid (58%). <sup>1</sup>H NMR δ 7.65 (d, <i>J</i> = 7.2 Hz, 1H), 7.40–7.31 (m, 4H), 7.21 (d, <i>J</i> = 8.0 Hz, 1H), 7.06–7.00 (m, 1H), 6.95–6.8 (m, 2H), 6.48 (d, <i>J</i> = 1.9 Hz, 1H), 6.41 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.10 (s, 2H), 4.74 (d, <i>J</i> = 5.9 Hz, 1H), 4.52 (br s, 1H), 3.79 (br s, 1H), 3.74 (s, 3H), 2.05–1.92 (m, 1H), 1.78–1.52 (m, 3H), 1.54 (m, 1H), 1.41–1.20 (m, 3H). <sup>13</sup>C NMR δ 161.8, 158.9, 155.4, 148.3, 134.1, 130.3, 129.9, 129.2, 128.7, 127.1, 121.1, 118.4, 113.8, 113.5, 106.9, 69.4, 69.2, 55.1, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>28</sub>NO<sub>4</sub> [M + H]<sup>+</sup> calcd, 406.2; found, 406.2. LC-MS <i>t</i><sub>R</sub>: 3.74 min.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(2-Hydroxycyclohexyl)-4-(2-((2-(trifluoromethyl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8i</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with 2-(trifluoromethyl)benzyl chloride (45 μL, 0.31 mmol) according to general procedure B. After a total of 48 h of stirring with one further addition of K<sub>2</sub>CO<sub>3</sub> and 2-(trifluoromethyl)benzyl chloride, the mixture was worked up. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 85 mg of a white solid (68%). <sup>1</sup>H NMR δ 7.78 (d, <i>J</i> = 7.8 Hz, 1H), 7.73–7.62 (m, 3H), 7.60–7.52 (m, 1H), 7.45–7.36 (m, 2H), 7.15 (d, <i>J</i> = 8.0 Hz, 1H), 7.11–7.06 (m, 1H), 6.48 (d, <i>J</i> = 1.9 Hz, 7H), 6.41 (dd, <i>J</i> = 7.2/2.0 Hz, 7H), 5.30 (s, 2H), 4.74 (d, <i>J</i> = 5.7 Hz, 1H), 4.53 (br s, 1H), 3.79 (br s, 1H), 2.04–1.93 (m, 1H), 1.78–1.62 (m, 3H), 1.53 (m, 1H), 1.41–1.20 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.0, 148.2, 134.9 (app d, <i>J</i><sub>CF</sub> = 1.5 Hz), 134.2, 132.9, 130.4, 130.0, 129.6, 128.5, 127.3, 126.3 (q, <i>J</i><sub>CF</sub> = 30.4 Hz), 126.1 (q, <i>J</i><sub>CF</sub> = 5.6 Hz), 124.3 (q, <i>J</i><sub>CF</sub> = 274.0 Hz), 121.6, 118.5, 113.2, 106.9, 69.2, 66.5 (d, <i>J</i><sub>CF</sub> = 2.6 Hz), 35.4, 31.0, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>25</sub>F<sub>3</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 444.2; found, 444.3. LC-MS <i>t</i><sub>R</sub>: 3.89 min.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(2-Hydroxycyclohexyl)-4-(2-((3-(trifluoromethyl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8j</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with 3-(trifluoromethyl)benzyl bromide (47 μL, 0.31 mmol) according to general procedure B. After a total of 72 h of stirring with two further additions of K<sub>2</sub>CO<sub>3</sub> and 3-(trifluoromethyl)benzyl bromide, the mixture was worked up. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 79 mg of a yellow solid (64%). <sup>1</sup>H NMR δ 7.77 (s, 1H), 7.73–7.58 (m, 4H), 7.45–7.35 (m, 2H), 7.20 (d, <i>J</i> = 7.9 Hz, 1H), 7.07 (ddd, <i>J</i> = 7.5/7.5/0.8 Hz, 1H), 6.48 (d, <i>J</i> = 1.8 Hz, 1H), 6.45 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.30 (s, 2H), 4.54 (br s, 1H), 3.79 (br s, 1H), 3.38 (br s, 1H), 2.05–1.94 (m, 1H), 1.79–1.64 (m, 3H), 1.53 (m, 1H), 1.41–1.20 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.0, 148.3, 138.6, 134.2, 131.1, 130.4, 129.9, 129.6, 129.2 (app d, <i>J</i><sub>C<i>F</i></sub> = 31.6 Hz), 127.3, 124.4 (q, <i>J</i><sub>CF</sub> = 3.8 Hz), 124.2 (q, <i>J</i><sub>CF</sub> = 272.3 Hz), 123.5 (q, <i>J</i><sub>CF</sub> = 3.9 Hz), 121.4, 118.5, 113.4, 107.0, 69.3, 68.8, 35.4, 31.0, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>25</sub>F<sub>3</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 444.2; found, 444.3. LC-MS <i>t</i><sub>R</sub>: 3.82 min.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(trifluoromethyl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8k</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (80 mg, 0.28 mmol) was alkylated with 4-(trifluoromethyl)benzyl bromide (48 μL, 0.31 mmol) according to general procedure B. After a total of 48 h of stirring with one further addition of K<sub>2</sub>CO<sub>3</sub> and 4-(trifluoromethyl)benzyl chloride, the mixture was worked up. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 41 mg of a white solid (33%). <sup>1</sup>H NMR δ 7.74 (d, <i>J</i> = 8.2 Hz, 2H), 7.69 (d, <i>J</i> = 7.2 Hz, 1H), 7.62 (d, <i>J</i> = 8.1 Hz, 2H), 7.42–7.35 (m, 2H), 7.19–7.15 (m, 1H), 7.06 (ddd, <i>J</i> = 7.5/7.5/0.8 Hz, 1H), 6.50 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.31 (s, 2H), 4.54 (br s, 1H), 3.81 (br s, 1H), 3.43 (br s, 1H), 2.06–1.94 (m, 1H), 1.80–1.64 (m, 3H), 1.54 (m, 1H), 1.42–1.12 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.0, 148.3, 141.9, 134.2, 130.3, 129.9, 128.2 (app d, <i>J</i><sub>CF</sub> = 31.7 Hz), 127.6, 127.2, 125.3 (q, <i>J</i><sub>CF</sub> = 3.7 Hz), 124.2 (q, <i>J</i><sub>CF</sub> = 271.9 Hz), 121.4, 118.5, 113.4, 107.0, 69.2, 68.8, 35.4, 29.0, 25.0, 24.0. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>25</sub>F<sub>3</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 444.2; found, 444.2. LC-MS <i>t</i><sub>R</sub>: 3.83 min.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzonitrile (<b>8l</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 2-(bromomethyl)benzonitrile (76 mg, 0.39 mmol) according to general procedure B. A precipitate formed after pouring the reaction mixture into ice/water. The precipitate was collected by filtration (vacuum) to give 125 mg of beige solid (89%). <sup>1</sup>H NMR δ 7.91 (dd, <i>J</i> = 7.7/0.8 Hz, 1H), 7.73 (ddd, <i>J</i> = 7.6/7.6/1.2 Hz, 1H), 7.69–7.61 (m, 2H), 7.57 (ddd, <i>J</i> = 7.6/7.6/1.2 Hz, 1H), 7.47–7.37 (m, 2H), 7.26 (d, <i>J</i> = 8.1 Hz, 1H), 7.13–7.08 (m, 1H), 6.47 (d, <i>J</i> = 1.8 Hz, 1H), 6.45 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.32 (s, 2H), 4.73 (d, <i>J</i> = 6.0 Hz, 1H), 4.52 (br s, 1H), 3.79 (br s, 1H), 2.06–1.92 (m, 1H), 1.8–1.62 (m, 3H), 1.53 (m, 1H), 1.42–1.22 (m, 3H). <sup>13</sup>C NMR δ 161.7, 155.0, 148.1, 139.9, 134.1, 133.5, 133.2, 130.4, 130.0, 129.3, 129.1, 127.3, 121.7, 118.5, 117.2, 113.4, 111.0, 106.9, 69.2, 68.1, 35.4, 31.0, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 401.2; found, 401.2. LC-MS <i>t</i><sub>R</sub>: 3.60 min.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzonitrile (<b>8m</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 3-(bromomethyl)benzonitrile (76 mg, 0.39 mmol) according to general procedure B. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 130 mg of a white foam (93%). <sup>1</sup>H NMR δ 7.88–7.85 (m, 1H), 7.80 (ddd, <i>J</i> = 7.7/1.3/1.3 Hz, 1H), 7.77–7.73 (m, 1H), 7.68 (d, <i>J</i> = 7.2 Hz, 1H), 7.60 (dd, <i>J</i> = 7.7/7.7 Hz, 1H), 7.45–7.36 (m, 2H), 7.19 (d, <i>J</i> = 7.9 Hz, 1H), 7.08 (ddd, <i>J</i> = 7.5/7.5/0.9 Hz, 1H), 6.49 (d, <i>J</i> = 1.8 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.25 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.55 (br s, 1H), 3.80 (br s, 1H), 2.10–1.93 (m, 1H), 1.85–1.63 (m, 3H), 1.54 (m, 1H), 1.44–1.22 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.0, 148.2, 138.7, 134.1, 132.0, 131.6, 130.7, 130.4, 129.9, 129.8, 127.3, 121.5, 118.7, 118.5, 113.4, 111.4, 107.0, 69.2, 68.6, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 401.2; found, 401.2. LC-MS <i>t</i><sub>R</sub>: 3.64 min.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzonitrile (<b>8n</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 4-(bromomethyl)benzonitrile (76 mg, 0.39 mmol) according to general procedure B. A precipitate formed after pouring the reaction mixture into ice/water. Filtration (vacuum) of the precipitate gave 122 mg of a beige solid (87%). <sup>1</sup>H NMR δ 7.87–7.81 (m, 2H), 7.68 (d, <i>J</i> = 7.2 Hz, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 1H), 7.44–7.34 (m, 2H), 7.15 (dd, <i>J</i> = 8.8/0.8 Hz, 1H), 7.06 (ddd, <i>J</i> = 7.5/7.5/0.9 Hz, 1H), 6.48 (d, <i>J</i> = 1.8 Hz, 1H), 6.44 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.30 (s, 2H), 4.77 (br s, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.07–1.95 (m, 1H), 1.80–1.63 (m, 3H), 1.55 (m, 1H), 1.43–1.24 (m, 3H). <sup>13</sup>C NMR δ 161.8, 154.9, 148.3, 142.9, 134.2, 132.4, 130.3, 129.9, 127.7, 127.3, 121.5, 118.8, 118.5, 113.4, 110.4, 107.0, 69.3, 68.8, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 401.2; found, 401.3. LC-MS <i>t</i><sub>R</sub>: 3.63 min.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl 3-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzoate (<b>8o</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (200 mg, 0.70 mmol) was alkylated with methyl 3-(bromomethyl)benzoate (177 mg, 0.77 mmol) according to general procedure B. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 256 mg of a white foam (84%). <sup>1</sup>H NMR δ 8.03–8.01 (m, 1H), 7.92–7.87 (m, 1H), 7.71–7.64 (m, 2H), 7.53 (dd, <i>J</i> = 7.7/7.7 Hz, 1H), 7.42–7.35 (m, 2H), 7.19 (dd, <i>J</i> = 8.8/0.7 Hz, 1H), 7.05 (ddd, <i>J</i> = 7.5/7.5/0.9 Hz, 1H), 6.49 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.28 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.85 (s, 3H), 3.80 (br s, 1H), 2.06–1.92 (m, 1H), 1.79–1.64 (m, 3H), 1.54 (m, 1H), 1.42–1.21 (m, 3H). <sup>13</sup>C NMR δ 166.1, 161.8, 155.1, 148.3, 137.9, 134.1, 131.9, 130.3, 129.9, 129.8, 129.0, 128.4, 127.7, 127.3, 121.3, 118.5, 113.5, 107.0, 69.2, 69.0, 52.2, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>26</sub>H<sub>28</sub>NO<sub>5</sub> [M + H]<sup>+</sup> calcd, 434.2; found, 434.2. LC-MS <i>t</i><sub>R</sub>: 3.73 min.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl 4-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzoate (<b>8p</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (400 mg, 1.40 mmol) was alkylated with methyl 4-(bromomethyl)benzoate (354 mg, 1.54 mmol) according to general procedure B. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 329 mg of a white foam (54%). <sup>1</sup>H NMR δ 8.00–7.93 (m, 1H), 7.69 (d, <i>J</i> = 7.2 Hz, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 2H), 7.41–7.36 (m, 2H), 7.17 (dd, <i>J</i> = 8.7/0.8 Hz, 1H), 7.06 (ddd, <i>J</i> = 7.5/7.5/0.9 Hz, 1H), 5.28 (s, 1H), 4.76 (d, <i>J</i> = 6.1 Hz, 1H), 4.54 (br s, 1H), 3.85 (s, 3H), 3.81 (br s, 1H), 2.06–1.95 (m, 1H), 1.80–1.63 (m, 3H), 1.55 (m, 1H), 1.42–1.23 (m, 3H). <sup>13</sup>C NMR δ 166.0, 161.8, 155.1, 148.2, 142.6, 134.2, 130.3, 129.9, 129.3, 128.9, 127.2, 127.2, 121.4, 118.5, 113.3, 107.0, 69.2, 69.0, 52.2, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>26</sub>H<sub>28</sub>NO<sub>5</sub> [M + H]<sup>+</sup> calcd, 434.2; found, 434.3. LC-MS <i>t</i><sub>R</sub>: 3.72 min.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(oxazol-2-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8q</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 2-(4-(bromomethyl)phenyl)oxazole (92 mg, 0.39 mmol) according to general procedure B. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) gave 69 mg of a white solid (45%). <sup>1</sup>H NMR δ 8.23 (d, <i>J</i> = 0.8 Hz, 1H), 8.02–7.96 (m, 2H), 7.69 (d, <i>J</i> = 7.2 Hz, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.43–7.36 (m, 3H), 7.23–7.16 (m, 1H), 7.06 (td, <i>J</i> = 7.5/0.9 Hz, 1H), 6.53 (d, <i>J</i> = 1.9 Hz, 1H), 6.48 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.27 (s, 2H), 4.78 (d, <i>J</i> = 6.1 Hz, 1H), 4.55 (br s, 1H), 3.83 (br s, 1H), 2.07–1.95 (m, 1H), 1.80–1.64 (m, 3H), 1.62–1.44 (m, 1H), 1.43–1.24 (m, 3H). <sup>13</sup>C NMR δ 162.3, 161.1, 155.6, 148.8, 140.6, 140.0, 134.7, 130.8, 130.3, 129.0, 128.3, 127.6, 126.8, 126.5, 121.8, 119.0, 113.8, 107.5, 69.7, 69.6, 35.9, 31.5, 25.5, 24.5; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>27</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> calcd, 443.2; found, 443.3. LC-MS <i>t</i><sub>R</sub>: 3.58 min.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(thiazol-2-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8r</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (100 mg, 0.35 mmol) was alkylated with 2-(4-(chloromethyl)phenyl)thiazole (81 mg, 0.39 mmol) according to general procedure B. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) gave 154 mg of a white solid (96%). <sup>1</sup>H NMR δ 8.02–7.90 (m, 3H), 7.80 (d, <i>J</i> = 3.2 Hz, 1H), 7.70 (d, <i>J</i> = 7.2 Hz, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 7.46–7.34 (m, 2H), 7.21 (dd, <i>J</i> = 8.8/0.7 Hz, 1H), 7.06 (td, <i>J</i> = 7.5/0.9 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.47 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.26 (s, 2H), 4.77 (d, <i>J</i> = 6.0 Hz, 1H), 4.56 (s, 1H), 3.81 (s, 1H), 2.07–1.94 (m, 1H), 1.84–1.64 (m, 3H), 1.61–1.47 (m, 1H), 1.42–1.22 (m, 3H). <sup>13</sup>C NMR δ 167.2, 162.3, 155.7, 148.8, 144.3, 139.6, 132.9, 130.8, 130.4, 128.5, 127.6, 126.8, 121.7, 121.0, 118.9, 113.9, 107.5, 69.6, 69.5, 35.9, 31.3, 25.5, 24.5; resonances at δ 134.7, 69.5, and 31.3 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>27</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> calcd, 459.2; found, 459.3. LC-MS <i>t</i><sub>R</sub>: 3.66 min.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-phenoxybenzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>8s</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (60 mg, 0.21 mmol) was alkylated with 1-(bromomethyl)-4-phenoxybenzene (61 mg, 0.23 mmol) according to general procedure B. After a total of 4 d of stirring with one further addition of K<sub>2</sub>CO<sub>3</sub> and 1-(bromomethyl)-4-phenoxybenzene, the mixture was worked up. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 43 mg of a white solid (43%). <sup>1</sup>H NMR δ 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.47–7.34 (m, 6H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 7.15 (t, <i>J</i> = 7.4 Hz, 1H), 7.09–6.96 (m, 5H), 6.50 (d, <i>J</i> = 1.1 Hz, 1H), 6.45 (d, <i>J</i> = 7.1 Hz, 1H), 5.16 (s, 2H), 4.77 (d, <i>J</i> = 5.9 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.06–1.94 (m, 1H), 1.80–1.64 (m, 3H), 1.62–1.43 (m, 1H), 1.42–1.24 (m, 3H). <sup>13</sup>C NMR δ 162.3, 156.9, 156.7, 155.8, 148.8, 134.7, 132.3, 130.8, 130.5, 130.3, 129.8, 127.7, 124.0 (2×), 121.7, 119.2, 118.9, 114.0, 107.5, 69.7, 69.7, 35.9, 31.5, 25.5, 24.5; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>30</sub>H<sub>30</sub>NO<sub>4</sub> [M + H]<sup>+</sup> calcd, 468.2; found, 468.3. LC-MS <i>t</i><sub>R</sub>: 3.87 min.</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-(2-((4-Bromobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8t</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (759 mg, 2.66 mmol) was alkylated with 4-bromobenzyl bromide (731 mg, 2.93 mmol) according to general procedure B. A precipitate formed after pouring the reaction mixture into ice/water, with 2 M NaOH <sub>(aq)</sub> (15 mL) being added. This was stirred at room temperature for 10 min before collecting the precipitate by filtration (vacuum). Further purification by FCC (eluent EtOAc/PE 10:90 to 100:0) gave 1.12 g of a white solid (93%). <sup>1</sup>H NMR δ 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.59–7.54 (m, 2H), 7.41–7.34 (m, 4H), 7.17 (d, <i>J</i> = 8.1 Hz, 1H), 7.05 (ddd, <i>J</i> = 7.6/7.6/0.9 Hz, 1H), 6.48 (d, <i>J</i> = 1.9 Hz, 1H), 6.43 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.16 (s, 2H), 4.76 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.08–1.93 (m, 1H), 1.81–1.62 (m, 3H), 1.54 (m, 1H), 1.43–1.23 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.1, 148.3, 136.4, 134.1, 131.4, 130.3, 129.9, 129.5, 127.2, 121.3, 120.8, 118.5, 113.4, 107.0, 69.2, 68.9, 35.4, 31.0, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>25</sub>BrNO<sub>3</sub> [M + H]<sup>+</sup> calcd, 454.1; found, 454.2. LC-MS <i>t</i><sub>R</sub>: 3.84 min.</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzoic Acid (<b>9a</b>)</h4><div class="NLM_p last">Methyl 3-((2-(1-(2-hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy) methyl)benzoate (<b>8o</b>) (92 mg, 0.21 mmol) was hydrolyzed according to general procedure C to give 73 mg of a white solid (82%). <sup>1</sup>H NMR δ 13.04 (br s, 1H), 8.01 (s, 1H), 7.88 (d, <i>J</i> = 7.7 Hz, 1H), 7.65 (d, <i>J</i> = 7.3 Hz, 2H), 7.50 (t, <i>J</i> = 7.7 Hz, 1H), 7.43–7.34 (m, 2H), 7.19 (d, <i>J</i> = 8.6 Hz, 1H), 7.05 (t, <i>J</i> = 7.4 Hz, 1H), 6.51–6.44 (m, 2H), 5.27 (s, 2H), 4.54 (br s, 1H), 3.79 (br s, 1H), 3.60 (s, 6H), 2.04–1.93 (m, 1H), 1.80–1.63 (m, 3H), 1.55 (m, 1H), 1.42–1.20 (m, 3H). <sup>13</sup>C NMR δ 167.1, 161.8, 155.2, 148.4, 137.6, 134.0, 131.5, 131.0, 130.4, 129.9, 128.8, 128.6, 127.9, 127.2, 121.3, 118.4, 113.4, 107.1, 69.2, 69.1, 35.4, 31.0, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>26</sub>NO<sub>5</sub> [M + H]<sup>+</sup> calcd, 420.2; found, 420.3. LC-MS <i>t</i><sub>R</sub>: 3.54 min.</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzoic Acid (<b>9b</b>)</h4><div class="NLM_p last">Methyl 4-((2-(1-(2-hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy) methyl)benzoate (<b>8p</b>) (100 mg, 0.23 mmol) was hydrolyzed according to general procedure C to give 90 mg of a white solid (93%). <sup>1</sup>H NMR δ 12.98 (br s, 1H), 7.94 (d, <i>J</i> = 8.3 Hz, 2H), 7.69 (d, <i>J</i> = 7.2 Hz, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 7.45–7.34 (m, 2H), 7.18 (d, <i>J</i> = 8.1 Hz, 1H), 7.06 (ddd, <i>J</i> = 7.5/7.5/0.8 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.46 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.28 (s, 2H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.06–1.93 (m, 1H), 1.81–1.63 (m, 3H), 1.55 (m, 1H), 1.43–1.21 (m, 3H). <sup>13</sup>C NMR δ 167.1, 161.8, 155.1, 148.3, 142.1, 134.2, 130.3, 130.1, 129.9, 129.5, 127.2, 127.0, 121.3, 118.5, 113.3, 107.0, 69.2, 69.1, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>26</sub>NO<sub>5</sub> [M + H]<sup>+</sup> calcd, 420.2; found, 420.3. LC-MS <i>t</i><sub>R</sub>: 3.50 min.</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzamide (<b>9c</b>)</h4><div class="NLM_p last">Methyl 3-((2-(1-(2-hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzoate (<b>8o</b>) (90 mg, 0.21 mmol) was treated with ammonium hydroxide according to general procedure D to give 45 mg of a white solid (52%). <sup>1</sup>H NMR δ 7.98 (s, 1H), 7.94 (s, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.56 (d, <i>J</i> = 7.7 Hz, 1H), 7.46 (dd, <i>J</i> = 7.7/7.7 Hz, 1H), 7.43–7.35 (m, 3H), 7.23–7.17 (m, 1H), 7.06 (ddd, <i>J</i> = 7.5/7.5/0.8 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.47 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.24 (s, 2H), 4.77 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.07–1.94 (m, 1H), 1.81–1.64 (m, 3H), 1.54 (m, 1H), 1.42–1.21 (m, 3H). <sup>13</sup>C NMR δ 167.8, 161.8, 155.3, 148.3, 137.1, 134.6, 134.1, 130.4, 130.0, 129.9, 128.5, 127.1, 126.8, 126.5, 121.3, 118.5, 113.4, 107.0, 69.5, 69.2, 35.4, 31.0, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> calcd, 419.2; found, 419.3. LC-MS <i>t</i><sub>R</sub>: 3.44 min.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-((2-(1-(2-Hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzamide (<b>9d</b>)</h4><div class="NLM_p last">Methyl 4-((2-(1-(2-hydroxycyclohexyl)-2-oxo-1,2-dihydropyridin-4-yl)phenoxy)methyl)benzoate (<b>8p</b>) (105 mg, 0.24 mmol) was treated with ammonium hydroxide according to general procedure D to give 15 mg of a white solid (14%). <sup>1</sup>H NMR δ 7.97 (s, 1H), 7.86 (d, <i>J</i> = 8.3 Hz, 2H), 7.68 (d, <i>J</i> = 7.2 Hz, 1H), 7.47 (d, <i>J</i> = 8.3 Hz, 2H), 7.42–7.33 (m, 3H), 7.20–7.15 (m, 1H), 7.05 (ddd, <i>J</i> = 7.5/7.5/0.8 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.25 (s, 2H), 4.76 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.05–1.94 (m, 1H), 1.80–1.63 (m, 3H), 1.55 (m, 1H), 1.42–1.25 (m, 3H). <sup>13</sup>C NMR δ 167.6, 161.8, 155.2, 148.3, 140.2, 134.2, 133.6, 130.3, 129.9, 127.7, 127.1, 126.9, 121.3, 118.5, 113.4, 107.0, 69.2, 69.1, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>25</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> calcd, 419.2; found, 419.3. LC-MS <i>t</i><sub>R</sub>: 3.40 min.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(pyridin-3-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>10a</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8t</b>) (100 mg, 0.22 mmol) was coupled to pyridine-3-boronic acid (41 mg, 0.33 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 7.5:92.5) gave 48 mg of a white solid (48%). <sup>1</sup>H NMR δ 8.90 (d, <i>J</i> = 2.1 Hz, 1H), 8.57 (dd, <i>J</i> = 4.7/1.5 Hz, 1H), 8.10–8.05 (m, 1H), 7.74 (d, <i>J</i> = 8.2 Hz, 2H), 7.68 (d, <i>J</i> = 7.2 Hz, 1H), 7.54 (d, <i>J</i> = 8.2 Hz, 2H), 7.49 (dd, <i>J</i> = 7.9/4.8 Hz, 1H), 7.43–7.94 (m, 2H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 7.05 (t, <i>J</i> = 7.4 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.46 (dd, <i>J</i> = 7.2/1.9 Hz, 1H), 5.26 (s, 2H), 4.77 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.05–1.93 (m, 1H), 1.81–1.61 (m, 3H), 1.53 (m, 1H), 1.41–1.25 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.3, 148.6, 148.4, 147.7, 137.0, 136.5, 135.2, 134.2, 134.1, 130.3, 129.9, 128.1, 127.2, 127.0, 123.9, 121.2, 118.5, 113.5, 107.0, 69.2, 69.0, 35.4, 31.1, 25.0, 24.0; resonances at δ 134.2 and 69.0 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>29</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 453.2; found, 453.3. LC-MS <i>t</i><sub>R</sub>: 3.39 min.</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(pyridin-4-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>10b</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8t</b>) (100 mg, 0.22 mmol) was coupled to pyridine-4-boronic acid (41 mg, 0.33 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 7.5:92.5) gave 43 mg of a white solid (43%). <sup>1</sup>H NMR δ 8.63 (d, <i>J</i> = 5.5 Hz, 2H), 7.81 (d, <i>J</i> = 8.1 Hz, 2H), 7.75–7.65 (m, 3H), 7.56 (d, <i>J</i> = 8.1 Hz, 2H), 7.43–7.34 (m, 2H), 7.21 (d, <i>J</i> = 8.5 Hz, 1H), 7.05 (t, <i>J</i> = 7.4 Hz, 1H), 6.53–6.50 (m, 1H), 6.46 (dd, <i>J</i> = 7.1/1.3 Hz, 1H), 5.27 (s, 2H), 4.77 (d, <i>J</i> = 5.9 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.05–1.93 (m, 1H), 1.81–1.62 (m, 3H), 1.54 (m, 1H), 1.42–1.24 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.2, 150.3, 148.4, 146.6, 138.2, 136.5, 134.2, 130.3, 129.9, 128.0, 127.2, 127.0, 121.3, 121.2, 118.5, 113.4, 107.0, 69.2, 69.2, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>29</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 453.2; found, 453.3. LC-MS <i>t</i><sub>R</sub>: 3.31 min.</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(pyrimidin-5-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>10c</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8t</b>) (100 mg, 0.22 mmol) was coupled to pyrimidine-5-boronic acid (41 mg, 0.33 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 5:95) gave 38 mg of a white solid (38%). <sup>1</sup>H NMR δ 9.19 (s, 1H), 9.15 (s, 2H), 7.85–7.79 (m, 2H), 7.68 (d, <i>J</i> = 7.2 Hz, 1H), 7.57 (d, <i>J</i> = 8.3 Hz, 2H), 7.42–7.35 (m, 2H), 7.21 (d, <i>J</i> = 8.0 Hz, 1H), 7.05 (ddd, <i>J</i> = 7.6/7.6/0.9 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.46 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.28 (s, 2H), 4.77 (d, <i>J</i> = 5.9 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.05–1.94 (m, 1H), 1.80–1.62 (m, 3H), 1.54 (m, 1H), 1.42–1.24 (m, 3H). <sup>13</sup>C NMR δ 161.8, 157.3, 155.2, 155.2, 148.3, 137.8, 134.2, 133.1, 132.9, 130.3, 129.9, 128.1, 127.2, 127.1, 121.3, 118.5, 113.5, 107.0, 69.2, 69.1, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>28</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 454.2; found, 454.3. LC-MS <i>t</i><sub>R</sub>: 3.56 min.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>10d</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8t</b>) (100 mg, 0.22 mmol) was coupled to 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (69 mg, 0.33 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 5:95) gave 43 mg of a white solid (43%). <sup>1</sup>H NMR δ 8.12 (s, 1H), 7.85 (s, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.55 (d, <i>J</i> = 8.1 Hz, 2H), 7.42–7.34 (m, 2H), 7.21 (d, <i>J</i> = 8.3 Hz, 1H), 7.04 (t, <i>J</i> = 7.5 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.44 (dd, <i>J</i> = 7.2/1.9 Hz, 1H), 5.16 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.53 (br s, 1H), 3.85 (s, 3H), 3.80 (br s, 1H), 2.04–1.94 (m, 1H), 1.82–1.67 (m, 3H), 1.54 (m, 1H), 1.41–1.25 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.4, 148.3, 136.1, 134.4, 134.2, 132.2, 130.3, 129.9, 128.1, 127.9, 127.1, 125.0, 121.5, 121.1, 118.5, 113.4, 107.0, 69.5, 69.2, 38.9, 35.4, 31.1, 25.0, 24.0; resonance at δ 134.2 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>28</sub>H<sub>30</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 456.2; found, 456.3. LC-MS <i>t</i><sub>R</sub>: 3.61 min.</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-(2-Aminophenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>11</b>)</h4><div class="NLM_p last">4-Bromo-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>4b</b>) (200 mg, 0.73 mmol) was coupled to 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (244 g, 1.10 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 20:80) gave 181 mg of a brown solid (87%). <sup>1</sup>H NMR δ 7.71 (d, <i>J</i> = 7.2 Hz, 1H), 7.11–7.00 (m, 2H), 6.75 (dd, <i>J</i> = 8.1/0.9 Hz, 1H), 6.62 (td, <i>J</i> = 7.5/1.1 Hz, 1H), 6.37 (d, <i>J</i> = 1.8 Hz, 1H), 6.30 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 4.98 (s, 2H), 4.73 (d, <i>J</i> = 5.6 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.05–1.94 (m, 1H), 1.80–1.65 (m, 3H), 1.55 (m, 1H), 1.42–1.24 (m, 3H). <sup>13</sup>C NMR δ 162.0, 150.0, 145.2, 135.2, 129.4, 129.0, 122.5, 117.5, 116.6, 115.6, 106.2, 69.3, 35.3, 31.0, 25.0, 24.0; resonance at δ 135.2 ppm was taken from HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>21</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 285.2; found, 285.2. LC-MS <i>t</i><sub>R</sub>: 3.35 min.</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(2-((4-Bromobenzyl)amino)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>12</b>)</h4><div class="NLM_p last">To a mixture of 4-(2-aminophenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>11</b>) (100 mg, 0.35 mmol) and 4-bromobenzaldehyde (65 mg, 0.35 mmol, 1.0 equiv) in 1,2-dichloroethane (3.5 mL) was added AcOH (0.20 mL) and NaB(OAc)<sub>3</sub>H (149 mg, 0.70 mmol, 2.0 equiv). After 2 h, the reaction mixture was diluted with DCM (20 mL) washed with 10% K<sub>2</sub>CO<sub>3(aq)</sub> (20 mL) and brine (20 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by FCC (eluent EtOAc/PE 50:50 to 100:0) gave 81 mg of a yellow oil (50%). <sup>1</sup>H NMR δ 7.75 (d, <i>J</i> = 7.2 Hz, 1H), 7.53–7.47 (m, 2H), 7.30 (d, <i>J</i> = 8.4 Hz, 2H), 7.11–7.01 (m, 2H), 6.63 (ddd, <i>J</i> = 7.4/7.4/0.9 Hz, 1H), 6.46–6.40 (m, 2H), 6.31 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.72 (t, <i>J</i> = 5.9 Hz, 1H), 4.73 (d, <i>J</i> = 5.6 Hz, 1H), 4.56 (br s, 1H), 4.30 (d, <i>J</i> = 5.9 Hz, 2H), 3.82 (br s, 1H), 2.05–1.96 (m, 1H), 1.82–1.65 (m, 3H), 1.56 (m, 1H), 1.43–1.25 (m, 3H). <sup>13</sup>C NMR δ 162.0, 149.7, 144.4, 139.7, 135.4, 131.2, 129.5, 129.1, 129.1, 123.9, 119.5, 118.2, 116.4, 111.0, 106.6, 69.3, 45.8, 35.3, 30.7, 25.1, 24.0; resonances at δ 135.4 and 30.7 ppm were taken from HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>26</sub>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 453.1; found, 453.2. LC-MS <i>t</i><sub>R</sub>: 3.89.</div></div><div id="sec4_4_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(pyridin-3-yl)benzyl)amino)phenyl)pyridin-2(1<i>H</i>)-one (<b>13a</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)amino)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>12</b>) (80 mg, 0.18 mmol) was coupled to pyridine-3-boronic acid (33 mg, 0.26 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 5:95) gave 33 mg of a yellow oil (41%). <sup>1</sup>H NMR δ 8.87 (d, <i>J</i> = 1.8 Hz, 1H), 8.55 (dd, <i>J</i> = 4.7/1.5 Hz, 1H), 8.05 (ddd, <i>J</i> = 8.0/2.4/1.6 Hz, 1H), 7.77 (d, <i>J</i> = 7.2 Hz, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 2H), 7.50–7.44 (m, 3H), 7.12–7.06 (m, 1H), 7.05 (dd, <i>J</i> = 7.5/1.5 Hz, 1H), 6.63 (ddd, <i>J</i> = 7.4/7.4/0.9 Hz, 1H), 6.52 (d, <i>J</i> = 8.2 Hz, 1H), 6.45 (d, <i>J</i> = 1.9 Hz, 1H), 6.34 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.74 (t, <i>J</i> = 6.0 Hz, 1H), 4.74 (d, <i>J</i> = 5.6 Hz, 1H), 4.57 (br s, 1H), 4.40 (d, <i>J</i> = 5.9 Hz, 2H), 3.83 (br s, 1H), 2.07–1.95 (m, 1H), 1.84–1.65 (m, 3H), 1.57 (m, 1H), 1.44–1.26 (m, 3H). <sup>13</sup>C NMR δ 162.0, 149.8, 148.3, 147.6, 144.6, 140.3, 135.4, 135.4, 134.0, 129.5, 129.1, 127.6, 126.9, 123.9, 123.9, 118.1, 116.3, 111.1, 106.6, 69.3, 46.0, 35.3, 31.1, 25.0, 24.0; resonance at δ 135.4 ppm was taken from HSQC experiment. Missing an aromatic quaternary carbon resonance not observed in 2D NMR experiments. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>29</sub>H<sub>30</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 452.2; found, 452.3. LC-MS <i>t</i><sub>R</sub>: 3.44 min.</div></div><div id="sec4_4_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(pyridin-4-yl)benzyl)amino)phenyl)pyridin-2(1<i>H</i>)-one (<b>13b</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)amino)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>12</b>) (80 mg, 0.18 mmol) was coupled to pyridine-4-boronic acid (33 mg, 0.26 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 5:95) followed by preparative HPLC (30% to 100% buffer B, 20 min) gave 19 mg of a yellow oil (29%). <sup>1</sup>H NMR δ 8.63–8.59 (m, 2H), 7.77 (d, <i>J</i> = 8.2 Hz, 3H), 7.69 (dd, <i>J</i> = 4.6/1.6 Hz, 2H), 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.11–7.02 (m, 2H), 6.63 (ddd, <i>J</i> = 7.4/7.4/0.8 Hz, 1H), 6.50 (d, <i>J</i> = 8.2 Hz, 1H), 6.45 (d, <i>J</i> = 1.9 Hz, 1H), 6.34 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.76 (t, <i>J</i> = 5.9 Hz, 1H), 4.74 (d, <i>J</i> = 5.6 Hz, 1H), 4.57 (br s, 1H), 4.41 (d, <i>J</i> = 5.9 Hz, 2H), 3.83 (br s, 1H), 2.06–1.95 (m, 1H), 1.84–1.66 (m, 3H), 1.57 (m, 1H), 1.43–1.26 (m, 3H). <sup>13</sup>C NMR δ 162.0, 150.2, 149.8, 146.8, 144.5, 141.6, 135.5, 135.4, 129.5, 129.1, 127.6, 126.9, 123.9, 121.1, 118.1, 116.3, 111.1, 106.6, 69.3, 46.1, 35.3, 31.1, 25.1, 24.0; resonance at δ 135.5 ppm was taken from HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>29</sub>H<sub>30</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 452.2; found, 452.3. LC-MS <i>t</i><sub>R</sub>: 3.33 min.</div></div><div id="sec4_4_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(pyrimidin-5-yl)benzyl)amino)phenyl)pyridin-2(1<i>H</i>)-one (<b>13c</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)amino)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>12</b>) (80 mg, 0.18 mmol) was coupled to pyrimidine-5-boronic acid (33 mg, 0.26 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 5:95) followed by preparative HPLC (MeCN:H<sub>2</sub>O 40:60 to 100:0) gave 28 mg of a yellow oil (35%). <sup>1</sup>H NMR δ 9.16 (s, 1H), 9.12 (s, 2H), 7.77 (d, <i>J</i> = 8.2 Hz, 3H), 7.51 (d, <i>J</i> = 8.3 Hz, 2H), 7.11–7.02 (m, 2H), 6.63 (ddd, <i>J</i> = 7.4/7.4/0.9 Hz, 1H), 6.51 (d, <i>J</i> = 8.0 Hz, 1H), 6.45 (d, <i>J</i> = 1.9 Hz, 1H), 6.34 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.77 (t, <i>J</i> = 5.9 Hz, 1H), 4.74 (d, <i>J</i> = 5.6 Hz, 1H), 4.57 (br s, 1H), 4.41 (d, <i>J</i> = 5.9 Hz, 2H), 3.82 (br s, 1H), 2.06–1.96 (m, 1H), 1.83–1.65 (m, 3H), 1.58 (m, 1H), 1.44–1.25 (m, 3H). <sup>13</sup>C NMR δ 162.0, 157.1, 154.6, 149.8, 144.5, 141.3, 135.6, 133.1, 132.1, 129.5, 129.1, 127.7, 127.0, 123.9, 118.1, 116.3, 111.1, 106.6, 69.3, 46.0, 35.3, 31.1, 25.1, 24.0; resonance at δ 135.6 ppm was taken from HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>28</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 453.2; found, 453.3. LC-MS <i>t</i><sub>R</sub>: 3.55 min.</div></div><div id="sec4_4_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)amino)phenyl)pyridin-2(1<i>H</i>)-one (<b>13d</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)amino)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>12</b>) (80 mg, 0.18 mmol) was coupled to 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (55 mg, 0.26 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 5:95) followed by preparative HPLC (40% to 100% buffer B, 20 min) gave 30 mg of a yellow oil (37%). <sup>1</sup>H NMR δ 8.07 (s, 1H), 7.80 (d, <i>J</i> = 0.7 Hz, 1H), 7.75 (d, <i>J</i> = 7.2 Hz, 1H), 7.49 (d, <i>J</i> = 8.3 Hz, 2H), 7.31 (d, <i>J</i> = 8.3 Hz, 2H), 7.11–7.05 (m, 1H), 7.03 (dd, <i>J</i> = 7.5/1.6 Hz, 1H), 6.62 (ddd, <i>J</i> = 7.4/7.4/0.9 Hz, 1H), 6.52 (d, <i>J</i> = 8.2 Hz, 1H), 6.43 (d, <i>J</i> = 1.9 Hz, 1H), 6.33 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.62 (t, <i>J</i> = 5.9 Hz, 1H), 4.73 (d, <i>J</i> = 5.6 Hz, 1H), 4.56 (br s, 1H), 4.31 (d, <i>J</i> = 5.8 Hz, 2H), 3.90–3.76 (m, 4H), 2.06–1.95 (m, 1H), 1.83–1.64 (m, 3H), 1.56 (br s, 1H), 1.43–1.25 (m, 3H). <sup>13</sup>C NMR δ 162.0, 149.8, 144.7, 137.7, 135.9, 135.5, 131.0, 129.5, 129.1, 127.6, 127.3, 125.0, 123.9, 121.8, 118.1, 116.2, 111.1, 106.5, 69.1, 46.2, 38.6, 35.3, 31.1, 25.0, 24.0; resonances at δ 135.5 and 69.1 ppm were taken from HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>28</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 455.2; found, 455.3. LC-MS <i>t</i><sub>R</sub>: 3.22 min.</div></div><div id="sec4_4_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(2-(([1,1′-Biphenyl]-4-ylmethyl)amino)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>13e</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)amino)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>12</b>) (80 mg, 0.18 mmol) was coupled to phenylboronic acid (32 mg, 0.26 mmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 5:95) followed by preparative HPLC (40% to 100% buffer B, 20 min) gave 36 mg of a yellow oil (46%). <sup>1</sup>H NMR δ 7.76 (d, <i>J</i> = 7.2 Hz, 1H), 7.68–7.58 (m, 4H), 7.49–7.40 (m, 4H), 7.34 (ddd, <i>J</i> = 8.5/4.5/1.2 Hz, 1H), 7.12–7.06 (m, 1H), 7.04 (dd, <i>J</i> = 7.5/1.5 Hz, 1H), 6.63 (ddd, <i>J</i> = 7.4/7.4/0.9 Hz, 1H), 6.53 (d, <i>J</i> = 8.1 Hz, 1H), 6.44 (d, <i>J</i> = 1.9 Hz, 1H), 6.34 (dd, <i>J</i> = 7.1/2.0 Hz, 1H), 5.71 (t, <i>J</i> = 5.9 Hz, 1H), 4.74 (d, <i>J</i> = 5.6 Hz, 1H), 4.57 (br s, 1H), 4.38 (d, <i>J</i> = 5.9 Hz, 2H), 3.82 (br s, 1H), 2.06–1.96 (m, 1H), 1.83–1.65 (m, 3H), 1.57 (m, 1H), 1.43–1.25 (m, 3H). <sup>13</sup>C NMR δ 162.0, 149.8, 144.6, 140.0, 139.5, 138.6, 135.5, 129.6, 129.1, 128.9, 127.4, 127.3, 126.7, 126.6, 123.9, 118.1, 116.3, 111.1, 106.6, 69.1, 46.1, 35.3, 30.8, 25.1, 24.0; resonances at δ 135.5, 69.1, and 30.8 ppm were taken from HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>30</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 451.2; found, 451.3. LC-MS <i>t</i><sub>R</sub>: 4.00 min.</div></div><div id="sec4_4_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>8t</b>) (200 mg, 0.44 mmol) was coupled to 1-(<i>tert</i>-butoxycarbonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (194 mg, 0.66 mmol) according to general procedure A. LC-MS analysis of the crude residue indicated loss of the Boc group during the reaction. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90), gave 150 mg of a white solid (77%). <sup>1</sup>H NMR δ 12.94 (s, 1H), 8.19 (s, 1H), 7.92 (s, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.63–7.53 (m, 2H), 7.47–7.33 (m, 4H), 7.21 (d, <i>J</i> = 8.2 Hz, 1H), 7.04 (ddd, <i>J</i> = 7.6/7.6/0.9 Hz, 1H), 6.51 (d, <i>J</i> = 1.9 Hz, 1H), 6.44 (dd, <i>J</i> = 7.2, 2.0 Hz, 1H), 5.17 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.53 (s, 1H), 3.80 (s, 1H), 1.99 (s, 1H), 1.81–1.62 (m, 3H), 1.61–1.42 (m, 1H), 1.42–1.22 (m, 3H). <sup>13</sup>C NMR δ 161.8, 155.3, 148.3, 136.2, 134.6, 134.3, 132.5, 130.3, 129.9, 128.0, 127.1, 125.5, 125.1, 121.1, 120.8, 118.5, 113.5, 106.9, 69.5, 69.2, 35.4, 31.0, 25.0, 24.0. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>27</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> [MH]<sup>+</sup> calcd, 442.2; found, 442.3. LC-MS <i>t</i><sub>R</sub>: 3.47 min.</div></div><div id="sec4_4_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-(2-((4-(1-Ethyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>15a</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (65 mg, 147 μmol) was alkylated with 1-bromoethane (12 μL, 161 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, additional K<sub>2</sub>CO<sub>3</sub> (22 mg, 162 μmol), and 1-bromoethane (61 μL, 805 μmol) was added over 44 h at rt until the reaction appeared complete. The crude product was dried on the freeze-dryer to give 57 mg of white solid (82%). No further purification was required. <sup>1</sup>H NMR δ 8.19 (d, <i>J</i> = 0.5 Hz, 1H), 7.87 (d, <i>J</i> = 0.7 Hz, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.59–7.55 (m, 2H), 7.42–7.36 (m, 4H), 7.24–7.19 (m, 1H), 7.05 (td, <i>J</i> = 7.6/0.9 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.75 (d, <i>J</i> = 5.9 Hz, 1H), 4.54 (br s, 1H), 4.15 (q, <i>J</i> = 7.3 Hz, 2H), 3.81 (br s, 1H), 2.05–1.95 (m, 1H), 1.80–1.65 (m, 3H), 1.65–1.45 (m, 1H), 1.40 (t, <i>J</i> = 7.3 Hz, 3H), 1.33–1.22 (m, 3H). <sup>13</sup>C NMR δ 162.3, 155.8, 148.8, 136.4, 134.8, 134.8, 132.7, 130.8, 130.3, 128.5, 127.5, 126.8, 125.4, 121.8, 121.6, 118.9, 113.9, 107.4, 70.0, 69.6, 46.8, 35.9, 31.5, 25.5, 24.5, 15.9; resonance at δ 134.8 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>29</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 470.2; found, 470.3. LC-MS <i>t</i><sub>R</sub>: 3.58 min.</div></div><div id="sec4_4_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(1-(2-hydroxyethyl)-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>15b</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (80 mg, 181 μmol) was alkylated with bromoethanol (14 μL, 199 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, the reaction was stopped after 10 d at 100 °C. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) gave 19 mg of a white solid (22%). <sup>1</sup>H NMR δ 8.15 (s, 1H), 7.88 (d, <i>J</i> = 0.5 Hz, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.57 (d, <i>J</i> = 8.2 Hz, 2H), 7.43–7.35 (m, 4H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 7.08–7.01 (m, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.94 (t, <i>J</i> = 5.3 Hz, 1H), 4.76 (d, <i>J</i> = 6.0 Hz, 1H), 4.55 (br s, 1H), 4.16 (t, <i>J</i> = 5.6 Hz, 2H), 3.86–3.72 (m, 3H), 2.05–1.96 (m, 1H), 1.78–1.65 (m, 3H), 1.62–1.45 (m, 1H), 1.40–1.26 (m, 3H). <sup>13</sup>C NMR δ 162.3, 155.8, 148.8, 136.5, 134.8, 134.6, 132.7, 130.7, 130.3, 128.5, 128.1, 127.5, 125.4, 121.6, 121.6, 118.9, 113.9, 107.4, 70.0, 69.7, 60.5, 55.4, 35.9, 31.5, 25.5, 24.5; resonance at δ 134.6 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>29</sub>H<sub>32</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> calcd, 486.2; found, 486.3. LC-MS <i>t</i><sub>R</sub>: 3.42 min.</div></div><div id="sec4_4_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(1-propyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>15c</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (60 mg, 136 μmol) was alkylated with 1-bromopropane (14 μL, 149 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, and additional 1-bromopropane (54 μL, 596 μmol) was added over 48 h at rt until the reaction appeared complete. The crude product was dried on the freeze-dryer to give 51 mg of the desired product as of a white solid (77%). No further purification was required. <sup>1</sup>H NMR δ 8.18 (d, <i>J</i> = 0.5 Hz, 1H), 7.87 (d, <i>J</i> = 0.6 Hz, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.57 (d, <i>J</i> = 8.3 Hz, 2H), 7.43–7.35 (m, 4H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 7.05 (td, <i>J</i> = 7.6/0.8 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.76 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 4.07 (t, <i>J</i> = 7.0 Hz, 2H), 3.80 (br s, 1H), 2.05–1.95 (m, 1H), 1.85–1.73 (m, 2H), 1.76–1.65 (m, 3H), 1.60–1.48 (m, 1H), 1.41–1.19 (m, 3H), 0.85 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR δ 162.2, 155.8, 148.8, 136.4, 134.7, 134.8, 132.7, 130.8, 130.3, 128.5, 127.5, 125.4, 121.6, 121.6, 118.9, 113.9, 107.4, 70.0, 69.6, 53.5, 35.9, 31.5, 25.5, 24.5, 23.7, 11.4; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>30</sub>H<sub>34</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 484.3; found, 484.3. LC-MS <i>t</i><sub>R</sub>: 3.67 min.</div></div><div id="sec4_4_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-(2-Hydroxycyclohexyl)-4-(2-((4-(1-isopropyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>15d</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (60 mg, 136 μmol) was alkylated with 2-bromopropane (14 μL, 149 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, additional K<sub>2</sub>CO<sub>3</sub> (21 mg, 149 μmol) and 2-bromopropane (56 μL, 596 μmol) was added over 48 h at rt, and then the reaction mixture was heated to 40 °C for another 5 d until the reaction appeared complete. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 28 mg of a white solid (42%). <sup>1</sup>H NMR δ 8.22 (d, <i>J</i> = 0.5 Hz, 1H), 7.87 (d, <i>J</i> = 0.6 Hz, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.59 (d, <i>J</i> = 8.3 Hz, 2H), 7.44–7.33 (m, 4H), 7.26–7.18 (m, 1H), 7.05 (td, <i>J</i> = 7.5/0.8 Hz, 1H), 6.54 (d, <i>J</i> = 1.9 Hz, 1H), 6.46 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.78 (d, <i>J</i> = 6.0 Hz, 1H), 4.63–4.43 (m, 2H), 3.80 (br s, 1H), 2.05–1.95 (m, 1H), 1.78–1.65 (m, 3H), 1.62–1.50 (m, 1H), 1.45 (d, <i>J</i> = 6.7 Hz, 6H), 1.39–1.25 (m, 3H). <sup>13</sup>C NMR δ 162.3, 155.8, 148.8, 136.0, 134.7, 134.7, 132.8, 130.8, 130.3, 128.5, 127.5, 125.4, 125.2, 121.6, 121.5, 119.0, 113.9, 107.4, 70.0, 69.7, 53.6, 35.9, 31.6, 25.5, 24.5, 23.1; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>30</sub>H<sub>34</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 484.3; found, 484.3. LC-MS <i>t</i><sub>R</sub>: 3.63 min.</div></div><div id="sec4_4_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(2-((4-(1-Butyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>15e</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (60 mg, 136 μmol) was alkylated with 1-bromobutane (16 μL, 149 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, additional K<sub>2</sub>CO<sub>3</sub> (21 mg, 149 μmol) and 1-bromobutane (54 μL, 600 μmol) was added over 72 h at rt, and then the reaction mixture was heated to 40 °C for another 4 d until the reaction appeared complete. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 42 mg of a white solid (63%). <sup>1</sup>H NMR δ 8.18 (d, <i>J</i> = 0.5 Hz, 1H), 7.87 (d, <i>J</i> = 0.7 Hz, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.57 (d, <i>J</i> = 8.3 Hz, 2H), 7.44–7.34 (m, 4H), 7.25–7.19 (m, 1H), 7.04 (td, <i>J</i> = 7.5/0.8 Hz, 1H), 6.54 (d, <i>J</i> = 1.9 Hz, 1H), 6.46 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.78 (d, <i>J</i> = 6.0 Hz, 1H), 4.55 (br s, 1H), 4.11 (t, <i>J</i> = 7.0 Hz, 2H), 3.81 (br s, 1H), 2.05–1.96 (m, 1H), 1.83–1.64 (m, 5H), 1.61–1.45 (m, 1H), 1.41–1.19 (m, 5H), 0.89 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR δ 162.3, 155.8, 148.8, 136.4, 134.8, 134.7, 132.7, 130.7, 130.3, 128.5, 127.5, 127.5, 125.4, 121.7, 121.6, 118.9, 113.9, 107.4, 70.0, 69.7, 51.5, 35.9, 32.3, 31.5, 25.5, 24.5, 19.7, 13.9; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>31</sub>H<sub>36</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 498.3; found, 498.4. LC-MS <i>t</i><sub>R</sub>: 3.73 min.</div></div><div id="sec4_4_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-(2-((4-(1-Cyclopentyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>15f</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (72 mg, 163 μmol) was alkylated with bromocyclopentane (19 μL, 179 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, additional K<sub>2</sub>CO<sub>3</sub> (25 mg, 179 μmol) and bromocyclopentane (58 μL, 537 μmol) was added over 24 h at rt, and then the reaction mixture was heated to 40 °C for another 5 d until the reaction appeared complete. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 33 mg of a white solid (40%). <sup>1</sup>H NMR δ 8.22 (d, <i>J</i> = 0.5 Hz, 1H), 7.87 (d, <i>J</i> = 0.6 Hz, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.58 (d, <i>J</i> = 8.3 Hz, 2H), 7.45–7.33 (m, 4H), 7.28–7.18 (m, 1H), 7.05 (td, <i>J</i> = 7.5/0.8 Hz, 1H), 6.53 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.77 (d, <i>J</i> = 6.0 Hz, 1H), 4.73–4.62 (m, 1H), 4.55 (br s, 1H), 3.82 (br s, 1H), 2.16–2.05 (m, 2H), 2.04–1.89 (m, 3H), 1.88–1.44 (m, 8H), 1.41–1.23 (m, 3H). <sup>13</sup>C NMR δ 162.2, 155.8, 148.8, 136.3, 134.74, 134.7, 132.8, 130.7, 130.3, 128.5, 127.5, 126.2, 125.4, 121.6, 118.9, 113.9, 107.4, 70.0, 69.6, 62.7, 35.9, 33.1, 31.5, 25.5, 24.5, 24.2; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>32</sub>H<sub>36</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 510.3; found, 510.4. LC-MS <i>t</i><sub>R</sub>: 3.80 min.</div></div><div id="sec4_4_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-(2-((4-(1-Cyclohexyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>15g</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (72 mg, 163 μmol) was alkylated with bromocyclohexane (22 μL, 179 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, additional K<sub>2</sub>CO<sub>3</sub> (25 mg, 179 μmol), KI (3 mg, 16 μmol), and bromocyclohexane (22 μL, 179 μmol) was added over 24 h at rt, and then the reaction mixture was heated to 40 °C for another 5 d, then to 60 °C for 24 h, and 80 °C for another 24 h until the reaction appeared complete. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 6 mg of a white solid (6%). <sup>1</sup>H NMR δ 8.22 (s, 1H), 7.86 (d, <i>J</i> = 0.6 Hz, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.58 (d, <i>J</i> = 8.3 Hz, 2H), 7.38 (dd, <i>J</i> = 10.4/4.5 Hz, 4H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 7.05 (td, <i>J</i> = 7.6/0.8 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 4.20–4.05 (m, 1H), 3.82 (br s, 1H), 2.08–1.96 (m, 3H), 1.86–1.66 (m, 7H), 1.64–1.48 (m, 1H), 1.47–1.16 (m, 7H). <sup>13</sup>C NMR δ 162.2, 155.8, 148.7, 135.9, 134.7, 132.8, 130.7, 130.3, 128.5, 127.5, 125.4, 125.3, 121.6, 118.9, 113.9, 107.4, 70.0, 69.8, 60.7, 35.9, 33.4, 25.5, 25.4, 25.3, 24.5; resonances at δ 134.7, 69.8, and 31.7 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>33</sub>H<sub>38</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 524.3; found, 524.4. LC-MS <i>t</i><sub>R</sub>: 3.89 min.</div></div><div id="sec4_4_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-(2-((4-(1-(Cyclopropylmethyl)-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>15h</b>)</h4><div class="NLM_p last">Compound (<b>15h</b>) was the main “side” product when alkylating 14-(2-((4-(1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) with bromocyclobutane. The titled product was synthesized and isolated when the reaction was performed at rt or at 40 °C. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 10 mg of the titled compound as a white solid (12%). <sup>1</sup>H NMR δ 8.21 (d, <i>J</i> = 0.6 Hz, 1H), 7.87 (d, <i>J</i> = 0.7 Hz, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.61–7.55 (m, 2H), 7.47–7.33 (m, 4H), 7.26–7.18 (m, 1H), 7.05 (td, <i>J</i> = 7.5/0.9 Hz, 1H), 6.53 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.18 (s, 2H), 4.76 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.98 (d, <i>J</i> = 7.1 Hz, 2H), 3.82 (br s, 1H), 2.06–1.96 (m, 1H), 1.81–1.65 (m, 3H), 1.63–1.45 (m, 1H), 1.42–1.19 (m, 4H), 0.62–0.49 (m, 2H), 0.45–0.35 (m, 2H). <sup>13</sup>C NMR δ 162.2, 155.8, 148.8, 136.3, 134.8, 134.8, 132.7, 130.8, 130.3, 128.5, 127.5, 127.1, 125.4, 121.8, 121.6, 118.9, 113.9, 107.4, 70.0, 69.6, 56.3, 35.9, 31.4, 25.5, 24.5, 12.0, 4.1; resonances at δ 134.8 and 31.4 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>31</sub>H<sub>34</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 496.3; found, 496.3. LC-MS <i>t</i><sub>R</sub>: 3.70 min.</div></div><div id="sec4_4_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-(2-((4-(1-(Cyclohexylmethyl)-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>15i</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (80 mg, 181 μmol) was alkylated with bromomethylcyclohexane (29 μL, 199 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis, additional bromocyclopentane (199 μL, 597 μmol) was added over 4 d at rt, and then the reaction mixture was heated to 40 °C for another 2 d until the reaction appeared complete. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 65 mg of a white solid (67%). <sup>1</sup>H NMR δ 8.14 (s, 1H), 7.87 (s, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.57 (d, <i>J</i> = 8.2 Hz, 2H), 7.45–7.33 (m, 4H), 7.25–7.17 (m, 1H), 7.04 (dd, <i>J</i> = 10.9/4.1 Hz, 1H), 6.53 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.17 (s, 2H), 4.76 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (s, 1H), 3.95 (d, <i>J</i> = 7.2 Hz, 2H), 3.88–3.74 (m, 1H), 2.06–1.95 (m, 1H), 1.90–1.78 (m, 1H), 1.77–1.47 (m, 9H), 1.41–1.26 (m, 3H), 1.26–1.05 (m, 3H), 1.03–0.87 (m, 2H). <sup>13</sup>C NMR δ 162.2, 155.8, 148.8, 136.5, 134.8, 134.7, 132.7, 130.7, 130.3, 128.5, 128.0, 127.5, 125.4, 121.6, 121.5, 118.9, 113.9, 107.4, 70.0, 69.7, 58.0, 38.7, 35.9, 31.5, 30.4, 26.4, 25.6, 25.5, 24.5; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>34</sub>H<sub>40</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 538.4; found, 538.3. LC-MS <i>t</i><sub>R</sub>: 4.31 min.</div></div><div id="sec4_4_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-(2-((4-(1-Benzyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>15j</b>)</h4><div class="NLM_p last">14-(2-((4-(1<i>H</i>-Pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>14</b>) (80 mg, 181 μmol) was alkylated with benzyl bromide (24 μL, 199 μmol) according to general procedure B. Reaction progress was monitored via LC-MS analysis; after 21 h at rt, the reaction appeared complete. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 61 mg of a white solid (63%). <sup>1</sup>H NMR δ 8.30 (d, <i>J</i> = 0.5 Hz, 1H), 7.93 (d, <i>J</i> = 0.6 Hz, 1H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.58 (d, <i>J</i> = 8.3 Hz, 2H), 7.43–7.25 (m, 9H), 7.21 (d, <i>J</i> = 8.2 Hz, 1H), 7.09–7.01 (m, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.45 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.35 (s, 2H), 5.17 (s, 2H), 4.75 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.80 (br s, 1H), 2.04–1.96 (m, 1H), 1.79–1.65 (m, 3H), 1.62–1.44 (m, 1H), 1.41–1.25 (m, 3H). <sup>13</sup>C NMR δ 162.2, 155.8, 148.8, 138.0, 137.1, 135.0, 134.7, 132.5, 130.7, 130.3, 129.0, 128.5, 128.1, 128.0, 127.9, 127.5, 125.5, 122.3, 121.6, 118.9, 113.9, 107.4, 70.0, 69.6, 55.5, 35.9, 31.5, 25.5, 24.5; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>34</sub>H<sub>34</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 532.3; found, 532.4. LC-MS <i>t</i><sub>R</sub>: 3.74 min.</div></div><div id="sec4_4_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-(2-((6-Chloropyridin-3-yl)methoxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>16</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (200 mg, 0.70 mmol) was alkylated with 2-chloro-5-(chloromethyl)pyridine (125 mg, 0.77 mmol) according to general procedure B. After a total of 40 h of stirring, the mixture was worked up. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 181 mg of a yellow oil (63%). <sup>1</sup>H NMR δ 8.48 (d, <i>J</i> = 1.9 Hz, 1H), 7.89 (dd, <i>J</i> = 8.2/2.5 Hz, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.54 (dd, <i>J</i> = 8.2/0.6 Hz, 1H), 7.46–7.35 (m, 2H), 7.23 (d, <i>J</i> = 7.7 Hz, 1H), 7.08 (td, <i>J</i> = 7.5/0.9 Hz, 1H), 6.48 (d, <i>J</i> = 1.9 Hz, 1H), 6.43 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.23 (s, 2H), 4.77 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (br s, 1H), 3.82 (br s, 1H), 2.10–1.92 (m, 1H), 1.83–1.64 (m, 3H), 1.61–1.46 (m, 1H), 1.44–1.24 (m, 3H). <sup>13</sup>C NMR δ 162.2, 155.4, 150.1, 149.4, 148.6, 139.5, 132.6, 134.7, 130.8, 130.4, 127.7, 124.7, 122.0, 118.9, 113.9, 107.4, 69.7, 67.1, 35.9, 31.5, 25.5, 24.5; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>23</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 411.1; found, 411.2. LC-MS <i>t</i><sub>R</sub>: 3.74 min.</div></div><div id="sec4_4_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-(2-Hydroxycyclohexyl)-4-(2-((6-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)methoxy)phenyl)pyridin-2(1<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">4-(2-((6-Chloropyridin-3-yl)methoxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>16</b>) (145 mg, 353 μmol) was coupled to 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (110 mg, 529 μmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 51 mg of a white solid (32%). <sup>1</sup>H NMR δ 8.56 (d, <i>J</i> = 1.7 Hz, 1H), 8.28 (s, 1H), 8.00 (d, <i>J</i> = 0.6 Hz, 1H), 7.79 (dd, <i>J</i> = 8.2/2.3 Hz, 1H), 7.71–7.61 (m, 2H), 7.44–7.35 (m, 2H), 7.26 (d, <i>J</i> = 7.9 Hz, 1H), 7.07 (td, <i>J</i> = 7.5/0.8 Hz, 1H), 6.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.44 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.19 (s, 2H), 4.78 (d, <i>J</i> = 6.0 Hz, 1H), 4.55 (br s, 1H), 3.89 (s, 3H), 3.80 (br s, 1H), 2.06–1.96 (m, 1H), 1.79–1.64 (m, 3H), 1.63–1.41 (m, 1H), 1.41–1.22 (m, 3H). <sup>13</sup>C NMR δ 162.2, 155.6, 151.8, 149.2, 148.7, 137.6, 136.9, 134.7, 130.8, 130.4, 130.1, 129.8, 127.6, 123.0, 121.8, 119.4, 118.9, 114.0, 107.3, 69.7, 68.0, 39.2, 35.9, 31.5, 25.5, 24.5; resonance at δ 134.7 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>27</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 457.2; found, 457.3. LC-MS <i>t</i><sub>R</sub>: 3.34 min.</div></div><div id="sec4_4_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-(2-((4-Bromo-2-fluorobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">1-(2-Hydroxycyclohexyl)-4-(2-hydroxyphenyl)pyridin-2(1<i>H</i>)-one (<b>7</b>) (300 mg, 1.05 mmol) was alkylated with 4-bromo-1-(bromomethyl)-2-fluorobenzene (310 mg, 1.16 mmol) according to general procedure B. After a total of 64 h of stirring, the mixture was worked up. Purification by FCC (eluent MeOH/DCM 0:100 to 6:94) gave 310 mg of a yellow oil (62%). <sup>1</sup>H NMR δ 7.65 (d, <i>J</i> = 7.2 Hz, 1H), 7.63–7.57 (m, 1H), 7.49–7.36 (m, 4H), 7.24 (d, <i>J</i> = 7.8 Hz, 1H), 7.08 (td, <i>J</i> = 7.5/0.9 Hz, 1H), 6.47 (d, <i>J</i> = 1.9 Hz, 1H), 6.40 (dd, <i>J</i> = 7.2/2.0 Hz, 1H), 5.19 (s, 2H), 4.76 (d, <i>J</i> = 5.9 Hz, 1H), 4.53 (br s, 1H), 3.84 (br s, 1H), 2.06–1.94 (m, 1H), 1.78–1.64 (m, 3H), 1.62–1.43 (m, 1H), 1.41–1.24 (m, 3H). <sup>13</sup>C NMR δ 162.2, 161.8, 160.5 (d, <i>J</i><sub>CF</sub> = 252 Hz), 148.6, 134.8, 132.2 (d, <i>J</i><sub>CF</sub> = 4.7 Hz), 130.8, 130.4, 128.2 (d, <i>J</i><sub>CF</sub> = 3.5 Hz), 127.6, 127.6, 123.9 (d, <i>J</i><sub>CF</sub> = 14.5 Hz), 122.1, 122.0, 119.3 (d, <i>J</i><sub>CF</sub> = 24.7 Hz), 118.9, 113.8, 107.3, 69.6, 64.1 (d, <i>J</i><sub>CF</sub> = 3.1 Hz), 35.9, 31.5, 25.5, 24.5; resonance at δ 134.8 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>24</sub>BrFNO<sub>3</sub> [M + H]<sup>+</sup> calcd, 472.1; found, 472.2. LC-MS <i>t</i><sub>R</sub>: 3.79 min.</div></div><div id="sec4_4_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-(2-((2-Fluoro-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last">4-(2-((4-Bromo-2-fluorobenzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>18</b>) (150 mg, 318 μmol) was coupled to 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (99 mg, 476 μmol) according to general procedure A. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92), followed by freeze-drying of the combined product fractions to remove the remaining pinacol, gave 45 mg of a white solid (30%). <sup>1</sup>H NMR δ 8.22 (s, 1H), 7.94 (s, 1H), 7.64 (d, <i>J</i> = 7.2 Hz, 1H), 7.51–7.36 (m, 5H), 7.27 (d, <i>J</i> = 8.2 Hz, 1H), 7.07 (t, <i>J</i> = 7.4 Hz, 1H), 6.49 (d, <i>J</i> = 1.6 Hz, 1H), 6.41 (dd, <i>J</i> = 7.2/1.8 Hz, 1H), 5.19 (s, 2H), 4.74 (d, <i>J</i> = 6.0 Hz, 1H), 4.52 (br s, 1H), 3.87 (s, 3H), 3.78 (br s, 1H), 2.04–1.92 (m, 1H), 1.79–1.62 (m, 3H), 1.60–1.39 (m, 1H), 1.39–1.19 (m, 3H). <sup>13</sup>C NMR δ 162.2, 161.3 (d, <i>J</i><sub>CF</sub> = 246 Hz), 155.7, 148.6, 136.9, 135.6 (d, <i>J</i><sub>CF</sub> = 10.0 Hz), 134.6, 131.4 (d, <i>J</i><sub>CF</sub> = 4.7 Hz), 130.8, 130.4, 128.9, 121.8, 121.2, 121.1, 121.0 (d, <i>J</i><sub>CF</sub> = 2.2 Hz), 118.9, 113.8, 112.0 (d, <i>J</i><sub>CF</sub> = 4.7 Hz), 107.2, 69.6, 64.5, 39.2, 35.9, 31.3, 25.5, 24.4; resonances at δ 134.6 and 31.3 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>28</sub>H<sub>29</sub>FN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 474.2; found, 474.3. LC-MS <i>t</i><sub>R</sub>: 3.55 min.</div></div><div id="sec4_4_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-(3,6-Difluoro-2-methoxyphenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>20</b>)</h4><div class="NLM_p last">4-Bromo-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>4b</b>) (1.00 g, 3.67 mmol) was coupled to (3,6-difluoro-2-methoxyphenyl)boronic acid (1.04 g, 5.51 mmol) according to general procedure A. The reaction was stirred for 5 h before work up. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) and (eluent EtOAC 100%) gave 285 mg of the desired compound as a white solid (23%) in a 1:1 mixture of the desired product and an unidentified impurity. <sup>1</sup>H NMR δ 7.77 (d, <i>J</i> = 7.2 Hz, 1H), 7.41 (ddd, <i>J</i> = 11.3/9.3/5.3 Hz, 1H), 7.11 (td, <i>J</i> = 9.2/3.9 Hz, 1H), 6.39 (s, 1H), 6.26–6.20 (m, 1H), 4.82 (d, <i>J</i> = 6.1 Hz, 1H), 4.55 (br s, 1H), 3.82 (d, <i>J</i> = 1.9 Hz, 3H), 3.75 (br s, 1H), 2.06–1.90 (m, 1H), 1.81–1.64 (m, 3H), 1.62–1.46 (m, 1H), 1.42–1.21 (m, 3H).</div></div><div id="sec4_4_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 4-(3,6-Difluoro-2-hydroxyphenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>21</b>)</h4><div class="NLM_p last">Boron tribromide in hexane (1 M, 3.88 mL, 3.88 mmol) was added at 0 °C to a solution of 4-(3,6-difluoro-2-methoxyphenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>20</b>) (260 mg, 775 μmol) (1:1 mixture with unidentified impurity) in dichloromethane (8 mL). The mixture was stirred at rt under N<sub>2</sub> for 1 h and then poured into ice–water. The pH of the solution was adjusted to pH 6 by addition of satd NaHCO<sub>3</sub>. Dichloromethane (20 mL) was added, and the layers were separated. The organic layer was washed with water (2 × 20 mL) and brine (20 mL) and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent evaporated under reduced pressure. The desired compound was obtained as a white solid (89 mg, 72%). No further purification was required. <sup>1</sup>H NMR δ 10.33 (br s, 1H), 7.73 (d, <i>J</i> = 7.2 Hz, 1H), 7.27 (ddd, <i>J</i> = 10.4/9.2/5.3 Hz, 1H), 6.78 (td, <i>J</i> = 9.3/3.8 Hz, 1H), 6.38 (s, 1H), 6.27–6.20 (m, 1H), 4.80 (d, <i>J</i> = 6.0 Hz, 1H), 4.51 (br s, 1H), 3.81 (br s, 1H), 2.07–1.95 (m, 1H), 1.82–1.66 (m, 3H), 1.63–1.45 (m, 1H), 1.43–1.25 (m, 3H). <sup>13</sup>C NMR δ 162.0, 155.8 (dd, <i>J</i><sub>CF</sub> = 240.9/1.6 Hz), 148.8 (dd, <i>J</i><sub>CF</sub> = 234.9/2.7 Hz), 143.6 (dd, <i>J</i><sub>CF</sub> = 17.1/7.0 Hz), 142.0 (d, <i>J</i><sub>CF</sub> = 2.1 Hz), 135.1, 121.1, 117.0 (dd, <i>J</i><sub>CF</sub> = 19.0/2.8 Hz), 116.4 (dd, <i>J</i><sub>CF</sub> = 21.1/11.0 Hz), 107.9, 106.2 (dd, <i>J</i><sub>CF</sub> = 25.5/7.3 Hz), 69.6, 35.9, 31.5, 25.5, 24.5; resonance at δ 135.1 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>18</sub>F<sub>2</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 322.1; found, 322.1. LC-MS <i>t</i><sub>R</sub>: 3.35 min.</div></div><div id="sec4_4_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-(2-((4-Bromobenzyl)oxy)-3,6-difluorophenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">4-(3,6-Difluoro-2-hydroxyphenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>21</b>) (75 mg, 233 μmol, 1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (36 mg, 257 μmol, 1.1 equiv), KI (4 mg, 23 μmol, 0.1 equiv), and 1-bromo-4-(bromomethyl)benzene (64 mg, 257 mmol, 1.1 equiv) were stirred in DMF (3 mL) at rt for 3 h. The reaction mixture was poured onto water and stirred for 30 min before extraction with EtOAc (2 × 20 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent removed under reduced pressure. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) gave 83 mg of the desired product as a white solid (73%). <sup>1</sup>H NMR δ 7.75 (d, <i>J</i> = 7.2 Hz, 1H), 7.51–7.46 (m, 2H), 7.46–7.39 (m, 1H), 7.18–7.10 (m, 3H), 6.40–6.30 (m, 1H), 6.24–6.16 (m, 1H), 4.96 (s, 2H), 4.83 (d, <i>J</i> = 6.0 Hz, 1H), 4.56 (br s, 1H), 3.86 (br s, 1H), 2.11–1.97 (m, 1H), 1.83–1.67 (m, 3H), 1.67–1.48 (m, 1H), 1.44–1.29 (m, 3H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 161.7, 155.2 (dd, <i>J</i><sub>CF</sub> = 242.8/1.9 Hz), 152.4 (dd, <i>J</i><sub>CF</sub> = 242.1/3.0 Hz), 144.1 (dd, <i>J</i><sub>CF</sub> = 13.4/5.8 Hz), 141.5 (d, <i>J</i><sub>CF</sub> = 2.0 Hz), 135.9, 135.5, 131.7, 130.8, 122.7 (dd, <i>J</i><sub>CF</sub> = 18.5/2.3 Hz), 122.0, 121.1, 117.8 (dd, <i>J</i><sub>CF</sub> = 21.8/10.6 Hz), 112.0 (dd, <i>J</i><sub>CF</sub> = 25.1/8.1 Hz), 107.6, 75.3 (d, <i>J</i> = 5.3 Hz), 69.7, 35.8, 31.5, 25.5, 24.5; resonance at δ 135.5 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>24</sub>H<sub>23</sub>BrF<sub>2</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 490.1; found, 490.2. LC-MS <i>t</i><sub>R</sub>: 3.79 min.</div></div><div id="sec4_4_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-(3,6-Difluoro-2-((4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p last">4-(2-((4-Bromobenzyl)oxy)-3,6-difluorophenyl)-1-(2-hydroxycyclohexyl)pyridin-2(1<i>H</i>)-one (<b>22</b>) (77 mg, 157 μmol) was coupled to 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (49 mg, 236 μmol) according to general procedure A. The reaction was stirred at reflux for 2 h before work up. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) gave 24 mg of a white solid (31%). <sup>1</sup>H NMR δ 8.11 (s, 1H), 7.83 (d, <i>J</i> = 0.6 Hz, 1H), 7.74 (d, <i>J</i> = 7.2 Hz, 1H), 7.50–7.45 (m, 2H), 7.45–7.39 (m, 1H), 7.18–7.11 (m, 3H), 6.37 (d, <i>J</i> = 1.6 Hz, 1H), 6.26–6.15 (m, 1H), 4.94 (s, 2H), 4.83 (d, <i>J</i> = 6.0 Hz, 1H), 4.60 (br s, 1H), 3.86 (s, 3H), 3.81 (br s, 1H), 2.11–1.99 (m, 1H), 1.86–1.68 (m, 3H), 1.65–1.47 (m, 1H), 1.45–1.28 (m, 3H). <sup>13</sup>C NMR δ 161.7, 155.2 (dd, <i>J</i><sub>CF</sub> = 243.1/2.0 Hz), 152.5 (dd, <i>J</i><sub>CF</sub> = 242.0/2.9 Hz), 144.2 (dd, <i>J</i><sub>CF</sub> = 13.6/5.9 Hz), 141.6, 136.5, 135.4, 133.9, 133.1, 129.5, 128.4, 125.2, 122.8 (dd, <i>J</i><sub>CF</sub> = 18.2/2.2 Hz), 121.9, 121.1, 117.7 (dd, <i>J</i><sub>CF</sub> = 21.8/10.3 Hz), 111.9 (dd, <i>J</i><sub>CF</sub> = 25.1/8.1 Hz), 107.6, 76.0 (d, <i>J</i><sub>CF</sub> = 5.0 Hz), 69.7, 39.1, 35.9, 31.6, 25.5, 24.5; resonance at δ 135.4 ppm was taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>28</sub>H<sub>28</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 492.2; found, 492.3. LC-MS <i>t</i><sub>R</sub>: 3.59 min.</div></div><div id="sec4_4_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 6-(2-Methoxyphenyl)pyrimidin-4(3<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">6-Chloropyrimidin-4(3<i>H</i>)-one (<b>24</b>) (1.00 g, 7.66 mmol) was coupled to (2-methoxyphenyl)boronic acid (1.85 g, 11.5 mmol) according to general procedure A. The reaction was stirred for 48 h before work up. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) gave 315 mg of a white solid (20%). <sup>1</sup>H NMR δ 12.48 (br s, 1H), 8.24 (d, <i>J</i> = 1.0 Hz, 1H), 7.92 (dd, <i>J</i> = 7.8/1.8 Hz, 1H), 7.50–7.40 (m, 1H), 7.21–7.13 (m, 1H), 7.06 (td, <i>J</i> = 7.7/1.0 Hz, 1H), 6.90 (d, <i>J</i> = 1.0 Hz, 1H), 3.87 (s, 3H). <sup>13</sup>C NMR δ 162.0, 159.1, 158.1, 149.6, 131.9, 130.7, 125.4, 120.9, 115.0, 112.5, 56.1. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>11</sub>H<sub>11</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 203.2; found, 203.1. LC-MS <i>t</i><sub>R</sub>: 3.25 min.</div></div><div id="sec4_4_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 3-(2-Hydroxycyclohexyl)-6-(2-methoxyphenyl)pyrimidin-4(3<i>H</i>)-one (<b>26</b>)</h4><div class="NLM_p last">A mixture of 6-(2-methoxyphenyl)pyrimidin-4(3<i>H</i>)-one (<b>25</b>) (274 mg, 1.36 mmol, 1.0 equiv), 1,2-cyclohexene oxide (686 μL, 6.78 mmol, 5.0 equiv), and K<sub>2</sub>CO<sub>3</sub> (468 mg, 3.39 mmol, 2.5 equiv) was heated at 120 °C for 5 h. The reaction mixture was cooled to rt and concentrated to dryness under reduced pressure. The remaining residue was taken up in EtOAc (50 mL) and washed with water. The organic layer was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent removed under reduced pressure. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) and FCC eluent MeOH/DCM 0:100 to 6:94) yielded 153 mg of the desired compound as a colorless oil (38%). <sup>1</sup>H NMR δ 8.54 (br s, 1H), 7.95 (dd, <i>J</i> = 7.8/1.8 Hz, 1H), 7.68–7.53 (m, 1H), 7.16 (dd, <i>J</i> = 8.4/0.7 Hz, 1H), 7.07 (td, <i>J</i> = 7.7/1.0 Hz, 1H), 6.96 (d, <i>J</i> = 0.4 Hz, 1H), 4.98 (d, <i>J</i> = 5.7 Hz, 1H), 4.33 (br s, 1H), 3.97 (br s, 1H), 3.88 (s, 3H), 2.08–1.97 (m, 1H), 1.84–1.61 (m, 4H), 1.40–1.22 (m, 3H). <sup>13</sup>C NMR δ 161.5, 158.1, 157.0, 150.1, 131.8, 130.6, 125.2, 120.9, 113.9, 112.5, 69.2, 56.1, 35.7, 31.0, 25.4, 24.4; resonances at δ 150.1 and 31.0 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>17</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 301.2; found, 301.2. LC-MS <i>t</i><sub>R</sub>: 3.42 min.</div></div><div id="sec4_4_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 3-(2-Hydroxycyclohexyl)-6-(2-hydroxyphenyl)pyrimidin-4(3<i>H</i>)-one (<b>27</b>)</h4><div class="NLM_p last">A 1 M solution boron tribromide in hexane (2.37 mL, 2.37 mmol, 5.0 equiv) was added at 0 °C to a solution of 3-(2-hydroxycyclohexyl)-6-(2-methoxyphenyl)pyrimidin-4(3<i>H</i>)-one (<b>26</b>) (90 mg, 475 μmol, 1.0 equiv) in dichloromethane (4 mL). The mixture was stirred at rt under N<sub>2</sub> for 30 min and then poured into ice–water. The pH of the solution was adjusted to pH 6 by addition of satd NaHCO<sub>3</sub>. Dichloromethane (20 mL) was added, and the layers were separated. The organic layer was washed with water (2 × 20 mL) and brine (20 mL) and then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent evaporated under reduced pressure. The desired compound was obtained as a white solid (75 mg, 87%). No further purification was required. <sup>1</sup>H NMR δ 12.80–10.80 (br s, 1H), 8.61 (br s, 1H), 7.84 (dd, <i>J</i> = 7.9/1.6 Hz, 1H), 7.24 (ddd, <i>J</i> = 8.5/7.2/1.6 Hz, 1H), 6.99 (s, 1H), 6.87–6.77 (m, 2H), 4.78 (s, 1H), 4.25 (br s, 1H), 3.92–3.77 (br s, 1H), 1.96–1.88 (m, 1H), 1.79–1.53 (m, 4H), 1.31–1.16 (m, 3H). <sup>13</sup>C NMR δ 161.1, 158.8, 158.5, 150.4, 132.8, 128.8, 119.8, 118.2, 118.2, 109.3, 69.2, 35.6, 30.8, 25.4, 24.4; resonances at δ 150.4, 69.2, and 30.8 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>16</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 287.1; found, 287.2. LC-MS <i>t</i><sub>R</sub>: 3.46 min.</div></div><div id="sec4_4_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 6-(2-((4-Bromobenzyl)oxy)phenyl)-3-(2-hydroxycyclohexyl)pyrimidin-4(3<i>H</i>)-one (<b>28</b>)</h4><div class="NLM_p last">3-(2-Hydroxycyclohexyl)-6-(2-hydroxyphenyl)pyrimidin-4(3<i>H</i>)-one (<b>27</b>) (76 mg, 265 μmol, 1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (40 mg, 292 μmol, 1.1 equiv), KI (4 mg, 27 μmol, 0.1 equiv), and 1-bromo-4-(bromomethyl)benzene (73 mg, 292 mmol, 1.1 equiv) were stirred in DMF (3 mL) at rt for 4 h. The reaction mixture was poured onto water and stirred for 30 min before extraction with EtOAc (2 × 20 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent removed under reduced pressure. Purification by FCC (eluent MeOH/DCM 0:100 to 10:90) gave 66 mg of the desired product as a beige solid (55%). <sup>1</sup>H NMR δ 8.54 (s, 1H), 7.96 (dd, <i>J</i> = 7.8/1.8 Hz, 1H), 7.62–7.58 (m, 2H), 7.47–7.39 (m, 3H), 7.21 (d, <i>J</i> = 7.7 Hz, 1H), 7.12–7.06 (m, 1H), 6.98 (d, <i>J</i> = 0.6 Hz, 1H), 5.24 (s, 2H), 4.96 (d, <i>J</i> = 5.8 Hz, 1H), 4.27 (br s, 1H), 3.95 (br s, 1H), 2.06–1.95 (m, 1H), 1.85–1.62 (m, 4H), 1.40–1.23 (m, 3H). <sup>13</sup>C NMR δ 161.4, 157.0, 156.9, 150.1, 136.7, 131.9, 131.4, 130.8, 130.2, 125.6, 121.5, 121.3, 114.0, 113.9, 69.5, 69.1, 35.7, 31.0, 25.4, 24.4; resonances at δ 150.1, 69.1, and 31.0 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>23</sub>H<sub>24</sub>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 455.1; found, 455.2. LC-MS <i>t</i><sub>R</sub>: 3.77 min.</div></div><div id="sec4_4_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 3-(2-Hydroxycyclohexyl)-6-(2-((4-(1-methyl-1<i>H</i>-pyrazol-4-yl)benzyl)oxy)phenyl)pyrimidin-4(3<i>H</i>)-one (<b>29</b>)</h4><div class="NLM_p last">6-(2-((4-Bromobenzyl)oxy)phenyl)-3-(2-hydroxycyclohexyl)pyrimidin-4(3<i>H</i>)-one (<b>28</b>) (66 mg, 145 μmol) was coupled to 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (45 mg, 217 μmol) according to general procedure A. The reaction was stirred at reflux for 25 h before the work up. Purification by FCC (eluent MeOH/DCM 0:100 to 8:92) gave 7 mg of a white solid (11%). <sup>1</sup>H NMR δ 8.54 (br s, 1H), 8.15 (s, 1H), 7.99 (dd, <i>J</i> = 7.8/1.8 Hz, 1H), 7.87 (d, <i>J</i> = 0.7 Hz, 1H), 7.61–7.56 (m, 2H), 7.48–7.40 (m, 3H), 7.26 (d, <i>J</i> = 7.8 Hz, 1H), 7.13–7.06 (m, 1H), 7.05 (t, <i>J</i> = 3.1 Hz, 1H), 5.24 (s, 2H), 4.95 (d, <i>J</i> = 5.7 Hz, 1H), 4.39–4.22 (m, 1H), 3.99–3.91 (m, 1H), 3.87 (br s, 3H), 2.06–2.00 (m, 1H), 1.88–1.63 (m, 4H), 1.37–1.28 (m, 3H). <sup>13</sup>C NMR δ 161.4, 157.2, 156.9, 150.1, 136.5, 134.6, 132.8, 131.7, 130.8, 128.7, 128.3, 125.5, 122.0, 121.2, 120.8, 114.0, 113.9, 68.9, 39.1, 35.7, 29.4, 25.4, 21.2; resonances at δ 150.1, 114.0, and 69.9 ppm were taken from the HSQC experiment. <i>m</i>/<i>z</i> MS (TOF ES<sup>+</sup>) C<sub>27</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> calcd, 457.2; found, 457.3. LC-MS <i>t</i><sub>R</sub>: 3.53 min.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Pharmacology</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Intact Cell Radioligand Binding Assays</h4><div class="NLM_p last">Flp-In Chinese hamster ovary (CHO) cells expressing the human muscarinic acetylcholine M<sub>1–5</sub> receptor (hM<sub>1–5</sub> mAChR) were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen, Carlsbad, CA) supplemented with fetal bovine serum (FBS) (ThermoTrace (Melbourne, Australia) and 0.2 mg/mL hygromycin-B (Roche, Mannheim, Germany). The cells were plated at 10<sup>4</sup> cells per well in 96-well Isoplates (PerkinElmer). Prior to assay, the growth medium was removed and the attached cells were used to perform radioligand binding studies in the presence of 0.2 nM [<sup>3</sup>H]NMS and varying concentrations of acetylcholine (Sigma, St. Loius, MI) and PAMs in a total volume of 200 μL of binding buffer (10 mM HEPES, 145 mM NaCl, 1 mM MgSO<sub>4</sub>·7H<sub>2</sub>O, 10 mM glucose, 5 mM KCl, 2 mM CaCl<sub>2</sub>, 1.5 mM NaHCO<sub>3</sub>, pH 7.4). The binding reaction mixtures were incubated for 1 h at 37 °C in a humidified incubator and terminated by rapid removal of radioligand followed by two 100 μL washes with ice-cold 0.9% NaCl buffer. Radioactivity was determined by addition of 100 μL of Microscint scintillation liquid (PerkinElmer Life Sciences) to each well and counting in a MicroBeta plate reader (PerkinElmer Life Sciences).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> IP-One Accumulation Assays</h4><div class="NLM_p last">The IP-One assay kit (Cisbio, France) was used for the direct quantitative measurement of myo-inositol 1 phosphate (IP<sub>1</sub>) in FlpIn CHO cells stably expressing the hM<sub>1</sub> mAChR. The cells were detached and resuspended in IP<sub>1</sub> stimulation buffer (10 mM Hepes, 1 mM CaCl<sub>2</sub>, 0.5 mM MgCl<sub>2</sub>, 4.2 mM KCl, 146 mM NaCl, 5.5 mM glucose, 50 mM LiCl, pH 7.4). The stimulations were performed in 384-well Proxy-plates (PerkinElmer) in a total volume of 14 μL in the absence or presence of increasing concentrations of ACh and the PAMs at cell density of 10<sup>6</sup> million cells/mL for 1 h at 37 °C, 5% CO<sub>2</sub>. The reactions were terminated by addition of 6 μL of lysis buffer containing HTRF reagents (the anti-IP1 Tb cryptate conjugate and the IP1-D2 conjugate), followed by incubation for 1 h at room temperature. The emission signals were measured at 590 and 665 nm after excitation at 340 nm using an Envision multilabel plate reader (PerkinElmer), and the signal was expressed as the HTRF ratio: <i>F</i> = ((fluorescence<sub>665 nm</sub>/fluorescence<sub>590 nm</sub>) × 10<sup>4</sup>).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Data Analysis</h4><div class="NLM_p">All data were analyzed using Prism 6.01 (GraphPad Software, San Diego, CA). Binding interaction studies with allosteric ligands were fitted to the following allosteric ternary complex model (<a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>):<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a><span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/jm-2015-01562m_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>Y</i> is percentage (vehicle control) binding, <i>B</i><sub>max</sub> is the total number of receptors, [A], [B], and [I] are the concentrations of radioligand, allosteric modulator, and the orthosteric ligand, respectively, <i>K</i><sub>A</sub> and <i>K</i><sub>B</sub> and <i>K</i><sub>I</sub> are the equilibrium dissociation constants of the radioligand, allosteric modulator, and orthosteric ligand, respectively. α′ and α are the binding cooperativities between the allosteric ligand and [<sup>3</sup>H]NMS and the allosteric modulator and the agonist acetylcholine, respectively. Saturation binding experiments were used to determine the value of p<i>K</i><sub>A</sub> for [<sup>3</sup>H]NMS (p<i>K</i><sub>A</sub> = 9.70 ± 0.01, <i>K</i><sub>A</sub> = 0.2 nM).Values of α (or α′) > 1 denote positive cooperativity; values <1 (but >0) denote negative cooperativity, and value = 1 denotes neutral cooperativity. For the majority of compounds an unlimited displacement of [<sup>3</sup>H]NMS by the allosteric modulator was observed consistent with a high level of negative cooperativity. In these cases, to allow fitting of the data, Log α′ was fixed to −3 to reflect this high negative cooperativity. The dissociation constant of ACh (<i>K</i><sub>I</sub>) was not fixed in these analyses but rather determined for each separate experiment. No difference was observed in the value of <i>K</i><sub>I</sub> between experiments (mean p<i>K</i><sub>I</sub> = 4.56 ± 0.02, <i>K</i><sub>I</sub> = 28 μM).</div><div class="NLM_p">Concentration–response curves for the interaction between the allosteric ligand and the orthosteric ligand in the IP-One accumulation assays were globally fitted to the following operational model of allosterism and agonism (<a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>):<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/jm-2015-01562m_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>where <i>E</i><sub>m</sub> is the maximum possible cellular response, [A] and [B] are the concentrations of orthosteric and allosteric ligands, respectively, <i>K</i><sub>A</sub> and <i>K</i><sub>B</sub> are the equilibrium dissociation constant of the orthosteric and allosteric ligands, respectively, τ<sub>A</sub> and τ<sub>B</sub> are operational measures of orthosteric and allosteric ligand efficacy, respectively, α is the binding cooperativity parameter between the orthosteric and allosteric ligand, β denotes the magnitude of the allosteric effect of the modulator on the efficacy of the orthosteric agonist, and <i>n</i> denotes the transducer slope that describes the underlying stimulus–response coupling of the ligand-occupied receptor to the signal pathway. This parameter was constrained to be shared between all curves within a fitted data set for each interaction study and in all instances was not significantly different from unity (average across entire series, <i>n</i> = 1.04 ± 0.04). In many instances, the individual model parameters of <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a> could not be directly estimated via the nonlinear regression algorithm by analysis of the functional data alone due to parameter redundancy. To facilitate model convergence, therefore, we fixed the equilibrium dissociation constant of each ligand to that determined from the whole cell binding assays. For compounds <b>9c</b>, <b>15h</b>, and <b>17</b>, no agonism was observed, and therefore Log τ<sub>B</sub> was fixed to −3.</div><div class="NLM_p last">All affinity, potency, and cooperativity values were estimated as logarithms and statistical comparisons between values were by one-way analysis of variance using a Dunnett’s multiple comparison post test to determine significant differences between mutant receptors and the WT M<sub>1</sub> mAChR. A value of <i>p</i> <  0.05 was considered statistically significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01562">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01562" class="ext-link">10.1021/acs.jmedchem.5b01562</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Representative NMR experiments of the compound <b>8p</b> in DMSO-<i>d</i><sub>6</sub> and CDCl<sub>3</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_001.pdf">jm5b01562_si_001.pdf (350.24 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_002.csv">jm5b01562_si_002.csv (4.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01562" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Robert Lane</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#74261b165a38151a1134191b1a15071c5a111001"><span class="__cf_email__" data-cfemail="c694a9a4e88aa7a8a386aba9a8a7b5aee8a3a2b3">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Scammells</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#762613021304582515171b1b131a1a05361b191817051e58131203"><span class="__cf_email__" data-cfemail="3b6b5e4f5e491568585a56565e5757487b5654555a4853155e5f4e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shailesh N. Mistry</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Jörg</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herman Lim</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalie B. Vinh</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick M. Sexton</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Capuano</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur Christopoulos</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
Chemistry and ‡Drug Discovery Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria Australia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.N.M. and M.J. contributed equally to this work. The manuscript was written through contributions of all authors and all authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1386e10056-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by Discovery grant DP110100687 of the Australian Research Council as well as Program grant APP1055134 and Project grant APP1049564 of the National Health and Medicinal Research Council (NHMRC) of Australia. J.R.L. is a R.D. Wright Biomedical Career Development Fellow and a Larkin’s Fellow (Monash University, Australia) while A.C. is Senior Principal Research Fellow and P.M.S. is a Principal Research Fellow of the NHMRC.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> Abbreviations Used</h2><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylchloline</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">cat</td><td class="NLM_def"><p class="first last">catalytic</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FCC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr><tr><td class="NLM_term">M<sub>1</sub> mAChR</td><td class="NLM_def"><p class="first last">M<sub>1</sub> muscarinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum spirits 40–60</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SZ</td><td class="NLM_def"><p class="first last">schizophrenia</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reavill, C.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors as CNS drug targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.pharmthera.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18082893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=232-243&author=C.+J.+Langmeadauthor=J.+Watsonauthor=C.+Reavill&title=Muscarinic+acetylcholine+receptors+as+CNS+drug+targets&doi=10.1016%2Fj.pharmthera.2007.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors as CNS drug targets</span></div><div class="casAuthors">Langmead, Christopher J.; Watson, Jeannette; Reavill, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are widely expressed in the CNS where they control a variety of neuronal functions.  Due to their roles in a no. of CNS processes, mAChRs have long been a target of the drug discovery industry; however, the only mAChR ligands approved for use in the clinic are non-selective antagonists for the treatment of Parkinson's disease.  This article briefly reviews recent progress made in mAChR drug discovery for Alzheimer's disease (AD), schizophrenia and Parkinson's disease, with particular emphasis on novel target validation, as well as highlighting novel indications such as drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxKbNG-yy87Vg90H21EOLACvtfcHk0liJ3XF08RDReQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D&md5=a65c212d434f0172b4e6800cc19df427</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DReavill%26aufirst%3DC.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%2520as%2520CNS%2520drug%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D232%26epage%3D243%26doi%3D10.1016%2Fj.pharmthera.2007.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/j.tips.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.tips.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19201489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVGguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=148-155&author=P.+J.+Connauthor=C.+K.+Jonesauthor=C.+W.+Lindsley&title=Subtype-selective+allosteric+modulators+of+muscarinic+receptors+for+the+treatment+of+CNS+disorders&doi=10.1016%2Fj.tips.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</span></div><div class="casAuthors">Conn, P. Jeffrey; Jones, Carrie K.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-155</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) have long been viewed as viable targets for novel therapeutic agents for the treatment of Alzheimer's disease (AD) and other disorders involving impaired cognitive function.  More recent evidence indicates that mAChR activators might also have utility in treating psychosis and other symptoms assocd. with schizophrenia and other central nervous system (CNS) disorders.  Efforts to develop mAChR subtype-selective agonists have been hampered by difficulty in achieving high selectivity for individual mAChR subtypes important for CNS function (M1 and M4) and adverse effects due to activation of peripheral mAChRs (esp. M2 and M3).  Major advances have now been achieved in the discovery of allosteric agonists and pos. allosteric modulators of M1 and M4 that show greater selectivity for individual mAChR subtypes than do previous mAChR agonists.  Early studies indicate that these allosteric mAChR activators have properties needed for optimization as potential clin. candidates and have robust effects in animal models that predict efficacy in the treatment of AD, schizophrenia and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn8LX_geAENrVg90H21EOLACvtfcHk0lgTn5uIjzN4KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVGguro%253D&md5=65cf3e1dee603502b5eb72f60a98be98</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubtype-selective%2520allosteric%2520modulators%2520of%2520muscarinic%2520receptors%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D148%26epage%3D155%26doi%3D10.1016%2Fj.tips.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Dean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keriakous, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarr, E.</span><span> </span><span class="NLM_article-title">Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span><span class="refDoi"> DOI: 10.1038/sj.mp.4001199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fsj.mp.4001199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=12476323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=1083-1091&author=B.+Deanauthor=M.+McLeodauthor=D.+Keriakousauthor=J.+McKenzieauthor=E.+Scarr&title=Decreased+muscarinic1+receptors+in+the+dorsolateral+prefrontal+cortex+of+subjects+with+schizophrenia&doi=10.1038%2Fsj.mp.4001199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span></div><div class="casAuthors">Dean, B.; McLeod, M.; Keriakous, D.; McKenzie, J.; Scarr, E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1083-1091</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To test the hypothesis that muscarinic receptors are involved in the pathol. of schizophrenia, we measured muscarinic1 (M1R) and muscarinic4(M4R) protein and mRNA as well as [3H]pirenzepine binding in Brodmann's areas (BA) 9 and 40 obtained postmortem from 20 schizophrenic and 20 age/sex-matched control subjects.  There was a significant decrease in [3H]pirenzepine binding to BA 9 (mean ± SEM: 151 ± 15 vs 195 ± 10 fmol mg-1 ETE; P< 0.02), but not BA 40 (143 ± 13 vs 166 ± 11 fmol mg-1 ETE), from subjects with schizophrenia.  The level of M1R protein (0.11 ± 0.007 vs 0.15 ± 0.008 OD; P < 0.01), but not M4R protein, was decreased in BA9 from schizophrenic subjects with neither receptor protein being altered in BA 40.  The level of M1R mRNA was decreased in BA 9 (30 ± 7.0 vs 79 ± 14 dpm × 103 mg-1ETE, P < 0.01) and BA 40 (28 ± 5.9 vs 99 ± 14, P < 0.01) with schizophrenia but M4R mRNA was only decreased in BA 40 (48 ± 6.6 vs 89 ± 9.9, P < 0.005).  These data suggest that the M1R, at least in the dorsolateral prefrontal cortex, may have a role in the pathol. of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCGS6ZN-tPSbVg90H21EOLACvtfcHk0lgTn5uIjzN4KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D&md5=452f2732469bfcdf46def48079970f80</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001199%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DB.%26aulast%3DMcLeod%26aufirst%3DM.%26aulast%3DKeriakous%26aufirst%3DD.%26aulast%3DMcKenzie%26aufirst%3DJ.%26aulast%3DScarr%26aufirst%3DE.%26atitle%3DDecreased%2520muscarinic1%2520receptors%2520in%2520the%2520dorsolateral%2520prefrontal%2520cortex%2520of%2520subjects%2520with%2520schizophrenia%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D1083%26epage%3D1091%26doi%3D10.1038%2Fsj.mp.4001199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Scarr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, B.</span><span> </span><span class="NLM_article-title">Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05711.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1111%2Fj.1471-4159.2008.05711.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18957051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2mtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=1188-1195&author=E.+Scarrauthor=B.+Dean&title=Muscarinic+receptors%3A+do+they+have+a+role+in+the+pathology+and+treatment+of+schizophrenia%3F&doi=10.1111%2Fj.1471-4159.2008.05711.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?</span></div><div class="casAuthors">Scarr, Elizabeth; Dean, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1188-1195</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The high affinity of antipsychotic drugs for the dopamine D2 receptor focused attention onto the role of these receptors in the genesis of psychoses and the pathol. of schizophrenia.  However, psychotic symptoms are only one aspect of the complex symptom profile assocd. with schizophrenia.  Therefore, research continues into other neurochem. systems and their potential roles in key features assocd. with schizophrenia.  Modulating the cholinergic system in attempts to treat schizophrenia predates specific neurochem. hypotheses of the disorder.  Cholinergic modulation has progressed from the use of coma therapy, through the use of anticholinergic drugs to control side-effects of older (typical) antipsychotic medications, to the development of drugs designed to specifically activate selected muscarinic receptors.  This review presents data implicating a decrease in muscarinic receptors, particularly the M1 receptor, in the pathol. of schizophrenia and explores the potential physiol. consequences of such a change, drawing on data available from muscarinic receptor knockout mice as well as clin. and pre-clin. pharmacol.  The body of evidence presented suggests that deficits in muscarinic receptors are assocd. with some forms of schizophrenia and that targeting these receptors could prove to be of therapeutic benefit to patients with the disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkTLOGUCpkLVg90H21EOLACvtfcHk0lgTn5uIjzN4KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2mtb3F&md5=80444c8d8f15f6e0bbc68b358eb48588</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05711.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05711.x%26sid%3Dliteratum%253Aachs%26aulast%3DScarr%26aufirst%3DE.%26aulast%3DDean%26aufirst%3DB.%26atitle%3DMuscarinic%2520receptors%253A%2520do%2520they%2520have%2520a%2520role%2520in%2520the%2520pathology%2520and%2520treatment%2520of%2520schizophrenia%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D107%26spage%3D1188%26epage%3D1195%26doi%3D10.1111%2Fj.1471-4159.2008.05711.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Medeiros, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccamo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baglietto-Vargas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada-Hernandez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cribbs, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Loss of muscarinic M1 receptor exacerbates Alzheimer’s disease-like pathology and cognitive decline</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2011.04.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.ajpath.2011.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=21704011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=980-991&author=R.+Medeirosauthor=M.+Kitazawaauthor=A.+Caccamoauthor=D.+Baglietto-Vargasauthor=T.+Estrada-Hernandezauthor=D.+H.+Cribbsauthor=A.+Fisherauthor=F.+M.+LaFerla&title=Loss+of+muscarinic+M1+receptor+exacerbates+Alzheimer%E2%80%99s+disease-like+pathology+and+cognitive+decline&doi=10.1016%2Fj.ajpath.2011.04.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline</span></div><div class="casAuthors">Medeiros, Rodrigo; Kitazawa, Masashi; Caccamo, Antonella; Baglietto-Vargas, David; Estrada-Hernandez, Tatiana; Cribbs, David H.; Fisher, Avraham; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">980-991</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is pathol. characterized by tau-laden neurofibrillary tangles and β-amyloid deposits.  Dysregulation of cholinergic neurotransmission has been implicated in AD pathogenesis, contributing to the assocd. memory impairments; yet, the exact mechanisms remain to be defined.  Activating the muscarinic acetylcholine M1 receptors (M1Rs) reduces AD-like pathol. features and enhances cognition in AD transgenic models.  To elucidate the mol. mechanisms by which M1Rs affect AD pathophysiol. features, we crossed the 3xTgAD and transgenic mice expressing human Swedish, Dutch, and Iowa triple-mutant amyloid precursor protein (Tg-SwDI), two widely used animal models, with the M1R-/- mice.  Our data show that M1R deletion in the 3xTgAD and Tg-SwDI mice exacerbates the cognitive impairment through mechanisms dependent on the transcriptional dysregulation of genes required for memory and through acceleration of AD-related synaptotoxicity.  Ablating the M1R increased plaque and tangle levels in the brains of 3xTgAD mice and elevated cerebrovascular deposition of fibrillar Aβ in Tg-SwDI mice.  Notably, tau hyperphosphorylation and potentiation of amyloidogenic processing in the mice with AD lacking M1R were attributed to changes in the glycogen synthase kinase 3β and protein kinase C activities.  Finally, deleting the M1R increased the astrocytic and microglial response assocd. with Aβ plaques.  Our data highlight the significant role that disrupting the M1R plays in exacerbating AD-related cognitive decline and pathol. features and provide crit. preclin. evidence to justify further development and evaluation of selective M1R agonists for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmn8fzxarBbVg90H21EOLACvtfcHk0lgbj-Ms2Laeow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP&md5=f20cdd368aa5c1f8953ca565fd25cd5c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DKitazawa%26aufirst%3DM.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DBaglietto-Vargas%26aufirst%3DD.%26aulast%3DEstrada-Hernandez%26aufirst%3DT.%26aulast%3DCribbs%26aufirst%3DD.%2BH.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DLoss%2520of%2520muscarinic%2520M1%2520receptor%2520exacerbates%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%2520and%2520cognitive%2520decline%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26spage%3D980%26epage%3D991%26doi%3D10.1016%2Fj.ajpath.2011.04.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Anagnostaras, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahnama, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. J.</span><span> </span><span class="NLM_article-title">Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1038/nn992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fnn992" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=51-58&author=S.+G.+Anagnostarasauthor=G.+G.+Murphyauthor=S.+E.+Hamiltonauthor=S.+L.+Mitchellauthor=N.+P.+Rahnamaauthor=N.+M.+Nathansonauthor=A.+J.+Silva&title=Selective+cognitive+dysfunction+in+acetylcholine+M1+muscarinic+receptor+mutant+mice&doi=10.1038%2Fnn992"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnn992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn992%26sid%3Dliteratum%253Aachs%26aulast%3DAnagnostaras%26aufirst%3DS.%2BG.%26aulast%3DMurphy%26aufirst%3DG.%2BG.%26aulast%3DHamilton%26aufirst%3DS.%2BE.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRahnama%26aufirst%3DN.%2BP.%26aulast%3DNathanson%26aufirst%3DN.%2BM.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520cognitive%2520dysfunction%2520in%2520acetylcholine%2520M1%2520muscarinic%2520receptor%2520mutant%2520mice%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D6%26spage%3D51%26epage%3D58%26doi%3D10.1038%2Fnn992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, V. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roopun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriakidis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span> </span><span class="NLM_article-title">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28–1</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1038/bjp.2008.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fbjp.2008.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18454168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1104-1115&author=C.+J.+Langmeadauthor=N.+E.+Austinauthor=C.+L.+Branchauthor=J.+T.+Brownauthor=K.+A.+Buchananauthor=C.+H.+Daviesauthor=I.+T.+Forbesauthor=V.+A.+H.+Fryauthor=J.+J.+Haganauthor=H.+J.+Herdonauthor=G.+A.+Jonesauthor=R.+Jeggoauthor=J.+N.+C.+Kewauthor=A.+Mazzaliauthor=R.+Melarangeauthor=N.+Patelauthor=J.+Pardoeauthor=A.+D.+Randallauthor=C.+Robertsauthor=A.+Roopunauthor=K.+R.+Starrauthor=A.+Teriakidisauthor=M.+D.+Woodauthor=M.+Whittingtonauthor=Z.+Wuauthor=J.+Watson&title=Characterization+of+a+CNS+penetrant%2C+selective+M1+muscarinic+receptor+agonist%2C+77-LH-28%E2%80%931&doi=10.1038%2Fbjp.2008.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span></div><div class="casAuthors">Langmead, C. J.; Austin, N. E.; Branch, C. L.; Brown, J. T.; Buchanan, K. A.; Davies, C. H.; Forbes, I. T.; Fry, V. A. H.; Hagan, J. J.; Herdon, H. J.; Jones, G. A.; Jeggo, R.; Kew, J. N. C.; Mazzali, A.; Melarange, R.; Patel, N.; Pardoe, J.; Randall, A. D.; Roberts, C.; Roopun, A.; Starr, K. R.; Teriakidis, A.; Wood, M. D.; Whittington, M.; Wu, Z.; Watson, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1104-1115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: M1 muscarinic ACh receptors (mAChRs) represent an attractive drug target for the treatment of cognitive deficits assocd. with diseases such as Alzheimer's disease and schizophrenia.  However, the discovery of subtype-selective mAChR agonists has been hampered by the high degree of conservation of the orthosteric ACh-binding site among mAChR subtypes.  The advent of functional screening assays has enabled the identification of agonists such as AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine), which bind to an allosteric site and selectively activate the M1 mAChR subtype.  However, studies with this compd. have been limited to recombinantly expressed mAChRs.  Exptl. approach: In this study, we have compared the pharmacol. profile of AC-42 and a close structural analog, 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone) at human recombinant, and rat native, mAChRs by calcium mobilization, inositol phosphate accumulation and both in vitro and in vivo electrophysiol.  Key results: Calcium mobilization and inositol phosphate accumulation assays revealed that both AC-42 and 77-LH-28-1 display high selectivity to activate the M1 mAChR over other mAChR subtypes.  Furthermore, 77-LH-28-1(I), but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations.  Finally, 77-LH-28-1 stimulated cell firing in the rat hippocampus in vivo following s.c. administration.  Conclusions and implications: These data suggest that 77-LH-28-1 is a potent, selective, bioavailable and brain-penetrant agonist at the M1 mAChR and therefore that it represents a better tool than AC-42, with which to study the pharmacol. of the M1 mAChR.  British Journal of Pharmacol. (2008) 154, 1104-1115; doi:10.1038/bjp.2008.152; published online 5 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pNVy427ynLVg90H21EOLACvtfcHk0lh_qUGSklpDfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D&md5=8eeb8522c09910e1a13f9832f775f846</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.152%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DBuchanan%26aufirst%3DK.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DFry%26aufirst%3DV.%2BA.%2BH.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26aulast%3DJones%26aufirst%3DG.%2BA.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DMazzali%26aufirst%3DA.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPardoe%26aufirst%3DJ.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DRoopun%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DTeriakidis%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520a%2520CNS%2520penetrant%252C%2520selective%2520M1%2520muscarinic%2520receptor%2520agonist%252C%252077-LH-28%25E2%2580%25931%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1104%26epage%3D1115%26doi%3D10.1038%2Fbjp.2008.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantawy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">10422</span><span class="NLM_x">–</span> <span class="NLM_lpage">10433</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1850-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1523%2FJNEUROSCI.1850-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18842902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10422-10433&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=A.+A.+Davisauthor=Z.+Xiangauthor=M.+Bubserauthor=M.+N.+Tantawyauthor=A.+S.+Kaneauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+R.+Bradleyauthor=T.+E.+Petersonauthor=M.+S.+Ansariauthor=R.+M.+Baldwinauthor=R.+M.+Kesslerauthor=A.+Y.+Deutchauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Novel+selective+allosteric+activator+of+the+M1+muscarinic+acetylcholine+receptor+regulates+amyloid+processing+and+produces+antipsychotic-like+activity+in+rats&doi=10.1523%2FJNEUROSCI.1850-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span></div><div class="casAuthors">Jones, Carrie K.; Brady, Ashley E.; Davis, Albert A.; Xiang, Zixiu; Bubser, Michael; Tantawy, Mohammed Noor; Kane, Alexander S.; Bridges, Thomas M.; Kennedy, J. Phillip; Bradley, Stefania R.; Peterson, Todd E.; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.; Deutch, Ariel Y.; Lah, James J.; Levey, Allan I.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10422-10433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that subtype-selective activators of M1/M4 muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms assocd. with schizophrenia and Alzheimer's disease.  Previously developed muscarinic agonists have provided clin. data in support of this hypothesis, but failed in clin. development because of a lack of true subtype specificity and adverse effects assocd. with activation of other mAChR subtypes.  We now report characterization of a novel highly selective agonist for the M1 receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB [1-((1'-2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one].  Mutagenesis and mol. pharmacol. studies revealed that TBPB activates M1 through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely crit. for its unprecedented selectivity.  Whole-cell patch-clamp recordings demonstrated that activation of M1 by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M2 and M4.  TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists.  Finally, TBPB had effects on the processing of the amyloid precursor protein toward the non-amyloidogenic pathway and decreased Aβ prodn. in vitro.  Together, these data suggest that selective activation of M1 may provide a novel approach for the treatment of symptoms assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5LP3cEBPDvbVg90H21EOLACvtfcHk0lh_qUGSklpDfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF&md5=25b306eb2aa00bdce1c08ad24bd59b35</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1850-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1850-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DPeterson%26aufirst%3DT.%2BE.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520selective%2520allosteric%2520activator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520regulates%2520amyloid%2520processing%2520and%2520produces%2520antipsychotic-like%2520activity%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10422%26epage%3D10433%26doi%3D10.1523%2FJNEUROSCI.1850-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graufelds, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCampbell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danziger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15950</span><span class="NLM_x">–</span> <span class="NLM_lpage">15955</span><div class="note"><p class="first last">S15950/1–S15950/9.</p></div><span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0lhaW5WpSTMHiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pomara, N.</span><span> </span><span class="NLM_article-title">Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><div class="note"><p class="first last">author reply 111–113.</p></div><span class="refDoi"> DOI: 10.1176/appi.ajp.2008.08091352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1176%2Fappi.ajp.2008.08091352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19122018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FltFehsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=111&author=N.+Pomara&title=Reduction+in+muscarinic+M1-mediated+hypercholinergic+state+and+beneficial+cognitive+effects+of+muscarinic+agonists+in+schizophrenia&doi=10.1176%2Fappi.ajp.2008.08091352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophrenia</span></div><div class="casAuthors">Pomara Nunzio</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111; author reply 111-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWY1uTtS7bjRfKb6ELK8t0fW6udTcc2eZqrAQ5KROw3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FltFehsQ%253D%253D&md5=dbf3545f43414e1094d1303a0ba899e3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.08091352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.08091352%26sid%3Dliteratum%253Aachs%26aulast%3DPomara%26aufirst%3DN.%26atitle%3DReduction%2520in%2520muscarinic%2520M1-mediated%2520hypercholinergic%2520state%2520and%2520beneficial%2520cognitive%2520effects%2520of%2520muscarinic%2520agonists%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D111%26doi%3D10.1176%2Fappi.ajp.2008.08091352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dencker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grannan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locuson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Role for the M1 muscarinic acetylcholine receptor in top-down cognitive processing using a touchscreen visual discrimination task in mice</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1683-1695&author=R.+W.+Gouldauthor=D.+Denckerauthor=M.+Grannanauthor=M.+Bubserauthor=X.+Zhanauthor=J.+Wessauthor=Z.+Xiangauthor=C.+Locusonauthor=C.+W.+Lindsleyauthor=P.+J.+Connauthor=C.+K.+Jones&title=Role+for+the+M1+muscarinic+acetylcholine+receptor+in+top-down+cognitive+processing+using+a+touchscreen+visual+discrimination+task+in+mice&doi=10.1021%2Facschemneuro.5b00123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice</span></div><div class="casAuthors">Gould, R. W.; Dencker, D.; Grannan, M.; Bubser, M.; Zhan, X.; Wess, J.; Xiang, Z.; Locuson, C.; Lindsley, C. W.; Conn, P. J.; Jones, C. K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1683-1695</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M1 muscarinic acetylcholine receptor (mAChR) subtype has been implicated in the underlying mechanisms of learning and memory and represents an important potential pharmacotherapeutic target for the cognitive impairments obsd. in neuropsychiatric disorders such as schizophrenia.  Patients with schizophrenia show impairments in top-down processing involving conflict between sensory-driven and goal-oriented processes that can be modeled in preclin. studies using touchscreen-based cognition tasks.  The present studies used a touchscreen visual pairwise discrimination task in which mice discriminated between a less salient and a more salient stimulus to assess the influence of the M1 mAChR on top-down processing.  M1 mAChR knockout (M1 KO) mice showed a slower rate of learning, evidenced by slower increases in accuracy over 12 consecutive days, and required more days to acquire (achieve 80% accuracy) this discrimination task compared to wild-type mice.  In addn., the M1 pos. allosteric modulator BQCA enhanced the rate of learning this discrimination in wild-type, but not in M1 KO, mice when BQCA was administered daily prior to testing over 12 consecutive days.  Importantly, in discriminations between stimuli of equal salience, M1 KO mice did not show impaired acquisition and BQCA did not affect the rate of learning or acquisition in wild-type mice.  These studies are the first to demonstrate performance deficits in M1 KO mice using touchscreen cognitive assessments and enhanced rate of learning and acquisition in wild-type mice through M1 mAChR potentiation when the touchscreen discrimination task involves top-down processing.  Taken together, these findings provide further support for M1 potentiation as a potential treatment for the cognitive symptoms assocd. with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNNTq2P-jg7Vg90H21EOLACvtfcHk0lhaW5WpSTMHiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt7jN&md5=23a19d3c5d2c735f43d219b42ba6387c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00123%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DDencker%26aufirst%3DD.%26aulast%3DGrannan%26aufirst%3DM.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DZhan%26aufirst%3DX.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DLocuson%26aufirst%3DC.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DRole%2520for%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520in%2520top-down%2520cognitive%2520processing%2520using%2520a%2520touchscreen%2520visual%2520discrimination%2520task%2520in%2520mice%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1683%26epage%3D1695%26doi%3D10.1021%2Facschemneuro.5b00123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Thomsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caine, S. B.</span><span> </span><span class="NLM_article-title">Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">208</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span><span class="refDoi"> DOI: 10.1007/s00213-009-1740-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1007%2Fs00213-009-1740-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2010&pages=401-416&author=M.+Thomsenauthor=J.+Wessauthor=B.+S.+Fultonauthor=A.+Fink-Jensenauthor=S.+B.+Caine&title=Modulation+of+prepulse+inhibition+through+both+M1+and+M4+muscarinic+receptors+in+mice&doi=10.1007%2Fs00213-009-1740-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1740-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1740-z%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DM.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DFulton%26aufirst%3DB.%2BS.%26aulast%3DFink-Jensen%26aufirst%3DA.%26aulast%3DCaine%26aufirst%3DS.%2BB.%26atitle%3DModulation%2520of%2520prepulse%2520inhibition%2520through%2520both%2520M1%2520and%2520M4%2520muscarinic%2520receptors%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D208%26spage%3D401%26epage%3D416%26doi%3D10.1007%2Fs00213-009-1740-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lameh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohrmund, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajpai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalding, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabatabaei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span> </span><span class="NLM_article-title">AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.neuropharm.2009.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19835892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFymsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=365-73&author=S.+R.+Bradleyauthor=J.+Lamehauthor=L.+Ohrmundauthor=T.+Sonauthor=A.+Bajpaiauthor=D.+Nguyenauthor=M.+Fribergauthor=E.+S.+Bursteinauthor=T.+A.+Spaldingauthor=T.+R.+Ottauthor=H.+H.+Schifferauthor=A.+Tabatabaeiauthor=K.+McFarlandauthor=R.+E.+Davisauthor=D.+W.+Bonhaus&title=AC-260584%2C+an+orally+bioavailable+M%281%29+muscarinic+receptor+allosteric+agonist%2C+improves+cognitive+performance+in+an+animal+model&doi=10.1016%2Fj.neuropharm.2009.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model</span></div><div class="casAuthors">Bradley, Stefania Risso; Lameh, Jelveh; Ohrmund, Linda; Son, Thomas; Bajpai, Abhishek; Nguyen, Derek; Friberg, Mikael; Burstein, Ethan S.; Spalding, Tracy A.; Ott, Thomas R.; Schiffer, Hans H.; Tabatabaei, Ali; McFarland, Krista; Davis, Robert E.; Bonhaus, Douglas W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-373</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The recent discovery of allosteric potentiators and agonists of the muscarinic M1 receptor represents a significant advance in the muscarinic receptor pharmacol.  In the current study we describe the receptor pharmacol. and pro-cognitive action of the allosteric agonist AC-260584.  Using in vitro cell-based assays with cell proliferation, phosphatidylinositol hydrolysis or calcium mobilization as endpoints, AC-260584 was found to be a potent (pEC50 7.6-7.7) and efficacious (90-98% of carbachol) muscarinic M1 receptor agonist.  Furthermore, as compared to orthosteric binding agonists, AC-260584 showed functional selectivity for the M1 receptor over the M2, M3, M4 and M5 muscarinic receptor subtypes.  Using GTPγS binding assays, its selectivity was found to be similar in native tissues expressing mAChRs to its profile in recombinant systems.  In rodents, AC-260584 activated extracellular signal-regulated kinase 1 and 2 (ERK1/2) phosphorylation in the hippocampus, prefrontal cortex and perirhinal cortex.  The ERK1/2 activation was dependent upon muscarinic M1 receptor activation since it was not obsd. in M1 knockout mice.  AC-260584 also improved the cognitive performance of mice in the novel object recognition assay and its action is blocked by the muscarinic receptor antagonist pirenzepine.  Taken together these results indicate for the first time that a M1 receptor agonist selective over the other mAChR subtypes can have a symptomatically pro-cognitive action.  In addn., AC-260584 was found to be orally bioavailable in rodents.  Therefore, AC-260584 may serve as a lead compd. in the development of M1 selective drugs for the treatment of cognitive impairment assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18AGEUAeVq7Vg90H21EOLACvtfcHk0lghoNOlbbI-HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFymsLfO&md5=fb5deaa878be695f3936c580c24ab274</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DLameh%26aufirst%3DJ.%26aulast%3DOhrmund%26aufirst%3DL.%26aulast%3DSon%26aufirst%3DT.%26aulast%3DBajpai%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DFriberg%26aufirst%3DM.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DOtt%26aufirst%3DT.%2BR.%26aulast%3DSchiffer%26aufirst%3DH.%2BH.%26aulast%3DTabatabaei%26aufirst%3DA.%26aulast%3DMcFarland%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26atitle%3DAC-260584%252C%2520an%2520orally%2520bioavailable%2520M%25281%2529%2520muscarinic%2520receptor%2520allosteric%2520agonist%252C%2520improves%2520cognitive%2520performance%2520in%2520an%2520animal%2520model%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D365%26epage%3D73%26doi%3D10.1016%2Fj.neuropharm.2009.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovsky, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennenga, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bimonte-Nelson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Italiano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olive, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">8532</span><span class="NLM_x">–</span> <span class="NLM_lpage">8544</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0337-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1523%2FJNEUROSCI.0337-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=22723693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=8532-8544&author=G.+J.+Digbyauthor=M.+J.+Noetzelauthor=M.+Bubserauthor=T.+J.+Utleyauthor=A.+G.+Walkerauthor=N.+E.+Byunauthor=E.+P.+Leboisauthor=Z.+Xiangauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=A.+A.+Davisauthor=N.+E.+Nemirovskyauthor=S.+E.+Mennengaauthor=B.+W.+Campauthor=H.+A.+Bimonte-Nelsonauthor=J.+Bodeauthor=K.+Italianoauthor=R.+Morrisonauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=M.+F.+Oliveauthor=C.+W.+Lindsleyauthor=C.+K.+Jonesauthor=P.+J.+Conn&title=Novel+allosteric+agonists+of+M1+muscarinic+acetylcholine+receptors+induce+brain+region-specific+responses+that+correspond+with+behavioral+effects+in+animal+models&doi=10.1523%2FJNEUROSCI.0337-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span></div><div class="casAuthors">Digby, Gregory J.; Noetzel, Meredith J.; Bubser, Michael; Utley, Thomas J.; Walker, Adam G.; Byun, Nellie E.; Lebois, Evan P.; Xiang, Zixiu; Sheffler, Douglas J.; Cho, Hyekyung P.; Davis, Albert A.; Nemirovsky, Natali E.; Mennenga, Sarah E.; Camp, Bryan W.; Bimonte-Nelson, Heather A.; Bode, Jacob; Italiano, Kimberly; Morrison, Ryan; Daniels, J. Scott; Niswender, Colleen M.; Olive, M. Foster; Lindsley, Craig W.; Jones, Carrie K.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8532-8544</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) represent a viable target for treatment of multiple disorders of the central nervous system (CNS) including Alzheimer's disease and schizophrenia.  The recent discovery of highly selective allosteric agonists of M1 receptors has provided a major breakthrough in developing a viable approach for the discovery of novel therapeutic agents that target these receptors.  Here we describe the characterization of two novel M1 allosteric agonists, VU0357017 and VU0364572, that display profound differences in their efficacy in activating M1 coupling to different signaling pathways including Ca2+ and β-arrestin responses.  Interestingly, the ability of these agents to differentially activate coupling of M1 to specific signaling pathways leads to selective actions on some but not all M1-mediated responses in brain circuits.  These novel M1 allosteric agonists induced robust electrophysiol. effects in rat hippocampal slices, but showed lower efficacy in striatum and no measureable effects on M1-mediated responses in medial prefrontal cortical pyramidal cells in mice.  Consistent with these actions, both M1 agonists enhanced acquisition of hippocampal-dependent cognitive function but did not reverse amphetamine-induced hyperlocomotion in rats.  Together, these data reveal that M1 allosteric agonists can differentially regulate coupling of M1 to different signaling pathways, and this can dramatically alter the actions of these compds. on specific brain circuits important for learning and memory and psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh138Eac3vNrVg90H21EOLACvtfcHk0lghoNOlbbI-HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D&md5=6278ee1366f8e159729c23ef8ecc880d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0337-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0337-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DWalker%26aufirst%3DA.%2BG.%26aulast%3DByun%26aufirst%3DN.%2BE.%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DNemirovsky%26aufirst%3DN.%2BE.%26aulast%3DMennenga%26aufirst%3DS.%2BE.%26aulast%3DCamp%26aufirst%3DB.%2BW.%26aulast%3DBimonte-Nelson%26aufirst%3DH.%2BA.%26aulast%3DBode%26aufirst%3DJ.%26aulast%3DItaliano%26aufirst%3DK.%26aulast%3DMorrison%26aufirst%3DR.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DOlive%26aufirst%3DM.%2BF.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520allosteric%2520agonists%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%2520induce%2520brain%2520region-specific%2520responses%2520that%2520correspond%2520with%2520behavioral%2520effects%2520in%2520animal%2520models%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D8532%26epage%3D8544%26doi%3D10.1523%2FJNEUROSCI.0337-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ghoshal, A.; Rook, J. M.; Dickerson, J. W.; Roop, G. N.; Morrison, R. D.; Jalan-Sakrikar, N.; Lamsal, A.; Noetzel, M. J.; Poslusney, M. S.; Wood, M. R.; Melancon, B. J.; Stauffer, S. R.; Xiang, Z.; Daniels, J. S.; Niswender, C. M.; Jones, C. K.; Lindsley, C. W.; Conn, P. J.</span><span> </span><span class="NLM_article-title">Potentiation of M1 muscarinic receptor reverses plasticity deficits and negative and cognitive symptoms in a schizophrenia mouse model</span>.  <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1038/npp.2015.189</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fnpp.2015.189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Ghoshal&author=J.+M.+Rook&author=J.+W.+Dickerson&author=G.+N.+Roop&author=R.+D.+Morrison&author=N.+Jalan-Sakrikar&author=A.+Lamsal&author=M.+J.+Noetzel&author=M.+S.+Poslusney&author=M.+R.+Wood&author=B.+J.+Melancon&author=S.+R.+Stauffer&author=Z.+Xiang&author=J.+S.+Daniels&author=C.+M.+Niswender&author=C.+K.+Jones&author=C.+W.+Lindsley&author=P.+J.+Conn&title=Potentiation+of+M1+muscarinic+receptor+reverses+plasticity+deficits+and+negative+and+cognitive+symptoms+in+a+schizophrenia+mouse+model&doi=10.1038%2Fnpp.2015.189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.189%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26atitle%3DPotentiation%2520of%2520M1%2520muscarinic%2520receptor%2520reverses%2520plasticity%2520deficits%2520and%2520negative%2520and%2520cognitive%2520symptoms%2520in%2520a%2520schizophrenia%2520mouse%2520model%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26doi%3D10.1038%2Fnpp.2015.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bodick, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span> </span><span class="NLM_article-title">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1001/archneur.1997.00550160091022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1001%2Farchneur.1997.00550160091022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=9109749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=465-73&author=N.+C.+Bodickauthor=W.+W.+Offenauthor=A.+I.+Leveyauthor=N.+R.+Cutlerauthor=S.+G.+Gauthierauthor=A.+Satlinauthor=H.+E.+Shannonauthor=G.+D.+Tollefsonauthor=K.+Rasmussenauthor=F.+P.+Bymasterauthor=D.+J.+Hurleyauthor=W.+Z.+Potterauthor=S.+M.+Paul&title=Effects+of+xanomeline%2C+a+selective+muscarinic+receptor+agonist%2C+on+cognitive+function+and+behavioral+symptoms+in+Alzheimer+disease&doi=10.1001%2Farchneur.1997.00550160091022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</span></div><div class="casAuthors">Bodick N C; Offen W W; Levey A I; Cutler N R; Gauthier S G; Satlin A; Shannon H E; Tollefson G D; Rasmussen K; Bymaster F P; Hurley D J; Potter W Z; Paul S M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-73</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the therapeutic effects of selective cholinergic replacement with xanomeline tartrate, an m1 and m4 selective muscarinic receptor (mAChR) agonist in patients with probable Alzheimer disease (AD).  DESIGN:  A 6-month, randomized, double-blind, placebo-controlled, parallel-group trial followed by a 1-month, single-blind, placebo washout.  SETTING:  Outpatients at 17 centers in the United States and Canada.  PARTICIPANTS:  A total of 343 men and women at least 60 years of age with mild to moderate AD.  INTERVENTIONS:  Patients received 75, 150, or 225 mg (low, medium, and high doses) of xanomeline per day or placebo for 6 months.  OUTCOME MEASURES:  Scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog), the Clinician's Interview-Based Impression of Change (CIBIC+), the Alzheimer's Disease Symptomatology Scale (ADSS), and the Nurses' Observational Scale for Geriatric Patients (NOSGER).  RESULTS:  A significant treatment effect existed for ADAS-Cog (high dose vs placebo; P < or = .05), and CIBIC+ (high dose vs placebo; P < or = .02).  Treatment Emergent Signs and Symptoms analysis of the ADSS, which assesses behavioral symptoms in patients with AD, disclosed significant (P < or = .002) dose-dependent reductions in vocal outbursts, suspiciousness, delusions, agitation, and hallucinations.  On end-point analysis, NOSGER, which assesses memory, instrumental activities of daily living, self-care, mood, social behavior, and disturbing behavior in the elderly, also showed a significant dose-response relationship (P < or = .02).  In the high-dose arm, 52% of patients discontinued treatment because of adverse events; dose-dependent adverse events were predominantly gastrointestinal in nature.  Syncope, defined as loss of consciousness and muscle tone, occurred in 12.6% of patients in the high-dose group.  CONCLUSIONS:  The observed improvements in ADAS-Cog and CIBIC+ following treatment with xanomeline provide the first evidence, from a large-scale, placebo-controlled clinical trial, that a direct-acting muscarinic receptor agonist can improve cognitive function in patients with AD.  Furthermore, the dramatic and favorable effects on disturbing behaviors in AD suggest a novel approach for treatment of noncognitive symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5beLwC0CkxUGy1nwu7K2mfW6udTcc2ebg6yGxvxCIj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D&md5=a1d8d3b2b495133fb37078d387136243</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1997.00550160091022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1997.00550160091022%26sid%3Dliteratum%253Aachs%26aulast%3DBodick%26aufirst%3DN.%2BC.%26aulast%3DOffen%26aufirst%3DW.%2BW.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DCutler%26aufirst%3DN.%2BR.%26aulast%3DGauthier%26aufirst%3DS.%2BG.%26aulast%3DSatlin%26aufirst%3DA.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DTollefson%26aufirst%3DG.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DHurley%26aufirst%3DD.%2BJ.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26atitle%3DEffects%2520of%2520xanomeline%252C%2520a%2520selective%2520muscarinic%2520receptor%2520agonist%252C%2520on%2520cognitive%2520function%2520and%2520behavioral%2520symptoms%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1997%26volume%3D54%26spage%3D465%26epage%3D73%26doi%3D10.1001%2Farchneur.1997.00550160091022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Shekhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallinckrodt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2008.06091591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1176%2Fappi.ajp.2008.06091591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18593778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A280%3ADC%252BD1cvpt1OlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2008&pages=1033-9&author=A.+Shekharauthor=W.+Z.+Potterauthor=J.+Lightfootauthor=J.+Lienemannauthor=S.+Dubeauthor=C.+Mallinckrodtauthor=F.+P.+Bymasterauthor=D.+L.+McKinzieauthor=C.+C.+Felder&title=Selective+muscarinic+receptor+agonist+xanomeline+as+a+novel+treatment+approach+for+schizophrenia&doi=10.1176%2Fappi.ajp.2008.06091591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</span></div><div class="casAuthors">Shekhar Anantha; Potter William Z; Lightfoot Jeffrey; Lienemann John; Dube Sanjay; Mallinckrodt Craig; Bymaster Frank P; McKinzie David L; Felder Christian C</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1033-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  There are significant unmet needs in the treatment of schizophrenia, especially for the treatment of cognitive impairment, negative syndrome, and cognitive function.  Preclinical data suggest that agonists with selective affinity for acetylcholine muscarinic receptors provide a potentially new mechanism to treat schizophrenia.  The authors studied xanomeline, a relatively selective muscarinic type 1 and type 4 (M(1) and M(4)) receptor agonist, to determine if this agent is effective in the treatment of schizophrenia.  METHOD:  In this pilot study, the authors examined the efficacy of xanomeline on clinical outcomes in subjects with schizophrenia (N=20) utilizing a double-blind, placebo-controlled, 4-week treatment design.  Outcome measures included the Positive and Negative Syndrome Scale (PANSS) for schizophrenia, the Brief Psychiatric Rating Scale (BPRS), the Clinical Global Impression (CGI) scale, and a test battery designed to measure cognitive function in patients with schizophrenia.  RESULTS:  Subjects treated with xanomeline did significantly better than subjects in the placebo group on total BPRS scores and total PANSS scores.  In the cognitive test battery, subjects in the xanomeline group showed improvements most robustly in measures of verbal learning and short-term memory function.  CONCLUSIONS:  These results support further investigation of xanomeline as a novel approach to treating schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJVRr0TjQJN3RxY89Cm6SyfW6udTcc2ebg6yGxvxCIj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvpt1OlsA%253D%253D&md5=08667002f190c674d38f9c6134eb344c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.06091591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.06091591%26sid%3Dliteratum%253Aachs%26aulast%3DShekhar%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DLightfoot%26aufirst%3DJ.%26aulast%3DLienemann%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DS.%26aulast%3DMallinckrodt%26aufirst%3DC.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DSelective%2520muscarinic%2520receptor%2520agonist%2520xanomeline%2520as%2520a%2520novel%2520treatment%2520approach%2520for%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2008%26volume%3D165%26spage%3D1033%26epage%3D9%26doi%3D10.1176%2Fappi.ajp.2008.06091591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Massoud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span> </span><span class="NLM_article-title">Update on the pharmacological treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.2174/157015910790909520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.2174%2F157015910790909520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=20808547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=69-80&author=F.+Massoudauthor=S.+Gauthier&title=Update+on+the+pharmacological+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F157015910790909520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacological treatment of Alzheimer's disease</span></div><div class="casAuthors">Massoud, Fadi; Gauthier, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder.  Worldwide prevalence of the disease is estd. at more than 24 million cases.  With aging of populations, this no. will likely increase to more than 80 million cases by the year 2040.  The annual incidence worldwide is estd. at 4.6 million cases which is the equiv. of one new case every seven seconds!  The pathophysiol. of AD is complex and largely misunderstood.  It is thought to start with the accumulation of beta-amyloid (Aβ) that leads to deposition of insol. neuritic or senile plaques.  Secondary events in this "amyloid cascade" include hyperphosphorylation of the protein tau into neurofibrillary tangles, inflammation, oxidn., and excitotoxicity that eventually cause activation of apoptosis, cell death and neurotransmitter deficits.  This review will briefly summarize recent advances in the pathophysiol. of AD and focus on the pharmacol. treatment of the cognitive and functional symptoms of AD.  It will discuss the roles of vascular prevention, cholinesterase inhibitors and an NMDA-antagonist in the management of AD.  It will address the issues thought to be related to the lack of persistence or discontinuation of therapy with cholinesterase inhibitors shown in recent studies and some of the solns. proposed.  These include setting realistic expectations in light of a neurodegenerative condition and available symptomatic treatments, slowly titrating medications, and using alternate routes of administration.  Finally, it will introduce future therapeutic options currently under study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47V_ed98Ar7Vg90H21EOLACvtfcHk0lghfFkm3O7UdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtr3L&md5=6a6189280a3f0786c2c3963420b3d029</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F157015910790909520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015910790909520%26sid%3Dliteratum%253Aachs%26aulast%3DMassoud%26aufirst%3DF.%26aulast%3DGauthier%26aufirst%3DS.%26atitle%3DUpdate%2520on%2520the%2520pharmacological%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2010%26volume%3D8%26spage%3D69%26epage%3D80%26doi%3D10.2174%2F157015910790909520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Davie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Development of M<sub>1</sub> mAChR allosteric and bitopic ligands: Prospective therapeutics for the treatment of cognitive deficits</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span><span class="refDoi"> DOI: 10.1021/cn400086m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400086m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt12gtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1026-1048&author=B.+J.+Davieauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Development+of+M1+mAChR+allosteric+and+bitopic+ligands%3A+Prospective+therapeutics+for+the+treatment+of+cognitive+deficits&doi=10.1021%2Fcn400086m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of M1 mAChR Allosteric and Bitopic Ligands: Prospective Therapeutics for the Treatment of Cognitive Deficits</span></div><div class="casAuthors">Davie, Briana J.; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1026-1048</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Since the cholinergic hypothesis of memory dysfunction was first reported, extensive research efforts have focused on elucidating the mechanisms by which this intricate system contributes to the regulation of processes such as learning, memory, and higher executive function.  Several cholinergic therapeutic targets for the treatment of cognitive deficits, psychotic symptoms, and the underlying pathophysiol. of neurodegenerative disorders, such as Alzheimer's disease and schizophrenia, have since emerged.  Clin. approved drugs now exist for some of these targets; however, they all may be considered suboptimal therapeutics in that they produce undesirable off-target activity leading to side effects, fail to address the wide variety of symptoms and underlying pathophysiol. that characterize these disorders, and/or afford little to no therapeutic effect in subsets of patient populations.  A promising target for which there are presently no approved therapies is the M1 muscarinic acetylcholine receptor (M1 mAChR).  Despite avid investigation, development of agents that selectively activate this receptor via the orthosteric site has been hampered by the high sequence homol. of the binding site between the five muscarinic receptor subtypes and the wide distribution of this receptor family in both the central nervous system (CNS) and the periphery.  Hence, a plethora of ligands targeting less structurally conserved allosteric sites of the M1 mAChR have been investigated.  This Review aims to explain the rationale behind allosterically targeting the M1 mAChR, comprehensively summarize and critically evaluate the M1 mAChR allosteric ligand literature to date, highlight the challenges inherent in allosteric ligand investigation that are impeding their clin. advancement, and discuss potential methods for resolving these issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmU_uVw81d3LVg90H21EOLACvtfcHk0lghfFkm3O7UdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt12gtLk%253D&md5=24b78a7a4fd917960fc406f069f238b9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcn400086m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400086m%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DB.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520M1%2520mAChR%2520allosteric%2520and%2520bitopic%2520ligands%253A%2520Prospective%2520therapeutics%2520for%2520the%2520treatment%2520of%2520cognitive%2520deficits%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1026%26epage%3D1048%26doi%3D10.1021%2Fcn400086m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5172</span><span class="refDoi"> DOI: 10.1021/jm400540b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400540b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5151-5172&author=S.+N.+Mistryauthor=C.+Valantauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+profiling+of+analogues+of+benzyl+quinolone+carboxylic+acid+%28BQCA%29+as+allosteric+modulators+of+the+M1+muscarinic+receptor&doi=10.1021%2Fjm400540b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Valant, Celine; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5151-5172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Established therapy in Alzheimer's disease involves potentiation of the endogenous orthosteric ligand, acetylcholine, at the M1 muscarinic receptors found in higher concns. in the cortex and hippocampus.  Adverse effects, due to indiscriminate activation of other muscarinic receptor subtypes, are common.  M1 muscarinic pos. allosteric modulators/allosteric agonists such as BQCA [1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, I] offer an attractive soln., being exquisitely M1-selective over other muscarinic subtypes.  A common difficulty with allosteric ligands is interpreting SAR, based on composite potency values derived in the presence of fixed concn. of agonist.  In reality these values encompass multiple pharmacol. parameters, each potentially and differentially sensitive to structural modification of the ligand.  We report novel BQCA analogs which appear to augment ligand affinity for the receptor (pKB), intrinsic efficacy (τB), and both binding (α) and functional (β) cooperativity with acetylcholine.  Ultimately, development of such enriched SAR surrounding allosteric modulators will provide insight into their mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigST7OJR7vbVg90H21EOLACvtfcHk0lghfFkm3O7UdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D&md5=ab134e0b5400aa825916695eaf1203b1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400540b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400540b%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520profiling%2520of%2520analogues%2520of%2520benzyl%2520quinolone%2520carboxylic%2520acid%2520%2528BQCA%2529%2520as%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5151%26epage%3D5172%26doi%3D10.1021%2Fjm400540b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Watt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesterfield, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.1124/jpet.111.182063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1124%2Fjpet.111.182063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=21558436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFelsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=622-632&author=M.+L.+Wattauthor=D.+A.+Schoberauthor=S.+Hitchcockauthor=B.+Liuauthor=A.+K.+Chesterfieldauthor=D.+McKinzieauthor=C.+C.+Felder&title=Pharmacological+characterization+of+LY593093%2C+an+M1+muscarinic+acetylcholine+receptor-selective+partial+orthosteric+agonist&doi=10.1124%2Fjpet.111.182063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist</span></div><div class="casAuthors">Watt, Marla L.; Schober, Douglas A.; Hitchcock, Stephen; Liu, Bin; Chesterfield, Amy K.; McKinzie, David; Felder, Christian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">622-632</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Alzheimer's disease and schizophrenia are characterized by expression of psychotic, affective, and cognitive symptoms.  Currently, there is a lack of adequate treatment for the cognitive symptoms assocd. with these diseases.  Cholinergic signaling and, in particular, M1 muscarinic acetylcholine receptor (m1AChR) signaling have been implicated in the regulation of multiple cognitive domains.  Thus, the M1AChR has been identified as a therapeutic drug target for diseases, such as schizophrenia and Alzheimer's disease, that exhibit marked cognitive dysfunction as part of their clin. manifestation.  Unfortunately, the development of selective M1 agonist medications has not been successful, mostly because of the highly conserved orthosteric acetylcholine binding site among the five muscarinic receptor subtypes.  More recent efforts have focused on the development of allosteric M1AChR modulators that target regions of the receptor distinct from the orthosteric site that are less conserved between family members.  However, orthosteric and allosteric ligands may differentially modulate receptor function and ultimately downstream signaling pathways.  Thus, the need for highly selective M1AChR orthosteric agonists still exists, not only as a potential therapeutic but also as a pharmacol. tool to better understand the physiol. consequences of M1AChR orthosteric activation.  Here, we describe the novel, potent and selective M1AChR orthosteric partial agonist LY593093 [N-[(1R,2R)-6-({(1E)-1-[(4-fluorobenzyl)(methyl)amino]ethylidene})amino-2-hydroxy-2,3-dihydro-1H-inden-1-yl]biphenyl-4-carboxamide].  This compd. demonstrates modest to no activity at the other muscarinic receptor subtypes, stimulates Gαq-coupled signaling events as well as β-arrestin recruitment, and displays significant efficacy in in vivo models of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkikS6XzRybVg90H21EOLACvtfcHk0liAhpt2MNc3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFelsro%253D&md5=2bfc98e8243bcd4546c43625f542f41d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.182063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.182063%26sid%3Dliteratum%253Aachs%26aulast%3DWatt%26aufirst%3DM.%2BL.%26aulast%3DSchober%26aufirst%3DD.%2BA.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DChesterfield%26aufirst%3DA.%2BK.%26aulast%3DMcKinzie%26aufirst%3DD.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DPharmacological%2520characterization%2520of%2520LY593093%252C%2520an%2520M1%2520muscarinic%2520acetylcholine%2520receptor-selective%2520partial%2520orthosteric%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D622%26epage%3D632%26doi%3D10.1124%2Fjpet.111.182063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span><span class="refDoi"> DOI: 10.1074/jbc.M111.314278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1074%2Fjbc.M111.314278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=22086918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=650-659&author=M.+Canalsauthor=J.+R.+Laneauthor=A.+Wenauthor=P.+J.+Scammellsauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=A+Monod-Wyman-Changeux+mechanism+can+explain+G+protein-coupled+receptor+%28GPCR%29+allosteric+modulation&doi=10.1074%2Fjbc.M111.314278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation</span></div><div class="casAuthors">Canals, Meritxell; Lane, J. Robert; Wen, Adriel; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">650-659</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Monod-Wyman-Changeux (MWC) model was initially proposed to describe the allosteric properties of regulatory enzymes and subsequently extended to receptors.  Yet despite GPCRs representing the largest family of receptors and drug targets, no study has systematically evaluated the MWC mechanism as it applies to GPCR allosteric ligands.  We reveal how the recently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a strict, two-state MWC mechanism at the M1 muscarinic acetylcholine receptor (mAChR).  Despite having a low affinity for the M1 mAChR, BQCA demonstrated state dependence, exhibiting high pos. cooperativity with orthosteric agonists in a manner that correlated with efficacy but neg. cooperativity with inverse agonists.  The activity of BQCA was significantly increased at a constitutively active M1 mAChR but abolished at an inactive mutant.  Interestingly, BQCA possessed intrinsic signaling efficacy, ranging from near-quiescence to full agonism depending on the coupling efficiency of the chosen intracellular pathway.  This latter cellular property also detd. the difference in magnitude of pos. cooperativity between BQCA and the orthosteric agonist, carbachol, across pathways.  The lack of addnl., pathway-biased, allosteric modulation by BQCA was confirmed in genetically engineered yeast strains expressing different chimeras between the endogenous yeast Gpa1 protein and human Gα subunits.  These findings define a chem. biol. framework that can be applied to the study and classification of allosteric modulators across different GPCR families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrrH0vtUu5lbVg90H21EOLACvtfcHk0liAhpt2MNc3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVGh&md5=45d079afd141a137baf24fe171180124</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.314278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.314278%26sid%3Dliteratum%253Aachs%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DWen%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520Monod-Wyman-Changeux%2520mechanism%2520can%2520explain%2520G%2520protein-coupled%2520receptor%2520%2528GPCR%2529%2520allosteric%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D650%26epage%3D659%26doi%3D10.1074%2Fjbc.M111.314278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Shirey, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirk, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolle, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">14271</span><span class="NLM_x">–</span> <span class="NLM_lpage">14286</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3930-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1523%2FJNEUROSCI.3930-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19906975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=14271-14286&author=J.+K.+Shireyauthor=A.+E.+Bradyauthor=P.+J.+Jonesauthor=A.+A.+Davisauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+B.+Jadhavauthor=U.+N.+Menonauthor=Z.+Xiangauthor=M.+L.+Watsonauthor=E.+P.+Christianauthor=J.+J.+Dohertyauthor=M.+C.+Quirkauthor=D.+H.+Snyderauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=M.+M.+Nicolleauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=A+selective+allosteric+potentiator+of+the+M1+muscarinic+acetylcholine+receptor+increases+activity+of+medial+prefrontal+cortical+neurons+and+restores+impairments+in+reversal+learning&doi=10.1523%2FJNEUROSCI.3930-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span></div><div class="casAuthors">Shirey, Jana K.; Brady, Ashley E.; Jones, Paulianda J.; Davis, Albert A.; Bridges, Thomas M.; Kennedy, J. Phillip; Jadhav, Satyawan B.; Menon, Usha N.; Xiang, Zixiu; Watson, Mona L.; Christian, Edward P.; Doherty, James J.; Quirk, Michael C.; Snyder, Dean H.; Lah, James J.; Levey, Allan I.; Nicolle, Michelle M.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14271-14286</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) may represent a viable target for treatment of disorders involving impaired cognitive function.  However, a major limitation to testing this hypothesis has been a lack of highly selective ligands for individual mAChR subtypes.  We now report the rigorous mol. characterization of a novel compd., benzylquinolone carboxylic acid (BQCA), which acts as a potent, highly selective pos. allosteric modulator (PAM) of the rat M1 receptor.  This compd. does not directly activate the receptor, but acts at an allosteric site to increase functional responses to orthosteric agonists.  Radioligand binding studies revealed that BQCA increases M1 receptor affinity for acetylcholine.  We found that activation of the M1 receptor by BQCA induces a robust inward current and increases spontaneous EPSCs in medial prefrontal cortex (mPFC) pyramidal cells, effects which are absent in acute slices from M1 receptor knock-out mice.  Furthermore, to det. the effect of BQCA on intact and functioning brain circuits, multiple single-unit recordings were obtained from the mPFC of rats that showed BQCA increases firing of mPFC pyramidal cells in vivo.  BQCA also restored discrimination reversal learning in a transgenic mouse model of Alzheimer's disease and was found to regulate non-amyloidogenic APP processing in vitro, suggesting that M1 receptor PAMs have the potential to provide both symptomatic and disease modifying effects in Alzheimer's disease patients.  Together, these studies provide compelling evidence that M1 receptor activation induces a dramatic excitation of PFC neurons and suggest that selectively activating the M1 mAChR subtype may ameliorate impairments in cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPy39j1-erZLVg90H21EOLACvtfcHk0liAhpt2MNc3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL&md5=f9b017887d46ba34b925f747cea7ce3b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3930-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3930-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DShirey%26aufirst%3DJ.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DP.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DJadhav%26aufirst%3DS.%2BB.%26aulast%3DMenon%26aufirst%3DU.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DM.%2BL.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DQuirk%26aufirst%3DM.%2BC.%26aulast%3DSnyder%26aufirst%3DD.%2BH.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DNicolle%26aufirst%3DM.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520selective%2520allosteric%2520potentiator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520increases%2520activity%2520of%2520medial%2520prefrontal%2520cortical%2520neurons%2520and%2520restores%2520impairments%2520in%2520reversal%2520learning%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D14271%26epage%3D14286%26doi%3D10.1523%2FJNEUROSCI.3930-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">6067</span><span class="NLM_x">–</span> <span class="NLM_lpage">6079</span><span class="refDoi"> DOI: 10.1074/jbc.M113.539080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1074%2Fjbc.M113.539080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=6067-6079&author=A.+Abdul-Ridhaauthor=L.+Lopezauthor=P.+Keovauthor=D.+M.+Thalauthor=S.+N.+Mistryauthor=P.+M.+Sextonauthor=J.+R.+Laneauthor=M.+Canalsauthor=A.+Christopoulos&title=Molecular+determinants+of+allosteric+modulation+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M113.539080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.539080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.539080%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKeov%26aufirst%3DP.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DMolecular%2520determinants%2520of%2520allosteric%2520modulation%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D6067%26epage%3D6079%26doi%3D10.1074%2Fjbc.M113.539080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saffold, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span> </span><span class="NLM_article-title">Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.bmcl.2014.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=24485781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1417-1420&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=J.+R.+Saffoldauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=D.+C.+Beshore&title=Identification+of+a+methoxynaphthalene+scaffold+as+a+core+replacement+in+quinolizidinone+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2014.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators</span></div><div class="casAuthors">Kuduk, Scott D.; Di Marco, Christina N.; Saffold, Jonathan R.; Ray, William J.; Ma, Lei; Wittmann, Marion; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.; Beshore, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1417-1420</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of methoxynaphthalene amides I [R = Me, Cl, Et, etc.] were prepd. and evaluated as alternatives to quinolizidinone amide M1 pos. allosteric modulators.  A methoxy group was optimal for M1 activity and addressed key P-gp issues present in the aforementioned quinolizidinone amide series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHiLV64XSfi7Vg90H21EOLACvtfcHk0lg2ooGP0_yw_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cmsbk%253D&md5=c9483236a21b24bfaa05a8c649cb5f6e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DSaffold%26aufirst%3DJ.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DIdentification%2520of%2520a%2520methoxynaphthalene%2520scaffold%2520as%2520a%2520core%2520replacement%2520in%2520quinolizidinone%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1417%26epage%3D1420%26doi%3D10.1016%2Fj.bmcl.2014.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Eckhardt, M.; Himmelsbach, F.</span><span> </span><span class="NLM_article-title">Oxazinanone derivatives as 11β-HSD1 inhibitors and their preparation and use for the treatment of 11β-HSD1-mediated diseases</span>. WO2010089303A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Eckhardt&author=F.+Himmelsbach&title=Oxazinanone+derivatives+as+11%CE%B2-HSD1+inhibitors+and+their+preparation+and+use+for+the+treatment+of+11%CE%B2-HSD1-mediated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEckhardt%26aufirst%3DM.%26atitle%3DOxazinanone%2520derivatives%2520as%252011%25CE%25B2-HSD1%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%252011%25CE%25B2-HSD1-mediated%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Penfold, B. R.</span><span> </span><span class="NLM_article-title">The electron distribution in crystalline α-pyridone</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1107/S0365110X5300168X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1107%2FS0365110X5300168X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1953&pages=591-600&author=B.+R.+Penfold&title=The+electron+distribution+in+crystalline+%CE%B1-pyridone&doi=10.1107%2FS0365110X5300168X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0365110X5300168X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0365110X5300168X%26sid%3Dliteratum%253Aachs%26aulast%3DPenfold%26aufirst%3DB.%2BR.%26atitle%3DThe%2520electron%2520distribution%2520in%2520crystalline%2520%25CE%25B1-pyridone%26jtitle%3DActa%2520Crystallogr.%26date%3D1953%26volume%3D6%26spage%3D591%26epage%3D600%26doi%3D10.1107%2FS0365110X5300168X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. M.</span><span> </span><span class="NLM_article-title">Charge density study of 2-pyridone</span> <span class="citation_source-journal">Acta Crystallogr., Sect. B: Struct. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span><span class="refDoi"> DOI: 10.1107/S0108768198006545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1107%2FS0108768198006545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=9880899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlWmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=912-920&author=H.+W.+Yangauthor=R.+M.+Craven&title=Charge+density+study+of+2-pyridone&doi=10.1107%2FS0108768198006545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Charge density study of 2-pyridone</span></div><div class="casAuthors">Yang, H. W.; Craven, R. M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">B54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">912-920</span>CODEN:
                <span class="NLM_cas:coden">ASBSDK</span>;
        ISSN:<span class="NLM_cas:issn">0108-7681</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">The crystal structure of 2-pyridone was redetd. from high-resoln. x-ray data collected at 123 K.  The mol. is in the lactam form.  Bond lengths (cor. for rigid-body libration) and angles were detd. with s.u.'s of 0.001 Å and 0.1°, resp.  The H-bonded cyclic dimers which occur in the vapor and in soln. are absent in the crystal where mols. are linked by N-II···O H bonds to form puckered chains.  There also appears to be a weaker C-H···O interaction (H···O, 2.57 Å) and weak C-H···π or van der Waals interactions occurring on both sides of the pyridone ring.  Following a refinement of the structure assuming Stewart's rigid pseudo-atom model, the electronic charge d. distribution n the crystal and its Laplacian were calcd. for atoms at rest.  The total electrostatic potential was mapped for an isolated mol. and the mol. dipole moment was detd. [8.8(19) D; 1-dimensional ≃ 3.33564 × 10-30 C m].  Crit. points in the electron d. were located for the bonds within the mol. and for the mol. interactions cited above.  For the C-H···π interactions, only the spherical components of the valence d. for the pyridone ring atoms contribute effectively at the crit. points.  Hence, these may be better described as van der Waals interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm47xAbt5E_7Vg90H21EOLACvtfcHk0lg2ooGP0_yw_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlWmsQ%253D%253D&md5=3484b61d5f4740a3da9c0d5d4e265566</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0108768198006545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108768198006545%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BW.%26aulast%3DCraven%26aufirst%3DR.%2BM.%26atitle%3DCharge%2520density%2520study%2520of%25202-pyridone%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%26date%3D1998%26volume%3D54%26spage%3D912%26epage%3D920%26doi%3D10.1107%2FS0108768198006545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Aksnes, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kryvi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöstrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span> </span><span class="NLM_article-title">Substituent and solvent effects in the proton magnetic resonance (PMR) spectra of six 2-substituted pyridines</span> <span class="citation_source-journal">Acta Chem. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2266</span><span class="refDoi"> DOI: 10.3891/acta.chem.scand.26-2255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.3891%2Facta.chem.scand.26-2255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=2255-2266&author=D.+W.+Aksnesauthor=H.+Kryviauthor=O.+Samuelsonauthor=E.+Sj%C3%B6strandauthor=S.+Svensson&title=Substituent+and+solvent+effects+in+the+proton+magnetic+resonance+%28PMR%29+spectra+of+six+2-substituted+pyridines&doi=10.3891%2Facta.chem.scand.26-2255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.26-2255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.26-2255%26sid%3Dliteratum%253Aachs%26aulast%3DAksnes%26aufirst%3DD.%2BW.%26aulast%3DKryvi%26aufirst%3DH.%26aulast%3DSamuelson%26aufirst%3DO.%26aulast%3DSj%25C3%25B6strand%26aufirst%3DE.%26aulast%3DSvensson%26aufirst%3DS.%26atitle%3DSubstituent%2520and%2520solvent%2520effects%2520in%2520the%2520proton%2520magnetic%2520resonance%2520%2528PMR%2529%2520spectra%2520of%2520six%25202-substituted%2520pyridines%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1972%26volume%3D26%26spage%3D2255%26epage%3D2266%26doi%3D10.3891%2Facta.chem.scand.26-2255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Forlani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todesco, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monari, M.</span><span> </span><span class="NLM_article-title">Reinvestigation of the tautomerism of some substituted 2-hydroxypyridines</span> <span class="citation_source-journal">ARKIVOC</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=198-215&author=L.+Forlaniauthor=G.+Cristoniauthor=C.+Bogaauthor=P.+E.+Todescoauthor=E.+Del+Vecchioauthor=S.+Selvaauthor=M.+Monari&title=Reinvestigation+of+the+tautomerism+of+some+substituted+2-hydroxypyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForlani%26aufirst%3DL.%26aulast%3DCristoni%26aufirst%3DG.%26aulast%3DBoga%26aufirst%3DC.%26aulast%3DTodesco%26aufirst%3DP.%2BE.%26aulast%3DDel%2BVecchio%26aufirst%3DE.%26aulast%3DSelva%26aufirst%3DS.%26aulast%3DMonari%26aufirst%3DM.%26atitle%3DReinvestigation%2520of%2520the%2520tautomerism%2520of%2520some%2520substituted%25202-hydroxypyridines%26jtitle%3DARKIVOC%26date%3D2002%26spage%3D198%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0limC0_K_mEnjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1016/S0165-6147(98)01240-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2FS0165-6147%2898%2901240-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=351-357&author=A.+Christopoulos&title=Assessing+the+distribution+of+parameters+in+models+of+ligand-receptor+interaction%3A+to+log+or+not+to+log&doi=10.1016%2FS0165-6147%2898%2901240-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2898%2901240-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252898%252901240-1%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAssessing%2520the%2520distribution%2520of%2520parameters%2520in%2520models%2520of%2520ligand-receptor%2520interaction%253A%2520to%2520log%2520or%2520not%2520to%2520log%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D351%26epage%3D357%26doi%3D10.1016%2FS0165-6147%2898%2901240-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yang, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunda, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolt, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.bmcl.2009.11.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=531-536&author=F.+V.+Yangauthor=W.+D.+Shipeauthor=J.+L.+Bundaauthor=M.+B.+Noltauthor=D.+D.+Wisnoskiauthor=Z.+Zhaoauthor=J.+C.+Barrowauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=G.+D.+Hartmanauthor=C.+W.+Lindsley&title=Parallel+synthesis+of+N-biaryl+quinolone+carboxylic+acids+as+selective+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2009.11.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.100%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%2BV.%26aulast%3DShipe%26aufirst%3DW.%2BD.%26aulast%3DBunda%26aufirst%3DJ.%2BL.%26aulast%3DNolt%26aufirst%3DM.%2BB.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DParallel%2520synthesis%2520of%2520N-biaryl%2520quinolone%2520carboxylic%2520acids%2520as%2520selective%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D531%26epage%3D536%26doi%3D10.1016%2Fj.bmcl.2009.11.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Liljebris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazuk, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasdale, J. E.</span><span> </span><span class="NLM_article-title">Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: Identification of a tetrazole-containing inhibitor with cellular activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1785</span><span class="NLM_x">–</span> <span class="NLM_lpage">1798</span><span class="refDoi"> DOI: 10.1021/jm011100y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011100y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1785-1798&author=C.+Liljebrisauthor=S.+D.+Larsenauthor=D.+Oggauthor=B.+J.+Palazukauthor=J.+E.+Bleasdale&title=Investigation+of+potential+bioisosteric+replacements+for+the+carboxyl+groups+of+peptidomimetic+inhibitors+of+protein+tyrosine+phosphatase+1B%3A+Identification+of+a+tetrazole-containing+inhibitor+with+cellular+activity&doi=10.1021%2Fjm011100y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm011100y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011100y%26sid%3Dliteratum%253Aachs%26aulast%3DLiljebris%26aufirst%3DC.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DOgg%26aufirst%3DD.%26aulast%3DPalazuk%26aufirst%3DB.%2BJ.%26aulast%3DBleasdale%26aufirst%3DJ.%2BE.%26atitle%3DInvestigation%2520of%2520potential%2520bioisosteric%2520replacements%2520for%2520the%2520carboxyl%2520groups%2520of%2520peptidomimetic%2520inhibitors%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%253A%2520Identification%2520of%2520a%2520tetrazole-containing%2520inhibitor%2520with%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1785%26epage%3D1798%26doi%3D10.1021%2Fjm011100y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span><span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lg7xXytf_xFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Gonzalez, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksterowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2963</span><span class="NLM_x">–</span> <span class="NLM_lpage">2988</span><span class="refDoi"> DOI: 10.1021/jm401911v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401911v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2963-2988&author=A.+Z.+Gonzalezauthor=Z.+Liauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=J.+Duquetteauthor=J.+Eksterowiczauthor=B.+M.+Foxauthor=J.+Fuauthor=X.+Huangauthor=J.+Houzeauthor=L.+Jinauthor=Y.+Liauthor=Y.+Lingauthor=M.-C.+Loauthor=A.+M.+Longauthor=L.+R.+McGeeauthor=J.+McIntoshauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=Y.+Rewauthor=A.+Y.+Saikiauthor=P.+Shafferauthor=S.+Wortmanauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=S.+H.+Olsonauthor=D.+Sunauthor=J.+C.+Medina&title=Novel+inhibitors+of+the+MDM2-p53+interaction+featuring+hydrogen+bond+acceptors+as+carboxylic+acid+isosteres&doi=10.1021%2Fjm401911v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres</span></div><div class="casAuthors">Gonzalez, Ana Z.; Li, Zhihong; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chow, David; Duquette, Jason; Eksterowicz, John; Fox, Brian M.; Fu, Jiasheng; Huang, Xin; Houze, Jonathan; Jin, Lixia; Li, Yihong; Ling, Yun; Lo, Mei-Chu; Long, Alexander M.; McGee, Lawrence R.; McIntosh, Joel; Oliner, Jonathan D.; Osgood, Tao; Rew, Yosup; Saiki, Anne Y.; Shaffer, Paul; Wortman, Sarah; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Zhao, Xiaoning; Zhou, Jing; Olson, Steven H.; Sun, Daqing; Medina, Julio C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2963-2988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction.  These inhibitors have in common a carboxylic acid moiety that engages in an electrostatic interaction with MDM2-His96.  Our continued search for potent and diverse inhibitors led to the discovery of novel replacements for these acids uncovering new interactions with the MDM2 protein.  In particular, using pyridine or thiazole as isosteres of the carboxylic acid moiety resulted in very potent analogs.  From these, AM-6761 (I) emerged as a potent inhibitor with remarkable biochem. (HTRF IC50 = 0.1 nM) and cellular potency (SJSA-1 EdU IC50 = 16 nM), as well as favorable pharmacokinetic properties.  Compd. I also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED50 of 11 mg/kg.  Optimization efforts toward the discovery of these inhibitors as well as the new interactions obsd. with the MDM2 protein are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnAXnJUWxJHbVg90H21EOLACvtfcHk0lg7xXytf_xFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqsb4%253D&md5=7e12d238f454f1d1c91493a2fd48847d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm401911v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401911v%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DWortman%26aufirst%3DS.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DNovel%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%2520featuring%2520hydrogen%2520bond%2520acceptors%2520as%2520carboxylic%2520acid%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2963%26epage%3D2988%26doi%3D10.1021%2Fjm401911v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Huynh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span> </span><span class="NLM_article-title">Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8196</span><span class="NLM_x">–</span> <span class="NLM_lpage">8200</span><span class="refDoi"> DOI: 10.1021/jm401032k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401032k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8196-8200&author=T.+Huynhauthor=C.+Valantauthor=I.+T.+Crosbyauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=B.+Capuano&title=Probing+structural+requirements+of+positive+allosteric+modulators+of+the+M4+muscarinic+receptor&doi=10.1021%2Fjm401032k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Probing Structural Requirements of Positive Allosteric Modulators of the M4 Muscarinic Receptor</span></div><div class="casAuthors">Huynh, Tracey; Valant, Celine; Crosby, Ian T.; Sexton, Patrick M.; Christopoulos, Arthur; Capuano, Ben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8196-8200</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M4 mAChR is implicated in several CNS disorders and possesses an allosteric binding site for which ligands modulating the affinity and/or efficacy of ACh may be exploited for selective receptor targeting.  The authors report the synthesis of a focused library of putative M4 PAMs derived from VU0152100 and VU10005.  These compds. investigate the pharmacol. effects of previously identified methoxy and fluoro substituents, providing useful ests. of affinity, cooperativity, and direct agonist properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xoKOwOxTMLVg90H21EOLACvtfcHk0ljUelBH4jej_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrvJ&md5=0bbb4387b9ebdca5d8b00d6cd7b9d3a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm401032k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401032k%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DCrosby%26aufirst%3DI.%2BT.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DProbing%2520structural%2520requirements%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520M4%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8196%26epage%3D8200%26doi%3D10.1021%2Fjm401032k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">Spectra available in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">May, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=17009927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1-51&author=L.+T.+Mayauthor=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+G+protein-coupled+receptors&doi=10.1146%2Fannurev.pharmtox.47.120505.105159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of G protein-coupled receptors</span></div><div class="casAuthors">May, Lauren T.; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant growth in the identification of allosteric modulators of G protein-coupled receptors (GPCRs), i.e., ligands that interact with binding sites that are topog. distinct from the orthosteric site recognized by the receptor's endogenous agonist.  Because of their ability to modulate receptor conformations in the presence of orthosteric ligand, allosteric modulators can "fine-tune" classical pharmacol. responses.  This is advantageous in terms of a potential for engendering greater GPCR subtype-selectivity, but represents a significant challenge for detecting and validating allosteric behaviors.  Although allosteric sites need not have evolved to accommodate endogenous ligands, there are a no. of examples of where such modulators have been shown to contribute to physiol. or pathophysiol. processes.  Studies are also beginning to unravel the structural basis of allosteric modulation of GPCRs.  It remains to be detd. whether such modulation represents interactions within monomers vs. across dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6rgFXhej3ibVg90H21EOLACvtfcHk0ljUelBH4jej_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D&md5=848fa85abdfb3b40834887416479edec</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105159%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D1%26epage%3D51%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Leach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.tips.2007.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=17629965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=382-389&author=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+GPCR+modulators%3A+taking+advantage+of+permissive+receptor+pharmacology&doi=10.1016%2Fj.tips.2007.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span></div><div class="casAuthors">Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-389</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a dramatic increase in the identification of allosteric modulators of G-protein-coupled receptor (GPCR) activity.  Concomitantly, several new perspectives and hypotheses regarding the way ligands regulate GPCR signaling have also emerged.  Here, we briefly discuss how the concepts of collateral efficacy and permissive agonism-antagonism intersect the field of allosteric GPCR modulation.  Despite the challenges assocd. with detecting and quantifying the myriad of possible allosteric effects on GPCR activity, it is proposed that allosteric ligands offer the exciting prospect of engendering stimulus-bias in orthosteric ligand signaling, thus paving the way for not only receptor-selective but also signaling-pathway-selective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpHb_QsIW3TbVg90H21EOLACvtfcHk0ljUelBH4jej_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D&md5=943da2312e7b136cb594ba0346e00301</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520GPCR%2520modulators%253A%2520taking%2520advantage%2520of%2520permissive%2520receptor%2520pharmacology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D382%26epage%3D389%26doi%3D10.1016%2Fj.tips.2007.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':[],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Elham Khajehali, Sophie Bradley, Emma T. van der Westhuizen, Colin Molloy, Celine Valant, Lisa Finlayson, Craig W. Lindsley, Patrick M. Sexton, Andrew B. Tobin, <span class="NLM_string-name hlFld-ContribAuthor">Arthur Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Restoring Agonist Function at a Chemogenetically Modified M1 Muscarinic Acetylcholine Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (24)
                                     , 4270-4279. <a href="https://doi.org/10.1021/acschemneuro.0c00540" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00540%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRestoring%252BAgonist%252BFunction%252Bat%252Ba%252BChemogenetically%252BModified%252BM1%252BMuscarinic%252BAcetylcholine%252BReceptor%26aulast%3DKhajehali%26aufirst%3DElham%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17082020%26date%3D21102020%26date%3D16112020%26volume%3D11%26issue%3D24%26spage%3D4270%26epage%3D4279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cassandra J. Hatzipantelis, Monica Langiu, Teresa H. Vandekolk, Tracie L. Pierce, Jess Nithianantharajah, Gregory D. Stewart, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. Langmead</span>. </span><span class="cited-content_cbyCitation_article-title">Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (6)
                                     , 1042-1062. <a href="https://doi.org/10.1021/acsptsci.0c00117" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00117%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DTranslation-Focused%252BApproaches%252Bto%252BGPCR%252BDrug%252BDiscovery%252Bfor%252BCognitive%252BImpairments%252BAssociated%252Bwith%252BSchizophrenia%26aulast%3DHatzipantelis%26aufirst%3DCassandra%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20082020%26date%3D28102020%26volume%3D3%26issue%3D6%26spage%3D1042%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Karen J. Gregory, Thomas M. Bridges, Rocco G. Gogliotti, Shaun R. Stauffer, Meredith J. Noetzel, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, <span class="NLM_string-name hlFld-ContribAuthor">Colleen M. Niswender</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro to in Vivo Translation of Allosteric Modulator Concentration-Effect Relationships: Implications for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (6)
                                     , 442-452. <a href="https://doi.org/10.1021/acsptsci.9b00062" title="DOI URL">https://doi.org/10.1021/acsptsci.9b00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.9b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.9b00062%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DIn%252BVitro%252Bto%252Bin%252BVivo%252BTranslation%252Bof%252BAllosteric%252BModulator%252BConcentration-Effect%252BRelationships%25253A%252BImplications%252Bfor%252BDrug%252BDiscovery%26aulast%3DGregory%26aufirst%3DKaren%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07082019%26date%3D27112019%26date%3D15112019%26volume%3D2%26issue%3D6%26spage%3D442%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xufen Yu, Xi-Ping Huang, Terry P. Kenakin, Samuel T. Slocum, Xin Chen, Michael L. Martini, Jing Liu, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7557-7574. <a href="https://doi.org/10.1021/acs.jmedchem.9b00869" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00869%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252BOgerin-Based%252BPositive%252BAllosteric%252BModulators%252Bfor%252BG%252BProtein-Coupled%252BReceptor%252B68%252B%252528GPR68%252529%26aulast%3DYu%26aufirst%3DXufen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29052019%26date%3D01082019%26date%3D12072019%26volume%3D62%26issue%3D16%26spage%3D7557%26epage%3D7574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manuela Jörg, Emma T. van der Westhuizen, Elham Khajehali, Wessel A. C. Burger, Jonathan M. White, Kwok H. C. Choy, Andrew B. Tobin, Patrick M. Sexton, Celine Valant, Ben Capuano, Arthur Christopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1099-1114. <a href="https://doi.org/10.1021/acschemneuro.8b00613" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00613%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D6-Phenylpyrimidin-4-ones%252Bas%252BPositive%252BAllosteric%252BModulators%252Bat%252Bthe%252BM1%252BmAChR%25253A%252BThe%252BDeterminants%252Bof%252BAllosteric%252BActivity%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06112018%26date%3D14122018%26date%3D28122018%26date%3D14122018%26volume%3D10%26issue%3D3%26spage%3D1099%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Terry Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">Analytical Pharmacology: How Numbers Can Guide Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     , 9-17. <a href="https://doi.org/10.1021/acsptsci.8b00057" title="DOI URL">https://doi.org/10.1021/acsptsci.8b00057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.8b00057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.8b00057%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DAnalytical%252BPharmacology%25253A%252BHow%252BNumbers%252BCan%252BGuide%252BDrug%252BDiscovery%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D15122018%26date%3D08012019%26date%3D03012019%26volume%3D2%26issue%3D1%26spage%3D9%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 88-127. <a href="https://doi.org/10.1021/acs.jmedchem.8b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulation%252Bof%252BClass%252BA%252BGPCRs%25253A%252BTargets%25252C%252BAgents%25252C%252Band%252BEmerging%252BConcepts%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D02062018%26date%3D28082018%26date%3D14082018%26volume%3D62%26issue%3D1%26spage%3D88%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juliana
C. C. Dallagnol, Elham Khajehali, Emma T. van der Westhuizen, Manuela Jörg, Celine Valant, Alan G. Gonçalves, Ben Capuano, Arthur Christopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 2875-2894. <a href="https://doi.org/10.1021/acs.jmedchem.7b01812" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01812</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01812%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252BHeterocyclic%252BCarboxamides%25253A%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BM1%252BMuscarinic%252BAcetylcholine%252BReceptor%252Bwith%252BWeak%252BAgonist%252BActivity%252Band%252BDiverse%252BModulatory%252BProfiles%26aulast%3DDallagnol%26aufirst%3DJuliana%2BC.%2BC.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D10122017%26date%3D23032018%26date%3D15032018%26volume%3D61%26issue%3D7%26spage%3D2875%26epage%3D2894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer E.  Davoren</span>, <span class="hlFld-ContribAuthor ">Michelle  Garnsey</span>, <span class="hlFld-ContribAuthor ">Betty  Pettersen</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Jeremy R.  Edgerton</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Fortin</span>, <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Harris</span>, <span class="hlFld-ContribAuthor ">Stephen  Jenkinson</span>, <span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Susan M.  Lotarski</span>, <span class="hlFld-ContribAuthor ">Lisa  Nottebaum</span>, <span class="hlFld-ContribAuthor ">Steven V.  O’Neil</span>, <span class="hlFld-ContribAuthor ">Michael  Popiolek</span>, <span class="hlFld-ContribAuthor ">Simeon  Ramsey</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Thorn</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, and <span class="hlFld-ContribAuthor ">Damien  Webb</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6649-6663. <a href="https://doi.org/10.1021/acs.jmedchem.7b00597" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00597%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B%2525CE%2525B3-%252Band%252B%2525CE%2525B4-Lactam%252BM1%252BPositive%252BAllosteric%252BModulators%252B%252528PAMs%252529%25253A%252BConvulsion%252Band%252BCholinergic%252BToxicity%252Bof%252Ban%252BM1-Selective%252BPAM%252Bwith%252BWeak%252BAgonist%252BActivity%26aulast%3DDavoren%26aufirst%3DJennifer%2BE.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20042017%26date%3D26072017%26date%3D10082017%26date%3D09062017%26volume%3D60%26issue%3D15%26spage%3D6649%26epage%3D6663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerri M.  Rook</span>, <span class="hlFld-ContribAuthor ">Masahito  Abe</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Kellie D.  Nance</span>, <span class="hlFld-ContribAuthor ">Vincent B.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Jeffrey J.  Adams</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Dickerson</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Remke</span>, <span class="hlFld-ContribAuthor ">Pedro M.  Garcia-Barrantes</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Julie L.  Engers</span>, <span class="hlFld-ContribAuthor ">Sichen  Chang</span>, <span class="hlFld-ContribAuthor ">Jarrett J.  Foster</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, and <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>  . </span><span class="cited-content_cbyCitation_article-title">Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 866-883. <a href="https://doi.org/10.1021/acschemneuro.6b00429" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00429%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiverse%252BEffects%252Bon%252BM1%252BSignaling%252Band%252BAdverse%252BEffect%252BLiability%252Bwithin%252Ba%252BSeries%252Bof%252BM1%252BAgo-PAMs%26aulast%3DRook%26aufirst%3DJerri%2BM.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D07122016%26date%3D21122016%26date%3D10012017%26date%3D19042017%26date%3D21122016%26volume%3D8%26issue%3D4%26spage%3D866%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, and <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>  . </span><span class="cited-content_cbyCitation_article-title">Classics in Chemical Neuroscience: Xanomeline. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 435-443. <a href="https://doi.org/10.1021/acschemneuro.7b00001" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00001%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DClassics%252Bin%252BChemical%252BNeuroscience%25253A%252BXanomeline%26aulast%3DBender%26aufirst%3DAaron%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04012017%26date%3D31012017%26date%3D13022017%26date%3D15032017%26date%3D31012017%26volume%3D8%26issue%3D3%26spage%3D435%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer E.  Davoren</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Michelle  Garnsey</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Jason  Cordes</span>, <span class="hlFld-ContribAuthor ">Keith  Dlugolenski</span>, <span class="hlFld-ContribAuthor ">Jeremy R.  Edgerton</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Harris</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Stephen  Jenkinson</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Terrence P.  Kenakin</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Susan M.  Lotarski</span>, <span class="hlFld-ContribAuthor ">Yuxia  Mao</span>, <span class="hlFld-ContribAuthor ">Deane M.  Nason</span>, <span class="hlFld-ContribAuthor ">Carrie  Northcott</span>, <span class="hlFld-ContribAuthor ">Lisa  Nottebaum</span>, <span class="hlFld-ContribAuthor ">Steven V.  O’Neil</span>, <span class="hlFld-ContribAuthor ">Betty  Pettersen</span>, <span class="hlFld-ContribAuthor ">Michael  Popiolek</span>, <span class="hlFld-ContribAuthor ">Veronica  Reinhart</span>, <span class="hlFld-ContribAuthor ">Romelia  Salomon-Ferrer</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Damien  Webb</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, and <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6313-6328. <a href="https://doi.org/10.1021/acs.jmedchem.6b00544" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BPotent%252Band%252BSelective%252BM1%252BPAM-Agonist%252BN-%25255B%2525283R%25252C4S%252529-3-Hydroxytetrahydro-2H-pyran-4-yl%25255D-5-methyl-4-%25255B4-%2525281%25252C3-thiazol-4-yl%252529benzyl%25255Dpyridine-2-carboxamide%252B%252528PF-06767832%252529%25253A%252BEvaluation%252Bof%252BEfficacy%252Band%252BCholinergic%252BSide%252BEffects%26aulast%3DDavoren%26aufirst%3DJennifer%2BE.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11042016%26date%3D01072016%26date%3D14072016%26date%3D08062016%26volume%3D59%26issue%3D13%26spage%3D6313%26epage%3D6328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul K.  Spearing</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Vincent B.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Olivier  Boutaud</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P.  Jeffrey Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128193. <a href="https://doi.org/10.1016/j.bmcl.2021.128193" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128193%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bheteroaryl-pyrrolidinones%252Bas%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bmuscarinic%252Bacetylcholine%252Breceptor%252BM1%26aulast%3DSpearing%26aufirst%3DPaul%2BK.%26date%3D2021%26volume%3D47%26spage%3D128193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma T.  van der Westhuizen</span>, <span class="hlFld-ContribAuthor ">K. H. Christopher  Choy</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Simon  McKenzie-Nickson</span>, <span class="hlFld-ContribAuthor ">Sophie J.  Bradley</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.606656" title="DOI URL">https://doi.org/10.3389/fphar.2020.606656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.606656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.606656%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DFine%252BTuning%252BMuscarinic%252BAcetylcholine%252BReceptor%252BSignaling%252BThrough%252BAllostery%252Band%252BBias%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DEmma%2BT.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Emma T.  Westhuizen</span>, <span class="hlFld-ContribAuthor ">K. H.  C. Choy</span>, <span class="hlFld-ContribAuthor ">David M.  Shackleford</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel 4‐Arylpyridin‐2‐one and 6‐Arylpyrimidin‐4‐one Positive Allosteric Modulators of the M
              1
              Muscarinic Acetylcholine Receptor. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 216-233. <a href="https://doi.org/10.1002/cmdc.202000540" title="DOI URL">https://doi.org/10.1002/cmdc.202000540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000540%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDevelopment%252Bof%252BNovel%252B4%2525E2%252580%252590Arylpyridin%2525E2%252580%2525902%2525E2%252580%252590one%252Band%252B6%2525E2%252580%252590Arylpyrimidin%2525E2%252580%2525904%2525E2%252580%252590one%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BM%252B1%252BMuscarinic%252BAcetylcholine%252BReceptor%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D216%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Receptor Theory. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00010-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00010-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00010-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00010-4%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacological%252BReceptor%252BTheory%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Jakubik</span>, <span class="hlFld-ContribAuthor ">Esam E.  El-Fakahany</span>. </span><span class="cited-content_cbyCitation_article-title">Current Advances in Allosteric Modulation of Muscarinic Receptors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 325. <a href="https://doi.org/10.3390/biom10020325" title="DOI URL">https://doi.org/10.3390/biom10020325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10020325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10020325%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DCurrent%252BAdvances%252Bin%252BAllosteric%252BModulation%252Bof%252BMuscarinic%252BReceptors%26aulast%3DJakubik%26aufirst%3DJan%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 195-241. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00011-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BGPCRs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DMar%25C3%25ADa%2BL.%26date%3D2020%26spage%3D195%26epage%3D241%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miriam  Scarpa</span>, <span class="hlFld-ContribAuthor ">Sarah  Hesse</span>, <span class="hlFld-ContribAuthor ">Sophie J.  Bradley</span>. </span><span class="cited-content_cbyCitation_article-title">M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 277-310. <a href="https://doi.org/10.1016/bs.apha.2019.12.003" title="DOI URL">https://doi.org/10.1016/bs.apha.2019.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2019.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2019.12.003%26sid%3Dliteratum%253Aachs%26atitle%3DM1%252Bmuscarinic%252Bacetylcholine%252Breceptors%25253A%252BA%252Btherapeutic%252Bstrategy%252Bfor%252Bsymptomatic%252Band%252Bdisease-modifying%252Beffects%252Bin%252BAlzheimer%252527s%252Bdisease%25253F%26aulast%3DScarpa%26aufirst%3DMiriam%26date%3D2020%26spage%3D277%26epage%3D310%26pub%3DElsevier%26atitle%3DFrom%252BStructure%252Bto%252BClinical%252BDevelopment%25253A%252BAllosteric%252BModulation%252Bof%252BG%252BProtein-Coupled%252BReceptors%26date%3D2020%26volume%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shotaro  Miura</span>, <span class="hlFld-ContribAuthor ">Koichiro  Fukuda</span>, <span class="hlFld-ContribAuthor ">Shinichi  Masada</span>, <span class="hlFld-ContribAuthor ">Hirotsugu  Usutani</span>, <span class="hlFld-ContribAuthor ">Makoto  Kanematsu</span>, <span class="hlFld-ContribAuthor ">David G.  Cork</span>, <span class="hlFld-ContribAuthor ">Tetsuji  Kawamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid and efficient synthesis of a novel cholinergic muscarinic M
              1
              receptor positive allosteric modulator using flash chemistry. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (35)
                                     , 8166-8174. <a href="https://doi.org/10.1039/C9OB01718F" title="DOI URL">https://doi.org/10.1039/C9OB01718F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01718F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01718F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRapid%252Band%252Befficient%252Bsynthesis%252Bof%252Ba%252Bnovel%252Bcholinergic%252Bmuscarinic%252BM%252B1%252Breceptor%252Bpositive%252Ballosteric%252Bmodulator%252Busing%252Bflash%252Bchemistry%26aulast%3DMiura%26aufirst%3DShotaro%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D35%26spage%3D8166%26epage%3D8174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Bdioui</span>, <span class="hlFld-ContribAuthor ">Julien  Verdi</span>, <span class="hlFld-ContribAuthor ">Nicolas  Pierre</span>, <span class="hlFld-ContribAuthor ">Eric  Trinquet</span>, <span class="hlFld-ContribAuthor ">Thomas  Roux</span>, <span class="hlFld-ContribAuthor ">Terry  Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">The pharmacologic characterization of allosteric molecules: Gq protein activation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2019,</strong> <em>39 </em>
                                    (2)
                                     , 106-113. <a href="https://doi.org/10.1080/10799893.2019.1634101" title="DOI URL">https://doi.org/10.1080/10799893.2019.1634101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2019.1634101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2019.1634101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DThe%252Bpharmacologic%252Bcharacterization%252Bof%252Ballosteric%252Bmolecules%25253A%252BGq%252Bprotein%252Bactivation%26aulast%3DBdioui%26aufirst%3DSara%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D2%26spage%3D106%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Bdioui</span>, <span class="hlFld-ContribAuthor ">Julien  Verdi</span>, <span class="hlFld-ContribAuthor ">Nicolas  Pierre</span>, <span class="hlFld-ContribAuthor ">Eric  Trinquet</span>, <span class="hlFld-ContribAuthor ">Thomas  Roux</span>, <span class="hlFld-ContribAuthor ">Terry  Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">Equilibrium Assays Are Required to Accurately Characterize the Activity Profiles of Drugs Modulating Gq-Protein-Coupled Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>94 </em>
                                    (3)
                                     , 992-1006. <a href="https://doi.org/10.1124/mol.118.112573" title="DOI URL">https://doi.org/10.1124/mol.118.112573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.112573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.112573%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DEquilibrium%252BAssays%252BAre%252BRequired%252Bto%252BAccurately%252BCharacterize%252Bthe%252BActivity%252BProfiles%252Bof%252BDrugs%252BModulating%252BGq-Protein-Coupled%252BReceptors%26aulast%3DBdioui%26aufirst%3DSara%26date%3D2018%26date%3D2018%26volume%3D94%26issue%3D3%26spage%3D992%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the binding site of novel selective positive allosteric modulators at the M1 muscarinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>154 </em>, 243-254. <a href="https://doi.org/10.1016/j.bcp.2018.05.009" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DProbing%252Bthe%252Bbinding%252Bsite%252Bof%252Bnovel%252Bselective%252Bpositive%252Ballosteric%252Bmodulators%252Bat%252Bthe%252BM1%252Bmuscarinic%252Bacetylcholine%252Breceptor%26aulast%3DKhajehali%26aufirst%3DElham%26date%3D2018%26volume%3D154%26spage%3D243%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuti  Verma</span>, <span class="hlFld-ContribAuthor ">Ashwini  Kumar</span>, <span class="hlFld-ContribAuthor ">Timir  Tripathi</span>, <span class="hlFld-ContribAuthor ">Awanish  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2018,</strong> <em>70 </em>
                                    (8)
                                     , 985-993. <a href="https://doi.org/10.1111/jphp.12919" title="DOI URL">https://doi.org/10.1111/jphp.12919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.12919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.12919%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DMuscarinic%252Band%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bagonists%25253A%252Bcurrent%252Bscenario%252Bin%252BAlzheimer%252527s%252Bdisease%252Btherapy%26aulast%3DVerma%26aufirst%3DStuti%26date%3D2018%26date%3D2018%26volume%3D70%26issue%3D8%26spage%3D985%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Bock</span>, <span class="hlFld-ContribAuthor ">Ramona  Schrage</span>, <span class="hlFld-ContribAuthor ">Klaus  Mohr</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting CNS muscarinic receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>136 </em>, 427-437. <a href="https://doi.org/10.1016/j.neuropharm.2017.09.024" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BCNS%252Bmuscarinic%252Breceptors%26aulast%3DBock%26aufirst%3DAndreas%26date%3D2018%26volume%3D136%26spage%3D427%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean P.  Moran</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Dickerson</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Zixiu  Xiang</span>, <span class="hlFld-ContribAuthor ">James  Maksymetz</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Remke</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Lv</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Doyle</span>, <span class="hlFld-ContribAuthor ">Deepa H.  Rajan</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Jerri M.  Rook</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>43 </em>
                                    (8)
                                     , 1763-1771. <a href="https://doi.org/10.1038/s41386-018-0033-9" title="DOI URL">https://doi.org/10.1038/s41386-018-0033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0033-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DM1-positive%252Ballosteric%252Bmodulators%252Blacking%252Bagonist%252Bactivity%252Bprovide%252Bthe%252Boptimal%252Bprofile%252Bfor%252Benhancing%252Bcognition%26aulast%3DMoran%26aufirst%3DSean%2BP.%26date%3D2018%26date%3D2018%26volume%3D43%26issue%3D8%26spage%3D1763%26epage%3D1771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma T.  van der Westhuizen</span>, <span class="hlFld-ContribAuthor ">Arthur  Spathis</span>, <span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Shailesh N.  Mistry</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
              1
              Muscarinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>94 </em>
                                    (1)
                                     , 770-783. <a href="https://doi.org/10.1124/mol.118.111633" title="DOI URL">https://doi.org/10.1124/mol.118.111633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.111633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.111633%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DAssessment%252Bof%252Bthe%252BMolecular%252BMechanisms%252Bof%252BAction%252Bof%252BNovel%252B4-Phenylpyridine-2-One%252Band%252B6-Phenylpyrimidin-4-One%252BAllosteric%252BModulators%252Bat%252Bthe%252BM%252B1%252BMuscarinic%252BAcetylcholine%252BReceptors%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DEmma%2BT.%26date%3D2018%26date%3D2018%26volume%3D94%26issue%3D1%26spage%3D770%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2017,</strong> <em>92 </em>
                                    (4)
                                     , 414-424. <a href="https://doi.org/10.1124/mol.117.108787" title="DOI URL">https://doi.org/10.1124/mol.117.108787</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.117.108787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.117.108787%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DA%252BScale%252Bof%252BAgonism%252Band%252BAllosteric%252BModulation%252Bfor%252BAssessment%252Bof%252BSelectivity%25252C%252BBias%25252C%252Band%252BReceptor%252BMutation%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2017%26date%3D2017%26volume%3D92%26issue%3D4%26spage%3D414%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leon A.  Sakkal</span>, <span class="hlFld-ContribAuthor ">Kyle Z.  Rajkowski</span>, <span class="hlFld-ContribAuthor ">Roger S.  Armen</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2017,</strong> <em>38 </em>
                                    (15)
                                     , 1209-1228. <a href="https://doi.org/10.1002/jcc.24728" title="DOI URL">https://doi.org/10.1002/jcc.24728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.24728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.24728%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DPrediction%252Bof%252Bconsensus%252Bbinding%252Bmode%252Bgeometries%252Bfor%252Brelated%252Bchemical%252Bseries%252Bof%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Badenosine%252Band%252Bmuscarinic%252Bacetylcholine%252Breceptors%26aulast%3DSakkal%26aufirst%3DLeon%2BA.%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D15%26spage%3D1209%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn  Johnstone</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2239-2258. <a href="https://doi.org/10.1016/j.bmcl.2017.03.084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPharmacological%252Bproperty%252Boptimization%252Bfor%252Ballosteric%252Bligands%25253A%252BA%252Bmedicinal%252Bchemistry%252Bperspective%26aulast%3DJohnstone%26aufirst%3DShawn%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2239%26epage%3D2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Conceptual development of the novel M<sub>1</sub> mAChR PAM scaffold starting from <b>1</b><a onclick="showRef(event, 'ref9 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref9 ref22 ref23">(9, 22, 23)</a> via 5,8-difluoro-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-hydroxycyclohexyl)-1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (<b>2</b>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> to evolve to the general structure of the novel 4-phenylpyridin-2-one based compounds reported herein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Initial Series of 4-Phenylpyridin-2-one Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,2-cyclohexene oxide, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 77% (rac-<i>trans</i>); (b) 2-hydroxyphenylboronic acid or 2-(4,4,5,5-tetramethyl-1,2,3-dioxaborolan-2-yl)aniline, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 83–100%; (c) substituted benzyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 18–93%; (d) NaOH, EtOH/H<sub>2</sub>O, 50 °C, 82–93%; (e) NH<sub>4</sub>OH/MeOH, rt, 14–52%; (f) boronic acid or boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 29–77%; (g) 4-bromobenzaldehyde, AcOH, NaB(OAc)<sub>3</sub>H, 1,2-dichloroethane, rt, 50%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of a Series of <i>N</i>-Substituted Pyrazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(<i>tert</i>-butoxycarbonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 77%; (b) alkyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt to 100 °C, 6–82%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues with Modifications to the 4-(1-Methylpyrazol-4-yl)benzyl Pendant<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) substituted benzyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 63% for <b>16</b>, 62% for <b>18</b>; (b) boronic acid/boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, THF degassed, 100 °C, 32% for <b>17</b>, 30% for <b>19</b>.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Difluoro-substituted 4-Phenylpyridin-2-one <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>/THF degassed, 100 °C, 23% for <b>20</b>, 31% for <b>23</b>; (b) 1 M BBr<sub>3</sub> in hexane, DCM, 0 °C to rt, 72%; (c) 4-bromobenzyl bromide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 73%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the 6-Phenylpyrimidin-4-one Analogue <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (2-methoxyphenyl)boronic acid, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, THF degassed, 100 °C, 20%; (b) 1,2-cyclohexene oxide, K<sub>2</sub>CO<sub>3</sub>, 120 °C, 38%; (c) 1 M BBr<sub>3</sub> in hexane, DCM, 0 °C to rt, 87%; (d) 4-bromobenzyl halide, K<sub>2</sub>CO<sub>3</sub>, cat. KI, DMF, rt, 55%; (e) boronate ester, cat. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M Na<sub>2</sub>CO<sub>3(aq)</sub>, THF degassed, 100 °C, 11%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a–d) Pharmacological characterization of <b>1</b> and <b>10d</b> in binding and function at the mAChRs. (a,b) Radioligand binding experiments were performed using FlpIn-CHO cells expressing the M<sub>1</sub> mAChR, 0.1 nM of the radiolabeled antagonist [<sup>3</sup>H]NMS, increasing concentrations of ACh, with or without increasing concentrations of either <b>1</b> (a) or <b>10d</b> (b). (c,d) IP<sub>1</sub> accumulation experiments were performed using FlpIn-CHO cells expressing the M<sub>1</sub> mAChR and increasing concentrations of ACh with or without increasing concentrations of either compound <b>1</b> (c) or <b>10d</b> (d). 100% represents the maximal stimulation of ACh in the absence of test compound. (e–h) Activity of <b>1</b> and <b>10d</b> at the human M<sub>2–5</sub> mAChRs in a [<sup>3</sup>H]NMS binding assay. No detectable effect of these compounds was observed at the other mAChR subtypes up to a concentration of 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacological characterization of <b>29</b> in binding and function at the mAChRs. (a) Radioligand binding experiments were performed using FlpIn-CHO cells stably expressing the M<sub>1</sub> mAChR, 0.1 nM of the radiolabeled antagonist [<sup>3</sup>H]NMS, increasing concentrations of ACh, with or without increasing concentrations of <b>29</b>. (b) IP<sub>1</sub> accumulation experiments were performed using FlpIn-CHO cells stably expressing the M<sub>1</sub> mAChR, increasing concentrations of ACh with or without increasing concentrations of <b>29</b>. 100% represents the maximal stimulation of ACh in the absence of <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/medium/jm-2015-01562m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Correlation between binding and functional cooperativity for 4-phenylpyridin-2-one derivatives generated in the present study (Pearson’s test, <i>r</i> = 0.84, <i>p</i> < 0.05, slope = 1.00 ± 0.01). (b) Plots of functional cooperativity (Log αβ) versus intrinsic efficacy (Log τ<sub>B</sub>) for derivatives of <b>1</b> generated and characterized in our previous study reveal a positive correlation (Pearson’s test, <i>r</i> = 0.65, <i>p</i> < 0.05) between these two parameters. (c) A similar plot for 4-phenylpyridin-2-one derivatives generated in the present study reveals no such correlation. (d,e) IP<sub>1</sub> accumulation experiments were performed using FlpIn-CHO cells stably expressing the M<sub>1</sub> mAChR, increasing concentrations of ACh with or without increasing concentrations of <b>14</b> (d) and <b>17</b> (e). (d) <b>14</b> displays intrinsic activity comparable to that of <b>1</b>, but very weak positive cooperativity with ACh (e) <b>17</b> displays no intrinsic activity but robust positive cooperativity with ACh. 100% represents the maximal stimulation of ACh in the absence of test compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01562/20160113/images/large/jm-2015-01562m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01562&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reavill, C.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors as CNS drug targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.pharmthera.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18082893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=232-243&author=C.+J.+Langmeadauthor=J.+Watsonauthor=C.+Reavill&title=Muscarinic+acetylcholine+receptors+as+CNS+drug+targets&doi=10.1016%2Fj.pharmthera.2007.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors as CNS drug targets</span></div><div class="casAuthors">Langmead, Christopher J.; Watson, Jeannette; Reavill, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are widely expressed in the CNS where they control a variety of neuronal functions.  Due to their roles in a no. of CNS processes, mAChRs have long been a target of the drug discovery industry; however, the only mAChR ligands approved for use in the clinic are non-selective antagonists for the treatment of Parkinson's disease.  This article briefly reviews recent progress made in mAChR drug discovery for Alzheimer's disease (AD), schizophrenia and Parkinson's disease, with particular emphasis on novel target validation, as well as highlighting novel indications such as drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxKbNG-yy87Vg90H21EOLACvtfcHk0lhhJF8X0pYicg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D&md5=a65c212d434f0172b4e6800cc19df427</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DReavill%26aufirst%3DC.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%2520as%2520CNS%2520drug%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D232%26epage%3D243%26doi%3D10.1016%2Fj.pharmthera.2007.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.1016/j.tips.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.tips.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19201489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVGguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=148-155&author=P.+J.+Connauthor=C.+K.+Jonesauthor=C.+W.+Lindsley&title=Subtype-selective+allosteric+modulators+of+muscarinic+receptors+for+the+treatment+of+CNS+disorders&doi=10.1016%2Fj.tips.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</span></div><div class="casAuthors">Conn, P. Jeffrey; Jones, Carrie K.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-155</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) have long been viewed as viable targets for novel therapeutic agents for the treatment of Alzheimer's disease (AD) and other disorders involving impaired cognitive function.  More recent evidence indicates that mAChR activators might also have utility in treating psychosis and other symptoms assocd. with schizophrenia and other central nervous system (CNS) disorders.  Efforts to develop mAChR subtype-selective agonists have been hampered by difficulty in achieving high selectivity for individual mAChR subtypes important for CNS function (M1 and M4) and adverse effects due to activation of peripheral mAChRs (esp. M2 and M3).  Major advances have now been achieved in the discovery of allosteric agonists and pos. allosteric modulators of M1 and M4 that show greater selectivity for individual mAChR subtypes than do previous mAChR agonists.  Early studies indicate that these allosteric mAChR activators have properties needed for optimization as potential clin. candidates and have robust effects in animal models that predict efficacy in the treatment of AD, schizophrenia and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn8LX_geAENrVg90H21EOLACvtfcHk0lipvpPBTgzcGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVGguro%253D&md5=65cf3e1dee603502b5eb72f60a98be98</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubtype-selective%2520allosteric%2520modulators%2520of%2520muscarinic%2520receptors%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D148%26epage%3D155%26doi%3D10.1016%2Fj.tips.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Dean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keriakous, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarr, E.</span><span> </span><span class="NLM_article-title">Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span><span class="refDoi"> DOI: 10.1038/sj.mp.4001199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fsj.mp.4001199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=12476323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=1083-1091&author=B.+Deanauthor=M.+McLeodauthor=D.+Keriakousauthor=J.+McKenzieauthor=E.+Scarr&title=Decreased+muscarinic1+receptors+in+the+dorsolateral+prefrontal+cortex+of+subjects+with+schizophrenia&doi=10.1038%2Fsj.mp.4001199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span></div><div class="casAuthors">Dean, B.; McLeod, M.; Keriakous, D.; McKenzie, J.; Scarr, E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1083-1091</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To test the hypothesis that muscarinic receptors are involved in the pathol. of schizophrenia, we measured muscarinic1 (M1R) and muscarinic4(M4R) protein and mRNA as well as [3H]pirenzepine binding in Brodmann's areas (BA) 9 and 40 obtained postmortem from 20 schizophrenic and 20 age/sex-matched control subjects.  There was a significant decrease in [3H]pirenzepine binding to BA 9 (mean ± SEM: 151 ± 15 vs 195 ± 10 fmol mg-1 ETE; P< 0.02), but not BA 40 (143 ± 13 vs 166 ± 11 fmol mg-1 ETE), from subjects with schizophrenia.  The level of M1R protein (0.11 ± 0.007 vs 0.15 ± 0.008 OD; P < 0.01), but not M4R protein, was decreased in BA9 from schizophrenic subjects with neither receptor protein being altered in BA 40.  The level of M1R mRNA was decreased in BA 9 (30 ± 7.0 vs 79 ± 14 dpm × 103 mg-1ETE, P < 0.01) and BA 40 (28 ± 5.9 vs 99 ± 14, P < 0.01) with schizophrenia but M4R mRNA was only decreased in BA 40 (48 ± 6.6 vs 89 ± 9.9, P < 0.005).  These data suggest that the M1R, at least in the dorsolateral prefrontal cortex, may have a role in the pathol. of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCGS6ZN-tPSbVg90H21EOLACvtfcHk0lipvpPBTgzcGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D&md5=452f2732469bfcdf46def48079970f80</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001199%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DB.%26aulast%3DMcLeod%26aufirst%3DM.%26aulast%3DKeriakous%26aufirst%3DD.%26aulast%3DMcKenzie%26aufirst%3DJ.%26aulast%3DScarr%26aufirst%3DE.%26atitle%3DDecreased%2520muscarinic1%2520receptors%2520in%2520the%2520dorsolateral%2520prefrontal%2520cortex%2520of%2520subjects%2520with%2520schizophrenia%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D1083%26epage%3D1091%26doi%3D10.1038%2Fsj.mp.4001199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Scarr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, B.</span><span> </span><span class="NLM_article-title">Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05711.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1111%2Fj.1471-4159.2008.05711.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18957051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2mtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=1188-1195&author=E.+Scarrauthor=B.+Dean&title=Muscarinic+receptors%3A+do+they+have+a+role+in+the+pathology+and+treatment+of+schizophrenia%3F&doi=10.1111%2Fj.1471-4159.2008.05711.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?</span></div><div class="casAuthors">Scarr, Elizabeth; Dean, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1188-1195</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The high affinity of antipsychotic drugs for the dopamine D2 receptor focused attention onto the role of these receptors in the genesis of psychoses and the pathol. of schizophrenia.  However, psychotic symptoms are only one aspect of the complex symptom profile assocd. with schizophrenia.  Therefore, research continues into other neurochem. systems and their potential roles in key features assocd. with schizophrenia.  Modulating the cholinergic system in attempts to treat schizophrenia predates specific neurochem. hypotheses of the disorder.  Cholinergic modulation has progressed from the use of coma therapy, through the use of anticholinergic drugs to control side-effects of older (typical) antipsychotic medications, to the development of drugs designed to specifically activate selected muscarinic receptors.  This review presents data implicating a decrease in muscarinic receptors, particularly the M1 receptor, in the pathol. of schizophrenia and explores the potential physiol. consequences of such a change, drawing on data available from muscarinic receptor knockout mice as well as clin. and pre-clin. pharmacol.  The body of evidence presented suggests that deficits in muscarinic receptors are assocd. with some forms of schizophrenia and that targeting these receptors could prove to be of therapeutic benefit to patients with the disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkTLOGUCpkLVg90H21EOLACvtfcHk0lhpS4wd4hVqZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2mtb3F&md5=80444c8d8f15f6e0bbc68b358eb48588</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05711.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05711.x%26sid%3Dliteratum%253Aachs%26aulast%3DScarr%26aufirst%3DE.%26aulast%3DDean%26aufirst%3DB.%26atitle%3DMuscarinic%2520receptors%253A%2520do%2520they%2520have%2520a%2520role%2520in%2520the%2520pathology%2520and%2520treatment%2520of%2520schizophrenia%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D107%26spage%3D1188%26epage%3D1195%26doi%3D10.1111%2Fj.1471-4159.2008.05711.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Medeiros, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccamo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baglietto-Vargas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada-Hernandez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cribbs, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Loss of muscarinic M1 receptor exacerbates Alzheimer’s disease-like pathology and cognitive decline</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2011.04.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.ajpath.2011.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=21704011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=980-991&author=R.+Medeirosauthor=M.+Kitazawaauthor=A.+Caccamoauthor=D.+Baglietto-Vargasauthor=T.+Estrada-Hernandezauthor=D.+H.+Cribbsauthor=A.+Fisherauthor=F.+M.+LaFerla&title=Loss+of+muscarinic+M1+receptor+exacerbates+Alzheimer%E2%80%99s+disease-like+pathology+and+cognitive+decline&doi=10.1016%2Fj.ajpath.2011.04.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline</span></div><div class="casAuthors">Medeiros, Rodrigo; Kitazawa, Masashi; Caccamo, Antonella; Baglietto-Vargas, David; Estrada-Hernandez, Tatiana; Cribbs, David H.; Fisher, Avraham; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">980-991</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is pathol. characterized by tau-laden neurofibrillary tangles and β-amyloid deposits.  Dysregulation of cholinergic neurotransmission has been implicated in AD pathogenesis, contributing to the assocd. memory impairments; yet, the exact mechanisms remain to be defined.  Activating the muscarinic acetylcholine M1 receptors (M1Rs) reduces AD-like pathol. features and enhances cognition in AD transgenic models.  To elucidate the mol. mechanisms by which M1Rs affect AD pathophysiol. features, we crossed the 3xTgAD and transgenic mice expressing human Swedish, Dutch, and Iowa triple-mutant amyloid precursor protein (Tg-SwDI), two widely used animal models, with the M1R-/- mice.  Our data show that M1R deletion in the 3xTgAD and Tg-SwDI mice exacerbates the cognitive impairment through mechanisms dependent on the transcriptional dysregulation of genes required for memory and through acceleration of AD-related synaptotoxicity.  Ablating the M1R increased plaque and tangle levels in the brains of 3xTgAD mice and elevated cerebrovascular deposition of fibrillar Aβ in Tg-SwDI mice.  Notably, tau hyperphosphorylation and potentiation of amyloidogenic processing in the mice with AD lacking M1R were attributed to changes in the glycogen synthase kinase 3β and protein kinase C activities.  Finally, deleting the M1R increased the astrocytic and microglial response assocd. with Aβ plaques.  Our data highlight the significant role that disrupting the M1R plays in exacerbating AD-related cognitive decline and pathol. features and provide crit. preclin. evidence to justify further development and evaluation of selective M1R agonists for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmn8fzxarBbVg90H21EOLACvtfcHk0lhpS4wd4hVqZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGjsLzP&md5=f20cdd368aa5c1f8953ca565fd25cd5c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DKitazawa%26aufirst%3DM.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DBaglietto-Vargas%26aufirst%3DD.%26aulast%3DEstrada-Hernandez%26aufirst%3DT.%26aulast%3DCribbs%26aufirst%3DD.%2BH.%26aulast%3DFisher%26aufirst%3DA.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DLoss%2520of%2520muscarinic%2520M1%2520receptor%2520exacerbates%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%2520and%2520cognitive%2520decline%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26spage%3D980%26epage%3D991%26doi%3D10.1016%2Fj.ajpath.2011.04.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Anagnostaras, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahnama, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. J.</span><span> </span><span class="NLM_article-title">Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1038/nn992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fnn992" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=51-58&author=S.+G.+Anagnostarasauthor=G.+G.+Murphyauthor=S.+E.+Hamiltonauthor=S.+L.+Mitchellauthor=N.+P.+Rahnamaauthor=N.+M.+Nathansonauthor=A.+J.+Silva&title=Selective+cognitive+dysfunction+in+acetylcholine+M1+muscarinic+receptor+mutant+mice&doi=10.1038%2Fnn992"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnn992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn992%26sid%3Dliteratum%253Aachs%26aulast%3DAnagnostaras%26aufirst%3DS.%2BG.%26aulast%3DMurphy%26aufirst%3DG.%2BG.%26aulast%3DHamilton%26aufirst%3DS.%2BE.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRahnama%26aufirst%3DN.%2BP.%26aulast%3DNathanson%26aufirst%3DN.%2BM.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520cognitive%2520dysfunction%2520in%2520acetylcholine%2520M1%2520muscarinic%2520receptor%2520mutant%2520mice%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D6%26spage%3D51%26epage%3D58%26doi%3D10.1038%2Fnn992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, V. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roopun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriakidis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span> </span><span class="NLM_article-title">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28–1</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1038/bjp.2008.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fbjp.2008.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18454168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1104-1115&author=C.+J.+Langmeadauthor=N.+E.+Austinauthor=C.+L.+Branchauthor=J.+T.+Brownauthor=K.+A.+Buchananauthor=C.+H.+Daviesauthor=I.+T.+Forbesauthor=V.+A.+H.+Fryauthor=J.+J.+Haganauthor=H.+J.+Herdonauthor=G.+A.+Jonesauthor=R.+Jeggoauthor=J.+N.+C.+Kewauthor=A.+Mazzaliauthor=R.+Melarangeauthor=N.+Patelauthor=J.+Pardoeauthor=A.+D.+Randallauthor=C.+Robertsauthor=A.+Roopunauthor=K.+R.+Starrauthor=A.+Teriakidisauthor=M.+D.+Woodauthor=M.+Whittingtonauthor=Z.+Wuauthor=J.+Watson&title=Characterization+of+a+CNS+penetrant%2C+selective+M1+muscarinic+receptor+agonist%2C+77-LH-28%E2%80%931&doi=10.1038%2Fbjp.2008.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span></div><div class="casAuthors">Langmead, C. J.; Austin, N. E.; Branch, C. L.; Brown, J. T.; Buchanan, K. A.; Davies, C. H.; Forbes, I. T.; Fry, V. A. H.; Hagan, J. J.; Herdon, H. J.; Jones, G. A.; Jeggo, R.; Kew, J. N. C.; Mazzali, A.; Melarange, R.; Patel, N.; Pardoe, J.; Randall, A. D.; Roberts, C.; Roopun, A.; Starr, K. R.; Teriakidis, A.; Wood, M. D.; Whittington, M.; Wu, Z.; Watson, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1104-1115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: M1 muscarinic ACh receptors (mAChRs) represent an attractive drug target for the treatment of cognitive deficits assocd. with diseases such as Alzheimer's disease and schizophrenia.  However, the discovery of subtype-selective mAChR agonists has been hampered by the high degree of conservation of the orthosteric ACh-binding site among mAChR subtypes.  The advent of functional screening assays has enabled the identification of agonists such as AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine), which bind to an allosteric site and selectively activate the M1 mAChR subtype.  However, studies with this compd. have been limited to recombinantly expressed mAChRs.  Exptl. approach: In this study, we have compared the pharmacol. profile of AC-42 and a close structural analog, 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone) at human recombinant, and rat native, mAChRs by calcium mobilization, inositol phosphate accumulation and both in vitro and in vivo electrophysiol.  Key results: Calcium mobilization and inositol phosphate accumulation assays revealed that both AC-42 and 77-LH-28-1 display high selectivity to activate the M1 mAChR over other mAChR subtypes.  Furthermore, 77-LH-28-1(I), but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations.  Finally, 77-LH-28-1 stimulated cell firing in the rat hippocampus in vivo following s.c. administration.  Conclusions and implications: These data suggest that 77-LH-28-1 is a potent, selective, bioavailable and brain-penetrant agonist at the M1 mAChR and therefore that it represents a better tool than AC-42, with which to study the pharmacol. of the M1 mAChR.  British Journal of Pharmacol. (2008) 154, 1104-1115; doi:10.1038/bjp.2008.152; published online 5 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pNVy427ynLVg90H21EOLACvtfcHk0lgAC9t6zFye3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D&md5=8eeb8522c09910e1a13f9832f775f846</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.152%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DBuchanan%26aufirst%3DK.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DFry%26aufirst%3DV.%2BA.%2BH.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26aulast%3DJones%26aufirst%3DG.%2BA.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DMazzali%26aufirst%3DA.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPardoe%26aufirst%3DJ.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DRoopun%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DTeriakidis%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520a%2520CNS%2520penetrant%252C%2520selective%2520M1%2520muscarinic%2520receptor%2520agonist%252C%252077-LH-28%25E2%2580%25931%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1104%26epage%3D1115%26doi%3D10.1038%2Fbjp.2008.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantawy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">10422</span><span class="NLM_x">–</span> <span class="NLM_lpage">10433</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1850-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1523%2FJNEUROSCI.1850-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18842902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10422-10433&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=A.+A.+Davisauthor=Z.+Xiangauthor=M.+Bubserauthor=M.+N.+Tantawyauthor=A.+S.+Kaneauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+R.+Bradleyauthor=T.+E.+Petersonauthor=M.+S.+Ansariauthor=R.+M.+Baldwinauthor=R.+M.+Kesslerauthor=A.+Y.+Deutchauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Novel+selective+allosteric+activator+of+the+M1+muscarinic+acetylcholine+receptor+regulates+amyloid+processing+and+produces+antipsychotic-like+activity+in+rats&doi=10.1523%2FJNEUROSCI.1850-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span></div><div class="casAuthors">Jones, Carrie K.; Brady, Ashley E.; Davis, Albert A.; Xiang, Zixiu; Bubser, Michael; Tantawy, Mohammed Noor; Kane, Alexander S.; Bridges, Thomas M.; Kennedy, J. Phillip; Bradley, Stefania R.; Peterson, Todd E.; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.; Deutch, Ariel Y.; Lah, James J.; Levey, Allan I.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10422-10433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that subtype-selective activators of M1/M4 muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms assocd. with schizophrenia and Alzheimer's disease.  Previously developed muscarinic agonists have provided clin. data in support of this hypothesis, but failed in clin. development because of a lack of true subtype specificity and adverse effects assocd. with activation of other mAChR subtypes.  We now report characterization of a novel highly selective agonist for the M1 receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB [1-((1'-2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one].  Mutagenesis and mol. pharmacol. studies revealed that TBPB activates M1 through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely crit. for its unprecedented selectivity.  Whole-cell patch-clamp recordings demonstrated that activation of M1 by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M2 and M4.  TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists.  Finally, TBPB had effects on the processing of the amyloid precursor protein toward the non-amyloidogenic pathway and decreased Aβ prodn. in vitro.  Together, these data suggest that selective activation of M1 may provide a novel approach for the treatment of symptoms assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5LP3cEBPDvbVg90H21EOLACvtfcHk0lgAC9t6zFye3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF&md5=25b306eb2aa00bdce1c08ad24bd59b35</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1850-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1850-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DPeterson%26aufirst%3DT.%2BE.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520selective%2520allosteric%2520activator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520regulates%2520amyloid%2520processing%2520and%2520produces%2520antipsychotic-like%2520activity%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10422%26epage%3D10433%26doi%3D10.1523%2FJNEUROSCI.1850-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graufelds, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCampbell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danziger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15950</span><span class="NLM_x">–</span> <span class="NLM_lpage">15955</span><div class="note"><p class="first last">S15950/1–S15950/9.</p></div><span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0lgZJjbqeKgE7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pomara, N.</span><span> </span><span class="NLM_article-title">Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><div class="note"><p class="first last">author reply 111–113.</p></div><span class="refDoi"> DOI: 10.1176/appi.ajp.2008.08091352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1176%2Fappi.ajp.2008.08091352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19122018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FltFehsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=111&author=N.+Pomara&title=Reduction+in+muscarinic+M1-mediated+hypercholinergic+state+and+beneficial+cognitive+effects+of+muscarinic+agonists+in+schizophrenia&doi=10.1176%2Fappi.ajp.2008.08091352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction in muscarinic M1-mediated hypercholinergic state and beneficial cognitive effects of muscarinic agonists in schizophrenia</span></div><div class="casAuthors">Pomara Nunzio</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111; author reply 111-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWY1uTtS7bjRfKb6ELK8t0fW6udTcc2ebkzcgyI5TDCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FltFehsQ%253D%253D&md5=dbf3545f43414e1094d1303a0ba899e3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.08091352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.08091352%26sid%3Dliteratum%253Aachs%26aulast%3DPomara%26aufirst%3DN.%26atitle%3DReduction%2520in%2520muscarinic%2520M1-mediated%2520hypercholinergic%2520state%2520and%2520beneficial%2520cognitive%2520effects%2520of%2520muscarinic%2520agonists%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D111%26doi%3D10.1176%2Fappi.ajp.2008.08091352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dencker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grannan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locuson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Role for the M1 muscarinic acetylcholine receptor in top-down cognitive processing using a touchscreen visual discrimination task in mice</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1683-1695&author=R.+W.+Gouldauthor=D.+Denckerauthor=M.+Grannanauthor=M.+Bubserauthor=X.+Zhanauthor=J.+Wessauthor=Z.+Xiangauthor=C.+Locusonauthor=C.+W.+Lindsleyauthor=P.+J.+Connauthor=C.+K.+Jones&title=Role+for+the+M1+muscarinic+acetylcholine+receptor+in+top-down+cognitive+processing+using+a+touchscreen+visual+discrimination+task+in+mice&doi=10.1021%2Facschemneuro.5b00123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice</span></div><div class="casAuthors">Gould, R. W.; Dencker, D.; Grannan, M.; Bubser, M.; Zhan, X.; Wess, J.; Xiang, Z.; Locuson, C.; Lindsley, C. W.; Conn, P. J.; Jones, C. K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1683-1695</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M1 muscarinic acetylcholine receptor (mAChR) subtype has been implicated in the underlying mechanisms of learning and memory and represents an important potential pharmacotherapeutic target for the cognitive impairments obsd. in neuropsychiatric disorders such as schizophrenia.  Patients with schizophrenia show impairments in top-down processing involving conflict between sensory-driven and goal-oriented processes that can be modeled in preclin. studies using touchscreen-based cognition tasks.  The present studies used a touchscreen visual pairwise discrimination task in which mice discriminated between a less salient and a more salient stimulus to assess the influence of the M1 mAChR on top-down processing.  M1 mAChR knockout (M1 KO) mice showed a slower rate of learning, evidenced by slower increases in accuracy over 12 consecutive days, and required more days to acquire (achieve 80% accuracy) this discrimination task compared to wild-type mice.  In addn., the M1 pos. allosteric modulator BQCA enhanced the rate of learning this discrimination in wild-type, but not in M1 KO, mice when BQCA was administered daily prior to testing over 12 consecutive days.  Importantly, in discriminations between stimuli of equal salience, M1 KO mice did not show impaired acquisition and BQCA did not affect the rate of learning or acquisition in wild-type mice.  These studies are the first to demonstrate performance deficits in M1 KO mice using touchscreen cognitive assessments and enhanced rate of learning and acquisition in wild-type mice through M1 mAChR potentiation when the touchscreen discrimination task involves top-down processing.  Taken together, these findings provide further support for M1 potentiation as a potential treatment for the cognitive symptoms assocd. with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNNTq2P-jg7Vg90H21EOLACvtfcHk0lgZJjbqeKgE7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt7jN&md5=23a19d3c5d2c735f43d219b42ba6387c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00123%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DDencker%26aufirst%3DD.%26aulast%3DGrannan%26aufirst%3DM.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DZhan%26aufirst%3DX.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DLocuson%26aufirst%3DC.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DRole%2520for%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520in%2520top-down%2520cognitive%2520processing%2520using%2520a%2520touchscreen%2520visual%2520discrimination%2520task%2520in%2520mice%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1683%26epage%3D1695%26doi%3D10.1021%2Facschemneuro.5b00123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Thomsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caine, S. B.</span><span> </span><span class="NLM_article-title">Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">208</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span><span class="refDoi"> DOI: 10.1007/s00213-009-1740-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1007%2Fs00213-009-1740-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2010&pages=401-416&author=M.+Thomsenauthor=J.+Wessauthor=B.+S.+Fultonauthor=A.+Fink-Jensenauthor=S.+B.+Caine&title=Modulation+of+prepulse+inhibition+through+both+M1+and+M4+muscarinic+receptors+in+mice&doi=10.1007%2Fs00213-009-1740-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1740-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1740-z%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DM.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DFulton%26aufirst%3DB.%2BS.%26aulast%3DFink-Jensen%26aufirst%3DA.%26aulast%3DCaine%26aufirst%3DS.%2BB.%26atitle%3DModulation%2520of%2520prepulse%2520inhibition%2520through%2520both%2520M1%2520and%2520M4%2520muscarinic%2520receptors%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D208%26spage%3D401%26epage%3D416%26doi%3D10.1007%2Fs00213-009-1740-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lameh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohrmund, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajpai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalding, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabatabaei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span> </span><span class="NLM_article-title">AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.neuropharm.2009.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19835892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFymsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=365-73&author=S.+R.+Bradleyauthor=J.+Lamehauthor=L.+Ohrmundauthor=T.+Sonauthor=A.+Bajpaiauthor=D.+Nguyenauthor=M.+Fribergauthor=E.+S.+Bursteinauthor=T.+A.+Spaldingauthor=T.+R.+Ottauthor=H.+H.+Schifferauthor=A.+Tabatabaeiauthor=K.+McFarlandauthor=R.+E.+Davisauthor=D.+W.+Bonhaus&title=AC-260584%2C+an+orally+bioavailable+M%281%29+muscarinic+receptor+allosteric+agonist%2C+improves+cognitive+performance+in+an+animal+model&doi=10.1016%2Fj.neuropharm.2009.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model</span></div><div class="casAuthors">Bradley, Stefania Risso; Lameh, Jelveh; Ohrmund, Linda; Son, Thomas; Bajpai, Abhishek; Nguyen, Derek; Friberg, Mikael; Burstein, Ethan S.; Spalding, Tracy A.; Ott, Thomas R.; Schiffer, Hans H.; Tabatabaei, Ali; McFarland, Krista; Davis, Robert E.; Bonhaus, Douglas W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-373</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The recent discovery of allosteric potentiators and agonists of the muscarinic M1 receptor represents a significant advance in the muscarinic receptor pharmacol.  In the current study we describe the receptor pharmacol. and pro-cognitive action of the allosteric agonist AC-260584.  Using in vitro cell-based assays with cell proliferation, phosphatidylinositol hydrolysis or calcium mobilization as endpoints, AC-260584 was found to be a potent (pEC50 7.6-7.7) and efficacious (90-98% of carbachol) muscarinic M1 receptor agonist.  Furthermore, as compared to orthosteric binding agonists, AC-260584 showed functional selectivity for the M1 receptor over the M2, M3, M4 and M5 muscarinic receptor subtypes.  Using GTPγS binding assays, its selectivity was found to be similar in native tissues expressing mAChRs to its profile in recombinant systems.  In rodents, AC-260584 activated extracellular signal-regulated kinase 1 and 2 (ERK1/2) phosphorylation in the hippocampus, prefrontal cortex and perirhinal cortex.  The ERK1/2 activation was dependent upon muscarinic M1 receptor activation since it was not obsd. in M1 knockout mice.  AC-260584 also improved the cognitive performance of mice in the novel object recognition assay and its action is blocked by the muscarinic receptor antagonist pirenzepine.  Taken together these results indicate for the first time that a M1 receptor agonist selective over the other mAChR subtypes can have a symptomatically pro-cognitive action.  In addn., AC-260584 was found to be orally bioavailable in rodents.  Therefore, AC-260584 may serve as a lead compd. in the development of M1 selective drugs for the treatment of cognitive impairment assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18AGEUAeVq7Vg90H21EOLACvtfcHk0lhMnrGfwXGQIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFymsLfO&md5=fb5deaa878be695f3936c580c24ab274</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DLameh%26aufirst%3DJ.%26aulast%3DOhrmund%26aufirst%3DL.%26aulast%3DSon%26aufirst%3DT.%26aulast%3DBajpai%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DFriberg%26aufirst%3DM.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DOtt%26aufirst%3DT.%2BR.%26aulast%3DSchiffer%26aufirst%3DH.%2BH.%26aulast%3DTabatabaei%26aufirst%3DA.%26aulast%3DMcFarland%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26atitle%3DAC-260584%252C%2520an%2520orally%2520bioavailable%2520M%25281%2529%2520muscarinic%2520receptor%2520allosteric%2520agonist%252C%2520improves%2520cognitive%2520performance%2520in%2520an%2520animal%2520model%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D365%26epage%3D73%26doi%3D10.1016%2Fj.neuropharm.2009.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Digby, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebois, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovsky, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennenga, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bimonte-Nelson, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Italiano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olive, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">8532</span><span class="NLM_x">–</span> <span class="NLM_lpage">8544</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0337-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1523%2FJNEUROSCI.0337-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=22723693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=8532-8544&author=G.+J.+Digbyauthor=M.+J.+Noetzelauthor=M.+Bubserauthor=T.+J.+Utleyauthor=A.+G.+Walkerauthor=N.+E.+Byunauthor=E.+P.+Leboisauthor=Z.+Xiangauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=A.+A.+Davisauthor=N.+E.+Nemirovskyauthor=S.+E.+Mennengaauthor=B.+W.+Campauthor=H.+A.+Bimonte-Nelsonauthor=J.+Bodeauthor=K.+Italianoauthor=R.+Morrisonauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=M.+F.+Oliveauthor=C.+W.+Lindsleyauthor=C.+K.+Jonesauthor=P.+J.+Conn&title=Novel+allosteric+agonists+of+M1+muscarinic+acetylcholine+receptors+induce+brain+region-specific+responses+that+correspond+with+behavioral+effects+in+animal+models&doi=10.1523%2FJNEUROSCI.0337-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</span></div><div class="casAuthors">Digby, Gregory J.; Noetzel, Meredith J.; Bubser, Michael; Utley, Thomas J.; Walker, Adam G.; Byun, Nellie E.; Lebois, Evan P.; Xiang, Zixiu; Sheffler, Douglas J.; Cho, Hyekyung P.; Davis, Albert A.; Nemirovsky, Natali E.; Mennenga, Sarah E.; Camp, Bryan W.; Bimonte-Nelson, Heather A.; Bode, Jacob; Italiano, Kimberly; Morrison, Ryan; Daniels, J. Scott; Niswender, Colleen M.; Olive, M. Foster; Lindsley, Craig W.; Jones, Carrie K.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8532-8544</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) represent a viable target for treatment of multiple disorders of the central nervous system (CNS) including Alzheimer's disease and schizophrenia.  The recent discovery of highly selective allosteric agonists of M1 receptors has provided a major breakthrough in developing a viable approach for the discovery of novel therapeutic agents that target these receptors.  Here we describe the characterization of two novel M1 allosteric agonists, VU0357017 and VU0364572, that display profound differences in their efficacy in activating M1 coupling to different signaling pathways including Ca2+ and β-arrestin responses.  Interestingly, the ability of these agents to differentially activate coupling of M1 to specific signaling pathways leads to selective actions on some but not all M1-mediated responses in brain circuits.  These novel M1 allosteric agonists induced robust electrophysiol. effects in rat hippocampal slices, but showed lower efficacy in striatum and no measureable effects on M1-mediated responses in medial prefrontal cortical pyramidal cells in mice.  Consistent with these actions, both M1 agonists enhanced acquisition of hippocampal-dependent cognitive function but did not reverse amphetamine-induced hyperlocomotion in rats.  Together, these data reveal that M1 allosteric agonists can differentially regulate coupling of M1 to different signaling pathways, and this can dramatically alter the actions of these compds. on specific brain circuits important for learning and memory and psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh138Eac3vNrVg90H21EOLACvtfcHk0lhMnrGfwXGQIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2iu7w%253D&md5=6278ee1366f8e159729c23ef8ecc880d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0337-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0337-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DDigby%26aufirst%3DG.%2BJ.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DWalker%26aufirst%3DA.%2BG.%26aulast%3DByun%26aufirst%3DN.%2BE.%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DNemirovsky%26aufirst%3DN.%2BE.%26aulast%3DMennenga%26aufirst%3DS.%2BE.%26aulast%3DCamp%26aufirst%3DB.%2BW.%26aulast%3DBimonte-Nelson%26aufirst%3DH.%2BA.%26aulast%3DBode%26aufirst%3DJ.%26aulast%3DItaliano%26aufirst%3DK.%26aulast%3DMorrison%26aufirst%3DR.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DOlive%26aufirst%3DM.%2BF.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520allosteric%2520agonists%2520of%2520M1%2520muscarinic%2520acetylcholine%2520receptors%2520induce%2520brain%2520region-specific%2520responses%2520that%2520correspond%2520with%2520behavioral%2520effects%2520in%2520animal%2520models%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D8532%26epage%3D8544%26doi%3D10.1523%2FJNEUROSCI.0337-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ghoshal, A.; Rook, J. M.; Dickerson, J. W.; Roop, G. N.; Morrison, R. D.; Jalan-Sakrikar, N.; Lamsal, A.; Noetzel, M. J.; Poslusney, M. S.; Wood, M. R.; Melancon, B. J.; Stauffer, S. R.; Xiang, Z.; Daniels, J. S.; Niswender, C. M.; Jones, C. K.; Lindsley, C. W.; Conn, P. J.</span><span> </span><span class="NLM_article-title">Potentiation of M1 muscarinic receptor reverses plasticity deficits and negative and cognitive symptoms in a schizophrenia mouse model</span>.  <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1038/npp.2015.189</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1038%2Fnpp.2015.189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Ghoshal&author=J.+M.+Rook&author=J.+W.+Dickerson&author=G.+N.+Roop&author=R.+D.+Morrison&author=N.+Jalan-Sakrikar&author=A.+Lamsal&author=M.+J.+Noetzel&author=M.+S.+Poslusney&author=M.+R.+Wood&author=B.+J.+Melancon&author=S.+R.+Stauffer&author=Z.+Xiang&author=J.+S.+Daniels&author=C.+M.+Niswender&author=C.+K.+Jones&author=C.+W.+Lindsley&author=P.+J.+Conn&title=Potentiation+of+M1+muscarinic+receptor+reverses+plasticity+deficits+and+negative+and+cognitive+symptoms+in+a+schizophrenia+mouse+model&doi=10.1038%2Fnpp.2015.189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.189%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26atitle%3DPotentiation%2520of%2520M1%2520muscarinic%2520receptor%2520reverses%2520plasticity%2520deficits%2520and%2520negative%2520and%2520cognitive%2520symptoms%2520in%2520a%2520schizophrenia%2520mouse%2520model%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26doi%3D10.1038%2Fnpp.2015.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bodick, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span> </span><span class="NLM_article-title">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1001/archneur.1997.00550160091022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1001%2Farchneur.1997.00550160091022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=9109749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=465-73&author=N.+C.+Bodickauthor=W.+W.+Offenauthor=A.+I.+Leveyauthor=N.+R.+Cutlerauthor=S.+G.+Gauthierauthor=A.+Satlinauthor=H.+E.+Shannonauthor=G.+D.+Tollefsonauthor=K.+Rasmussenauthor=F.+P.+Bymasterauthor=D.+J.+Hurleyauthor=W.+Z.+Potterauthor=S.+M.+Paul&title=Effects+of+xanomeline%2C+a+selective+muscarinic+receptor+agonist%2C+on+cognitive+function+and+behavioral+symptoms+in+Alzheimer+disease&doi=10.1001%2Farchneur.1997.00550160091022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</span></div><div class="casAuthors">Bodick N C; Offen W W; Levey A I; Cutler N R; Gauthier S G; Satlin A; Shannon H E; Tollefson G D; Rasmussen K; Bymaster F P; Hurley D J; Potter W Z; Paul S M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-73</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the therapeutic effects of selective cholinergic replacement with xanomeline tartrate, an m1 and m4 selective muscarinic receptor (mAChR) agonist in patients with probable Alzheimer disease (AD).  DESIGN:  A 6-month, randomized, double-blind, placebo-controlled, parallel-group trial followed by a 1-month, single-blind, placebo washout.  SETTING:  Outpatients at 17 centers in the United States and Canada.  PARTICIPANTS:  A total of 343 men and women at least 60 years of age with mild to moderate AD.  INTERVENTIONS:  Patients received 75, 150, or 225 mg (low, medium, and high doses) of xanomeline per day or placebo for 6 months.  OUTCOME MEASURES:  Scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog), the Clinician's Interview-Based Impression of Change (CIBIC+), the Alzheimer's Disease Symptomatology Scale (ADSS), and the Nurses' Observational Scale for Geriatric Patients (NOSGER).  RESULTS:  A significant treatment effect existed for ADAS-Cog (high dose vs placebo; P < or = .05), and CIBIC+ (high dose vs placebo; P < or = .02).  Treatment Emergent Signs and Symptoms analysis of the ADSS, which assesses behavioral symptoms in patients with AD, disclosed significant (P < or = .002) dose-dependent reductions in vocal outbursts, suspiciousness, delusions, agitation, and hallucinations.  On end-point analysis, NOSGER, which assesses memory, instrumental activities of daily living, self-care, mood, social behavior, and disturbing behavior in the elderly, also showed a significant dose-response relationship (P < or = .02).  In the high-dose arm, 52% of patients discontinued treatment because of adverse events; dose-dependent adverse events were predominantly gastrointestinal in nature.  Syncope, defined as loss of consciousness and muscle tone, occurred in 12.6% of patients in the high-dose group.  CONCLUSIONS:  The observed improvements in ADAS-Cog and CIBIC+ following treatment with xanomeline provide the first evidence, from a large-scale, placebo-controlled clinical trial, that a direct-acting muscarinic receptor agonist can improve cognitive function in patients with AD.  Furthermore, the dramatic and favorable effects on disturbing behaviors in AD suggest a novel approach for treatment of noncognitive symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5beLwC0CkxUGy1nwu7K2mfW6udTcc2eYp4CANv1bMxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D&md5=a1d8d3b2b495133fb37078d387136243</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1997.00550160091022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1997.00550160091022%26sid%3Dliteratum%253Aachs%26aulast%3DBodick%26aufirst%3DN.%2BC.%26aulast%3DOffen%26aufirst%3DW.%2BW.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DCutler%26aufirst%3DN.%2BR.%26aulast%3DGauthier%26aufirst%3DS.%2BG.%26aulast%3DSatlin%26aufirst%3DA.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DTollefson%26aufirst%3DG.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DHurley%26aufirst%3DD.%2BJ.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26atitle%3DEffects%2520of%2520xanomeline%252C%2520a%2520selective%2520muscarinic%2520receptor%2520agonist%252C%2520on%2520cognitive%2520function%2520and%2520behavioral%2520symptoms%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1997%26volume%3D54%26spage%3D465%26epage%3D73%26doi%3D10.1001%2Farchneur.1997.00550160091022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Shekhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallinckrodt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2008.06091591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1176%2Fappi.ajp.2008.06091591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=18593778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A280%3ADC%252BD1cvpt1OlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2008&pages=1033-9&author=A.+Shekharauthor=W.+Z.+Potterauthor=J.+Lightfootauthor=J.+Lienemannauthor=S.+Dubeauthor=C.+Mallinckrodtauthor=F.+P.+Bymasterauthor=D.+L.+McKinzieauthor=C.+C.+Felder&title=Selective+muscarinic+receptor+agonist+xanomeline+as+a+novel+treatment+approach+for+schizophrenia&doi=10.1176%2Fappi.ajp.2008.06091591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</span></div><div class="casAuthors">Shekhar Anantha; Potter William Z; Lightfoot Jeffrey; Lienemann John; Dube Sanjay; Mallinckrodt Craig; Bymaster Frank P; McKinzie David L; Felder Christian C</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1033-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  There are significant unmet needs in the treatment of schizophrenia, especially for the treatment of cognitive impairment, negative syndrome, and cognitive function.  Preclinical data suggest that agonists with selective affinity for acetylcholine muscarinic receptors provide a potentially new mechanism to treat schizophrenia.  The authors studied xanomeline, a relatively selective muscarinic type 1 and type 4 (M(1) and M(4)) receptor agonist, to determine if this agent is effective in the treatment of schizophrenia.  METHOD:  In this pilot study, the authors examined the efficacy of xanomeline on clinical outcomes in subjects with schizophrenia (N=20) utilizing a double-blind, placebo-controlled, 4-week treatment design.  Outcome measures included the Positive and Negative Syndrome Scale (PANSS) for schizophrenia, the Brief Psychiatric Rating Scale (BPRS), the Clinical Global Impression (CGI) scale, and a test battery designed to measure cognitive function in patients with schizophrenia.  RESULTS:  Subjects treated with xanomeline did significantly better than subjects in the placebo group on total BPRS scores and total PANSS scores.  In the cognitive test battery, subjects in the xanomeline group showed improvements most robustly in measures of verbal learning and short-term memory function.  CONCLUSIONS:  These results support further investigation of xanomeline as a novel approach to treating schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJVRr0TjQJN3RxY89Cm6SyfW6udTcc2eYp4CANv1bMxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvpt1OlsA%253D%253D&md5=08667002f190c674d38f9c6134eb344c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.06091591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.06091591%26sid%3Dliteratum%253Aachs%26aulast%3DShekhar%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DLightfoot%26aufirst%3DJ.%26aulast%3DLienemann%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DS.%26aulast%3DMallinckrodt%26aufirst%3DC.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DSelective%2520muscarinic%2520receptor%2520agonist%2520xanomeline%2520as%2520a%2520novel%2520treatment%2520approach%2520for%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2008%26volume%3D165%26spage%3D1033%26epage%3D9%26doi%3D10.1176%2Fappi.ajp.2008.06091591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Massoud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span> </span><span class="NLM_article-title">Update on the pharmacological treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.2174/157015910790909520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.2174%2F157015910790909520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=20808547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=69-80&author=F.+Massoudauthor=S.+Gauthier&title=Update+on+the+pharmacological+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F157015910790909520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacological treatment of Alzheimer's disease</span></div><div class="casAuthors">Massoud, Fadi; Gauthier, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder.  Worldwide prevalence of the disease is estd. at more than 24 million cases.  With aging of populations, this no. will likely increase to more than 80 million cases by the year 2040.  The annual incidence worldwide is estd. at 4.6 million cases which is the equiv. of one new case every seven seconds!  The pathophysiol. of AD is complex and largely misunderstood.  It is thought to start with the accumulation of beta-amyloid (Aβ) that leads to deposition of insol. neuritic or senile plaques.  Secondary events in this "amyloid cascade" include hyperphosphorylation of the protein tau into neurofibrillary tangles, inflammation, oxidn., and excitotoxicity that eventually cause activation of apoptosis, cell death and neurotransmitter deficits.  This review will briefly summarize recent advances in the pathophysiol. of AD and focus on the pharmacol. treatment of the cognitive and functional symptoms of AD.  It will discuss the roles of vascular prevention, cholinesterase inhibitors and an NMDA-antagonist in the management of AD.  It will address the issues thought to be related to the lack of persistence or discontinuation of therapy with cholinesterase inhibitors shown in recent studies and some of the solns. proposed.  These include setting realistic expectations in light of a neurodegenerative condition and available symptomatic treatments, slowly titrating medications, and using alternate routes of administration.  Finally, it will introduce future therapeutic options currently under study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47V_ed98Ar7Vg90H21EOLACvtfcHk0lgf4kv-n2KyaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtr3L&md5=6a6189280a3f0786c2c3963420b3d029</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F157015910790909520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015910790909520%26sid%3Dliteratum%253Aachs%26aulast%3DMassoud%26aufirst%3DF.%26aulast%3DGauthier%26aufirst%3DS.%26atitle%3DUpdate%2520on%2520the%2520pharmacological%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2010%26volume%3D8%26spage%3D69%26epage%3D80%26doi%3D10.2174%2F157015910790909520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Davie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Development of M<sub>1</sub> mAChR allosteric and bitopic ligands: Prospective therapeutics for the treatment of cognitive deficits</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span><span class="refDoi"> DOI: 10.1021/cn400086m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400086m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt12gtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1026-1048&author=B.+J.+Davieauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Development+of+M1+mAChR+allosteric+and+bitopic+ligands%3A+Prospective+therapeutics+for+the+treatment+of+cognitive+deficits&doi=10.1021%2Fcn400086m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of M1 mAChR Allosteric and Bitopic Ligands: Prospective Therapeutics for the Treatment of Cognitive Deficits</span></div><div class="casAuthors">Davie, Briana J.; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1026-1048</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Since the cholinergic hypothesis of memory dysfunction was first reported, extensive research efforts have focused on elucidating the mechanisms by which this intricate system contributes to the regulation of processes such as learning, memory, and higher executive function.  Several cholinergic therapeutic targets for the treatment of cognitive deficits, psychotic symptoms, and the underlying pathophysiol. of neurodegenerative disorders, such as Alzheimer's disease and schizophrenia, have since emerged.  Clin. approved drugs now exist for some of these targets; however, they all may be considered suboptimal therapeutics in that they produce undesirable off-target activity leading to side effects, fail to address the wide variety of symptoms and underlying pathophysiol. that characterize these disorders, and/or afford little to no therapeutic effect in subsets of patient populations.  A promising target for which there are presently no approved therapies is the M1 muscarinic acetylcholine receptor (M1 mAChR).  Despite avid investigation, development of agents that selectively activate this receptor via the orthosteric site has been hampered by the high sequence homol. of the binding site between the five muscarinic receptor subtypes and the wide distribution of this receptor family in both the central nervous system (CNS) and the periphery.  Hence, a plethora of ligands targeting less structurally conserved allosteric sites of the M1 mAChR have been investigated.  This Review aims to explain the rationale behind allosterically targeting the M1 mAChR, comprehensively summarize and critically evaluate the M1 mAChR allosteric ligand literature to date, highlight the challenges inherent in allosteric ligand investigation that are impeding their clin. advancement, and discuss potential methods for resolving these issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmU_uVw81d3LVg90H21EOLACvtfcHk0lgf4kv-n2KyaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt12gtLk%253D&md5=24b78a7a4fd917960fc406f069f238b9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcn400086m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400086m%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DB.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520M1%2520mAChR%2520allosteric%2520and%2520bitopic%2520ligands%253A%2520Prospective%2520therapeutics%2520for%2520the%2520treatment%2520of%2520cognitive%2520deficits%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1026%26epage%3D1048%26doi%3D10.1021%2Fcn400086m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5172</span><span class="refDoi"> DOI: 10.1021/jm400540b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400540b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5151-5172&author=S.+N.+Mistryauthor=C.+Valantauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+profiling+of+analogues+of+benzyl+quinolone+carboxylic+acid+%28BQCA%29+as+allosteric+modulators+of+the+M1+muscarinic+receptor&doi=10.1021%2Fjm400540b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Valant, Celine; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5151-5172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Established therapy in Alzheimer's disease involves potentiation of the endogenous orthosteric ligand, acetylcholine, at the M1 muscarinic receptors found in higher concns. in the cortex and hippocampus.  Adverse effects, due to indiscriminate activation of other muscarinic receptor subtypes, are common.  M1 muscarinic pos. allosteric modulators/allosteric agonists such as BQCA [1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, I] offer an attractive soln., being exquisitely M1-selective over other muscarinic subtypes.  A common difficulty with allosteric ligands is interpreting SAR, based on composite potency values derived in the presence of fixed concn. of agonist.  In reality these values encompass multiple pharmacol. parameters, each potentially and differentially sensitive to structural modification of the ligand.  We report novel BQCA analogs which appear to augment ligand affinity for the receptor (pKB), intrinsic efficacy (τB), and both binding (α) and functional (β) cooperativity with acetylcholine.  Ultimately, development of such enriched SAR surrounding allosteric modulators will provide insight into their mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigST7OJR7vbVg90H21EOLACvtfcHk0lgf4kv-n2KyaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D&md5=ab134e0b5400aa825916695eaf1203b1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400540b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400540b%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520profiling%2520of%2520analogues%2520of%2520benzyl%2520quinolone%2520carboxylic%2520acid%2520%2528BQCA%2529%2520as%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5151%26epage%3D5172%26doi%3D10.1021%2Fjm400540b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Watt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesterfield, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.1124/jpet.111.182063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1124%2Fjpet.111.182063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=21558436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFelsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=622-632&author=M.+L.+Wattauthor=D.+A.+Schoberauthor=S.+Hitchcockauthor=B.+Liuauthor=A.+K.+Chesterfieldauthor=D.+McKinzieauthor=C.+C.+Felder&title=Pharmacological+characterization+of+LY593093%2C+an+M1+muscarinic+acetylcholine+receptor-selective+partial+orthosteric+agonist&doi=10.1124%2Fjpet.111.182063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist</span></div><div class="casAuthors">Watt, Marla L.; Schober, Douglas A.; Hitchcock, Stephen; Liu, Bin; Chesterfield, Amy K.; McKinzie, David; Felder, Christian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">622-632</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Alzheimer's disease and schizophrenia are characterized by expression of psychotic, affective, and cognitive symptoms.  Currently, there is a lack of adequate treatment for the cognitive symptoms assocd. with these diseases.  Cholinergic signaling and, in particular, M1 muscarinic acetylcholine receptor (m1AChR) signaling have been implicated in the regulation of multiple cognitive domains.  Thus, the M1AChR has been identified as a therapeutic drug target for diseases, such as schizophrenia and Alzheimer's disease, that exhibit marked cognitive dysfunction as part of their clin. manifestation.  Unfortunately, the development of selective M1 agonist medications has not been successful, mostly because of the highly conserved orthosteric acetylcholine binding site among the five muscarinic receptor subtypes.  More recent efforts have focused on the development of allosteric M1AChR modulators that target regions of the receptor distinct from the orthosteric site that are less conserved between family members.  However, orthosteric and allosteric ligands may differentially modulate receptor function and ultimately downstream signaling pathways.  Thus, the need for highly selective M1AChR orthosteric agonists still exists, not only as a potential therapeutic but also as a pharmacol. tool to better understand the physiol. consequences of M1AChR orthosteric activation.  Here, we describe the novel, potent and selective M1AChR orthosteric partial agonist LY593093 [N-[(1R,2R)-6-({(1E)-1-[(4-fluorobenzyl)(methyl)amino]ethylidene})amino-2-hydroxy-2,3-dihydro-1H-inden-1-yl]biphenyl-4-carboxamide].  This compd. demonstrates modest to no activity at the other muscarinic receptor subtypes, stimulates Gαq-coupled signaling events as well as β-arrestin recruitment, and displays significant efficacy in in vivo models of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkikS6XzRybVg90H21EOLACvtfcHk0ljq31u5ZnyLew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFelsro%253D&md5=2bfc98e8243bcd4546c43625f542f41d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.182063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.182063%26sid%3Dliteratum%253Aachs%26aulast%3DWatt%26aufirst%3DM.%2BL.%26aulast%3DSchober%26aufirst%3DD.%2BA.%26aulast%3DHitchcock%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DChesterfield%26aufirst%3DA.%2BK.%26aulast%3DMcKinzie%26aufirst%3DD.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DPharmacological%2520characterization%2520of%2520LY593093%252C%2520an%2520M1%2520muscarinic%2520acetylcholine%2520receptor-selective%2520partial%2520orthosteric%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D622%26epage%3D632%26doi%3D10.1124%2Fjpet.111.182063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span><span class="refDoi"> DOI: 10.1074/jbc.M111.314278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1074%2Fjbc.M111.314278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=22086918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=650-659&author=M.+Canalsauthor=J.+R.+Laneauthor=A.+Wenauthor=P.+J.+Scammellsauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=A+Monod-Wyman-Changeux+mechanism+can+explain+G+protein-coupled+receptor+%28GPCR%29+allosteric+modulation&doi=10.1074%2Fjbc.M111.314278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation</span></div><div class="casAuthors">Canals, Meritxell; Lane, J. Robert; Wen, Adriel; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">650-659</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Monod-Wyman-Changeux (MWC) model was initially proposed to describe the allosteric properties of regulatory enzymes and subsequently extended to receptors.  Yet despite GPCRs representing the largest family of receptors and drug targets, no study has systematically evaluated the MWC mechanism as it applies to GPCR allosteric ligands.  We reveal how the recently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a strict, two-state MWC mechanism at the M1 muscarinic acetylcholine receptor (mAChR).  Despite having a low affinity for the M1 mAChR, BQCA demonstrated state dependence, exhibiting high pos. cooperativity with orthosteric agonists in a manner that correlated with efficacy but neg. cooperativity with inverse agonists.  The activity of BQCA was significantly increased at a constitutively active M1 mAChR but abolished at an inactive mutant.  Interestingly, BQCA possessed intrinsic signaling efficacy, ranging from near-quiescence to full agonism depending on the coupling efficiency of the chosen intracellular pathway.  This latter cellular property also detd. the difference in magnitude of pos. cooperativity between BQCA and the orthosteric agonist, carbachol, across pathways.  The lack of addnl., pathway-biased, allosteric modulation by BQCA was confirmed in genetically engineered yeast strains expressing different chimeras between the endogenous yeast Gpa1 protein and human Gα subunits.  These findings define a chem. biol. framework that can be applied to the study and classification of allosteric modulators across different GPCR families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrrH0vtUu5lbVg90H21EOLACvtfcHk0ljq31u5ZnyLew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVGh&md5=45d079afd141a137baf24fe171180124</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.314278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.314278%26sid%3Dliteratum%253Aachs%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DWen%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DA%2520Monod-Wyman-Changeux%2520mechanism%2520can%2520explain%2520G%2520protein-coupled%2520receptor%2520%2528GPCR%2529%2520allosteric%2520modulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D650%26epage%3D659%26doi%3D10.1074%2Fjbc.M111.314278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Shirey, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirk, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolle, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">14271</span><span class="NLM_x">–</span> <span class="NLM_lpage">14286</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3930-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1523%2FJNEUROSCI.3930-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=19906975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=14271-14286&author=J.+K.+Shireyauthor=A.+E.+Bradyauthor=P.+J.+Jonesauthor=A.+A.+Davisauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+B.+Jadhavauthor=U.+N.+Menonauthor=Z.+Xiangauthor=M.+L.+Watsonauthor=E.+P.+Christianauthor=J.+J.+Dohertyauthor=M.+C.+Quirkauthor=D.+H.+Snyderauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=M.+M.+Nicolleauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=A+selective+allosteric+potentiator+of+the+M1+muscarinic+acetylcholine+receptor+increases+activity+of+medial+prefrontal+cortical+neurons+and+restores+impairments+in+reversal+learning&doi=10.1523%2FJNEUROSCI.3930-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span></div><div class="casAuthors">Shirey, Jana K.; Brady, Ashley E.; Jones, Paulianda J.; Davis, Albert A.; Bridges, Thomas M.; Kennedy, J. Phillip; Jadhav, Satyawan B.; Menon, Usha N.; Xiang, Zixiu; Watson, Mona L.; Christian, Edward P.; Doherty, James J.; Quirk, Michael C.; Snyder, Dean H.; Lah, James J.; Levey, Allan I.; Nicolle, Michelle M.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14271-14286</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) may represent a viable target for treatment of disorders involving impaired cognitive function.  However, a major limitation to testing this hypothesis has been a lack of highly selective ligands for individual mAChR subtypes.  We now report the rigorous mol. characterization of a novel compd., benzylquinolone carboxylic acid (BQCA), which acts as a potent, highly selective pos. allosteric modulator (PAM) of the rat M1 receptor.  This compd. does not directly activate the receptor, but acts at an allosteric site to increase functional responses to orthosteric agonists.  Radioligand binding studies revealed that BQCA increases M1 receptor affinity for acetylcholine.  We found that activation of the M1 receptor by BQCA induces a robust inward current and increases spontaneous EPSCs in medial prefrontal cortex (mPFC) pyramidal cells, effects which are absent in acute slices from M1 receptor knock-out mice.  Furthermore, to det. the effect of BQCA on intact and functioning brain circuits, multiple single-unit recordings were obtained from the mPFC of rats that showed BQCA increases firing of mPFC pyramidal cells in vivo.  BQCA also restored discrimination reversal learning in a transgenic mouse model of Alzheimer's disease and was found to regulate non-amyloidogenic APP processing in vitro, suggesting that M1 receptor PAMs have the potential to provide both symptomatic and disease modifying effects in Alzheimer's disease patients.  Together, these studies provide compelling evidence that M1 receptor activation induces a dramatic excitation of PFC neurons and suggest that selectively activating the M1 mAChR subtype may ameliorate impairments in cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPy39j1-erZLVg90H21EOLACvtfcHk0lg-fTSZopJOfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL&md5=f9b017887d46ba34b925f747cea7ce3b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3930-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3930-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DShirey%26aufirst%3DJ.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DP.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DJadhav%26aufirst%3DS.%2BB.%26aulast%3DMenon%26aufirst%3DU.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DM.%2BL.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DQuirk%26aufirst%3DM.%2BC.%26aulast%3DSnyder%26aufirst%3DD.%2BH.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DNicolle%26aufirst%3DM.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520selective%2520allosteric%2520potentiator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520increases%2520activity%2520of%2520medial%2520prefrontal%2520cortical%2520neurons%2520and%2520restores%2520impairments%2520in%2520reversal%2520learning%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D14271%26epage%3D14286%26doi%3D10.1523%2FJNEUROSCI.3930-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">6067</span><span class="NLM_x">–</span> <span class="NLM_lpage">6079</span><span class="refDoi"> DOI: 10.1074/jbc.M113.539080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1074%2Fjbc.M113.539080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=6067-6079&author=A.+Abdul-Ridhaauthor=L.+Lopezauthor=P.+Keovauthor=D.+M.+Thalauthor=S.+N.+Mistryauthor=P.+M.+Sextonauthor=J.+R.+Laneauthor=M.+Canalsauthor=A.+Christopoulos&title=Molecular+determinants+of+allosteric+modulation+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M113.539080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.539080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.539080%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKeov%26aufirst%3DP.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DMolecular%2520determinants%2520of%2520allosteric%2520modulation%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D6067%26epage%3D6079%26doi%3D10.1074%2Fjbc.M113.539080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saffold, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span> </span><span class="NLM_article-title">Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.bmcl.2014.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=24485781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1417-1420&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=J.+R.+Saffoldauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=D.+C.+Beshore&title=Identification+of+a+methoxynaphthalene+scaffold+as+a+core+replacement+in+quinolizidinone+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2014.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators</span></div><div class="casAuthors">Kuduk, Scott D.; Di Marco, Christina N.; Saffold, Jonathan R.; Ray, William J.; Ma, Lei; Wittmann, Marion; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.; Beshore, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1417-1420</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of methoxynaphthalene amides I [R = Me, Cl, Et, etc.] were prepd. and evaluated as alternatives to quinolizidinone amide M1 pos. allosteric modulators.  A methoxy group was optimal for M1 activity and addressed key P-gp issues present in the aforementioned quinolizidinone amide series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHiLV64XSfi7Vg90H21EOLACvtfcHk0lg-fTSZopJOfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cmsbk%253D&md5=c9483236a21b24bfaa05a8c649cb5f6e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DSaffold%26aufirst%3DJ.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DIdentification%2520of%2520a%2520methoxynaphthalene%2520scaffold%2520as%2520a%2520core%2520replacement%2520in%2520quinolizidinone%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1417%26epage%3D1420%26doi%3D10.1016%2Fj.bmcl.2014.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Eckhardt, M.; Himmelsbach, F.</span><span> </span><span class="NLM_article-title">Oxazinanone derivatives as 11β-HSD1 inhibitors and their preparation and use for the treatment of 11β-HSD1-mediated diseases</span>. WO2010089303A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Eckhardt&author=F.+Himmelsbach&title=Oxazinanone+derivatives+as+11%CE%B2-HSD1+inhibitors+and+their+preparation+and+use+for+the+treatment+of+11%CE%B2-HSD1-mediated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEckhardt%26aufirst%3DM.%26atitle%3DOxazinanone%2520derivatives%2520as%252011%25CE%25B2-HSD1%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%252011%25CE%25B2-HSD1-mediated%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Penfold, B. R.</span><span> </span><span class="NLM_article-title">The electron distribution in crystalline α-pyridone</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1107/S0365110X5300168X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1107%2FS0365110X5300168X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1953&pages=591-600&author=B.+R.+Penfold&title=The+electron+distribution+in+crystalline+%CE%B1-pyridone&doi=10.1107%2FS0365110X5300168X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0365110X5300168X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0365110X5300168X%26sid%3Dliteratum%253Aachs%26aulast%3DPenfold%26aufirst%3DB.%2BR.%26atitle%3DThe%2520electron%2520distribution%2520in%2520crystalline%2520%25CE%25B1-pyridone%26jtitle%3DActa%2520Crystallogr.%26date%3D1953%26volume%3D6%26spage%3D591%26epage%3D600%26doi%3D10.1107%2FS0365110X5300168X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yang, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, R. M.</span><span> </span><span class="NLM_article-title">Charge density study of 2-pyridone</span> <span class="citation_source-journal">Acta Crystallogr., Sect. B: Struct. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span><span class="refDoi"> DOI: 10.1107/S0108768198006545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1107%2FS0108768198006545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=9880899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlWmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=912-920&author=H.+W.+Yangauthor=R.+M.+Craven&title=Charge+density+study+of+2-pyridone&doi=10.1107%2FS0108768198006545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Charge density study of 2-pyridone</span></div><div class="casAuthors">Yang, H. W.; Craven, R. M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">B54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">912-920</span>CODEN:
                <span class="NLM_cas:coden">ASBSDK</span>;
        ISSN:<span class="NLM_cas:issn">0108-7681</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">The crystal structure of 2-pyridone was redetd. from high-resoln. x-ray data collected at 123 K.  The mol. is in the lactam form.  Bond lengths (cor. for rigid-body libration) and angles were detd. with s.u.'s of 0.001 Å and 0.1°, resp.  The H-bonded cyclic dimers which occur in the vapor and in soln. are absent in the crystal where mols. are linked by N-II···O H bonds to form puckered chains.  There also appears to be a weaker C-H···O interaction (H···O, 2.57 Å) and weak C-H···π or van der Waals interactions occurring on both sides of the pyridone ring.  Following a refinement of the structure assuming Stewart's rigid pseudo-atom model, the electronic charge d. distribution n the crystal and its Laplacian were calcd. for atoms at rest.  The total electrostatic potential was mapped for an isolated mol. and the mol. dipole moment was detd. [8.8(19) D; 1-dimensional ≃ 3.33564 × 10-30 C m].  Crit. points in the electron d. were located for the bonds within the mol. and for the mol. interactions cited above.  For the C-H···π interactions, only the spherical components of the valence d. for the pyridone ring atoms contribute effectively at the crit. points.  Hence, these may be better described as van der Waals interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm47xAbt5E_7Vg90H21EOLACvtfcHk0lhR-2_O5VivEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlWmsQ%253D%253D&md5=3484b61d5f4740a3da9c0d5d4e265566</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0108768198006545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108768198006545%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BW.%26aulast%3DCraven%26aufirst%3DR.%2BM.%26atitle%3DCharge%2520density%2520study%2520of%25202-pyridone%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%26date%3D1998%26volume%3D54%26spage%3D912%26epage%3D920%26doi%3D10.1107%2FS0108768198006545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Aksnes, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kryvi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöstrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span> </span><span class="NLM_article-title">Substituent and solvent effects in the proton magnetic resonance (PMR) spectra of six 2-substituted pyridines</span> <span class="citation_source-journal">Acta Chem. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2266</span><span class="refDoi"> DOI: 10.3891/acta.chem.scand.26-2255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.3891%2Facta.chem.scand.26-2255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=2255-2266&author=D.+W.+Aksnesauthor=H.+Kryviauthor=O.+Samuelsonauthor=E.+Sj%C3%B6strandauthor=S.+Svensson&title=Substituent+and+solvent+effects+in+the+proton+magnetic+resonance+%28PMR%29+spectra+of+six+2-substituted+pyridines&doi=10.3891%2Facta.chem.scand.26-2255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.26-2255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.26-2255%26sid%3Dliteratum%253Aachs%26aulast%3DAksnes%26aufirst%3DD.%2BW.%26aulast%3DKryvi%26aufirst%3DH.%26aulast%3DSamuelson%26aufirst%3DO.%26aulast%3DSj%25C3%25B6strand%26aufirst%3DE.%26aulast%3DSvensson%26aufirst%3DS.%26atitle%3DSubstituent%2520and%2520solvent%2520effects%2520in%2520the%2520proton%2520magnetic%2520resonance%2520%2528PMR%2529%2520spectra%2520of%2520six%25202-substituted%2520pyridines%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1972%26volume%3D26%26spage%3D2255%26epage%3D2266%26doi%3D10.3891%2Facta.chem.scand.26-2255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Forlani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todesco, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monari, M.</span><span> </span><span class="NLM_article-title">Reinvestigation of the tautomerism of some substituted 2-hydroxypyridines</span> <span class="citation_source-journal">ARKIVOC</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=198-215&author=L.+Forlaniauthor=G.+Cristoniauthor=C.+Bogaauthor=P.+E.+Todescoauthor=E.+Del+Vecchioauthor=S.+Selvaauthor=M.+Monari&title=Reinvestigation+of+the+tautomerism+of+some+substituted+2-hydroxypyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForlani%26aufirst%3DL.%26aulast%3DCristoni%26aufirst%3DG.%26aulast%3DBoga%26aufirst%3DC.%26aulast%3DTodesco%26aufirst%3DP.%2BE.%26aulast%3DDel%2BVecchio%26aufirst%3DE.%26aulast%3DSelva%26aufirst%3DS.%26aulast%3DMonari%26aufirst%3DM.%26atitle%3DReinvestigation%2520of%2520the%2520tautomerism%2520of%2520some%2520substituted%25202-hydroxypyridines%26jtitle%3DARKIVOC%26date%3D2002%26spage%3D198%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lhR-2_O5VivEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1016/S0165-6147(98)01240-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2FS0165-6147%2898%2901240-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=351-357&author=A.+Christopoulos&title=Assessing+the+distribution+of+parameters+in+models+of+ligand-receptor+interaction%3A+to+log+or+not+to+log&doi=10.1016%2FS0165-6147%2898%2901240-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2898%2901240-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252898%252901240-1%26sid%3Dliteratum%253Aachs%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAssessing%2520the%2520distribution%2520of%2520parameters%2520in%2520models%2520of%2520ligand-receptor%2520interaction%253A%2520to%2520log%2520or%2520not%2520to%2520log%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D351%26epage%3D357%26doi%3D10.1016%2FS0165-6147%2898%2901240-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yang, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunda, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolt, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.bmcl.2009.11.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=531-536&author=F.+V.+Yangauthor=W.+D.+Shipeauthor=J.+L.+Bundaauthor=M.+B.+Noltauthor=D.+D.+Wisnoskiauthor=Z.+Zhaoauthor=J.+C.+Barrowauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=G.+D.+Hartmanauthor=C.+W.+Lindsley&title=Parallel+synthesis+of+N-biaryl+quinolone+carboxylic+acids+as+selective+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2009.11.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.100%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%2BV.%26aulast%3DShipe%26aufirst%3DW.%2BD.%26aulast%3DBunda%26aufirst%3DJ.%2BL.%26aulast%3DNolt%26aufirst%3DM.%2BB.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DParallel%2520synthesis%2520of%2520N-biaryl%2520quinolone%2520carboxylic%2520acids%2520as%2520selective%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D531%26epage%3D536%26doi%3D10.1016%2Fj.bmcl.2009.11.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Liljebris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazuk, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasdale, J. E.</span><span> </span><span class="NLM_article-title">Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: Identification of a tetrazole-containing inhibitor with cellular activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1785</span><span class="NLM_x">–</span> <span class="NLM_lpage">1798</span><span class="refDoi"> DOI: 10.1021/jm011100y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011100y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1785-1798&author=C.+Liljebrisauthor=S.+D.+Larsenauthor=D.+Oggauthor=B.+J.+Palazukauthor=J.+E.+Bleasdale&title=Investigation+of+potential+bioisosteric+replacements+for+the+carboxyl+groups+of+peptidomimetic+inhibitors+of+protein+tyrosine+phosphatase+1B%3A+Identification+of+a+tetrazole-containing+inhibitor+with+cellular+activity&doi=10.1021%2Fjm011100y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm011100y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011100y%26sid%3Dliteratum%253Aachs%26aulast%3DLiljebris%26aufirst%3DC.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DOgg%26aufirst%3DD.%26aulast%3DPalazuk%26aufirst%3DB.%2BJ.%26aulast%3DBleasdale%26aufirst%3DJ.%2BE.%26atitle%3DInvestigation%2520of%2520potential%2520bioisosteric%2520replacements%2520for%2520the%2520carboxyl%2520groups%2520of%2520peptidomimetic%2520inhibitors%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%253A%2520Identification%2520of%2520a%2520tetrazole-containing%2520inhibitor%2520with%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1785%26epage%3D1798%26doi%3D10.1021%2Fjm011100y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span><span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lgLJYN7pNhlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Gonzalez, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksterowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2963</span><span class="NLM_x">–</span> <span class="NLM_lpage">2988</span><span class="refDoi"> DOI: 10.1021/jm401911v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401911v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2963-2988&author=A.+Z.+Gonzalezauthor=Z.+Liauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=J.+Duquetteauthor=J.+Eksterowiczauthor=B.+M.+Foxauthor=J.+Fuauthor=X.+Huangauthor=J.+Houzeauthor=L.+Jinauthor=Y.+Liauthor=Y.+Lingauthor=M.-C.+Loauthor=A.+M.+Longauthor=L.+R.+McGeeauthor=J.+McIntoshauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=Y.+Rewauthor=A.+Y.+Saikiauthor=P.+Shafferauthor=S.+Wortmanauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=S.+H.+Olsonauthor=D.+Sunauthor=J.+C.+Medina&title=Novel+inhibitors+of+the+MDM2-p53+interaction+featuring+hydrogen+bond+acceptors+as+carboxylic+acid+isosteres&doi=10.1021%2Fjm401911v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres</span></div><div class="casAuthors">Gonzalez, Ana Z.; Li, Zhihong; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chow, David; Duquette, Jason; Eksterowicz, John; Fox, Brian M.; Fu, Jiasheng; Huang, Xin; Houze, Jonathan; Jin, Lixia; Li, Yihong; Ling, Yun; Lo, Mei-Chu; Long, Alexander M.; McGee, Lawrence R.; McIntosh, Joel; Oliner, Jonathan D.; Osgood, Tao; Rew, Yosup; Saiki, Anne Y.; Shaffer, Paul; Wortman, Sarah; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Zhao, Xiaoning; Zhou, Jing; Olson, Steven H.; Sun, Daqing; Medina, Julio C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2963-2988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction.  These inhibitors have in common a carboxylic acid moiety that engages in an electrostatic interaction with MDM2-His96.  Our continued search for potent and diverse inhibitors led to the discovery of novel replacements for these acids uncovering new interactions with the MDM2 protein.  In particular, using pyridine or thiazole as isosteres of the carboxylic acid moiety resulted in very potent analogs.  From these, AM-6761 (I) emerged as a potent inhibitor with remarkable biochem. (HTRF IC50 = 0.1 nM) and cellular potency (SJSA-1 EdU IC50 = 16 nM), as well as favorable pharmacokinetic properties.  Compd. I also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED50 of 11 mg/kg.  Optimization efforts toward the discovery of these inhibitors as well as the new interactions obsd. with the MDM2 protein are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnAXnJUWxJHbVg90H21EOLACvtfcHk0lgLJYN7pNhlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqsb4%253D&md5=7e12d238f454f1d1c91493a2fd48847d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm401911v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401911v%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DWortman%26aufirst%3DS.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DNovel%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%2520featuring%2520hydrogen%2520bond%2520acceptors%2520as%2520carboxylic%2520acid%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2963%26epage%3D2988%26doi%3D10.1021%2Fjm401911v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Huynh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span> </span><span class="NLM_article-title">Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8196</span><span class="NLM_x">–</span> <span class="NLM_lpage">8200</span><span class="refDoi"> DOI: 10.1021/jm401032k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401032k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8196-8200&author=T.+Huynhauthor=C.+Valantauthor=I.+T.+Crosbyauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=B.+Capuano&title=Probing+structural+requirements+of+positive+allosteric+modulators+of+the+M4+muscarinic+receptor&doi=10.1021%2Fjm401032k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Probing Structural Requirements of Positive Allosteric Modulators of the M4 Muscarinic Receptor</span></div><div class="casAuthors">Huynh, Tracey; Valant, Celine; Crosby, Ian T.; Sexton, Patrick M.; Christopoulos, Arthur; Capuano, Ben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8196-8200</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M4 mAChR is implicated in several CNS disorders and possesses an allosteric binding site for which ligands modulating the affinity and/or efficacy of ACh may be exploited for selective receptor targeting.  The authors report the synthesis of a focused library of putative M4 PAMs derived from VU0152100 and VU10005.  These compds. investigate the pharmacol. effects of previously identified methoxy and fluoro substituents, providing useful ests. of affinity, cooperativity, and direct agonist properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xoKOwOxTMLVg90H21EOLACvtfcHk0liOgO8eLDJRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrvJ&md5=0bbb4387b9ebdca5d8b00d6cd7b9d3a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm401032k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401032k%26sid%3Dliteratum%253Aachs%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DCrosby%26aufirst%3DI.%2BT.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DProbing%2520structural%2520requirements%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520M4%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8196%26epage%3D8200%26doi%3D10.1021%2Fjm401032k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">Spectra available in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">May, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=17009927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1-51&author=L.+T.+Mayauthor=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+G+protein-coupled+receptors&doi=10.1146%2Fannurev.pharmtox.47.120505.105159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of G protein-coupled receptors</span></div><div class="casAuthors">May, Lauren T.; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a significant growth in the identification of allosteric modulators of G protein-coupled receptors (GPCRs), i.e., ligands that interact with binding sites that are topog. distinct from the orthosteric site recognized by the receptor's endogenous agonist.  Because of their ability to modulate receptor conformations in the presence of orthosteric ligand, allosteric modulators can "fine-tune" classical pharmacol. responses.  This is advantageous in terms of a potential for engendering greater GPCR subtype-selectivity, but represents a significant challenge for detecting and validating allosteric behaviors.  Although allosteric sites need not have evolved to accommodate endogenous ligands, there are a no. of examples of where such modulators have been shown to contribute to physiol. or pathophysiol. processes.  Studies are also beginning to unravel the structural basis of allosteric modulation of GPCRs.  It remains to be detd. whether such modulation represents interactions within monomers vs. across dimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6rgFXhej3ibVg90H21EOLACvtfcHk0liOgO8eLDJRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1altr0%253D&md5=848fa85abdfb3b40834887416479edec</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105159%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D1%26epage%3D51%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Leach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=10.1016%2Fj.tips.2007.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=17629965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=382-389&author=K.+Leachauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+GPCR+modulators%3A+taking+advantage+of+permissive+receptor+pharmacology&doi=10.1016%2Fj.tips.2007.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology</span></div><div class="casAuthors">Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-389</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The past decade has witnessed a dramatic increase in the identification of allosteric modulators of G-protein-coupled receptor (GPCR) activity.  Concomitantly, several new perspectives and hypotheses regarding the way ligands regulate GPCR signaling have also emerged.  Here, we briefly discuss how the concepts of collateral efficacy and permissive agonism-antagonism intersect the field of allosteric GPCR modulation.  Despite the challenges assocd. with detecting and quantifying the myriad of possible allosteric effects on GPCR activity, it is proposed that allosteric ligands offer the exciting prospect of engendering stimulus-bias in orthosteric ligand signaling, thus paving the way for not only receptor-selective but also signaling-pathway-selective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpHb_QsIW3TbVg90H21EOLACvtfcHk0liOgO8eLDJRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWltLs%253D&md5=943da2312e7b136cb594ba0346e00301</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DK.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520GPCR%2520modulators%253A%2520taking%2520advantage%2520of%2520permissive%2520receptor%2520pharmacology%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D382%26epage%3D389%26doi%3D10.1016%2Fj.tips.2007.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01562">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41075"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01562">10.1021/acs.jmedchem.5b01562</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Representative NMR experiments of the compound <b>8p</b> in DMSO-<i>d</i><sub>6</sub> and CDCl<sub>3</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_001.pdf">jm5b01562_si_001.pdf (350.24 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01562/suppl_file/jm5b01562_si_002.csv">jm5b01562_si_002.csv (4.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-1%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01562%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01562" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998ef058a824cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
